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& H A P  T E R 1
General introduction: 
DC-SIGN and LFA-1 ”a battle for ligand”
Diederik A. Bleijs, Teunis B.H. Geijtenbeek, Carl G. Figdor, and Yvette van Kooyk
From Department of Tumor Immunology, UMC Nijmegen, The Netherlands

General introduction
Abstract
The intercellular adhesion molecules (ICAMs) play a prominent role in the regulating 
migration and activation of both dendritic cells (DC) and T lymphocytes in the immune 
system. Recent observations demonstrated that both LFA-1 and DC-SIGN, two structurally 
unrelated adhesion receptors, regulate leukocyte and dendritic cell function by binding of the 
same ICAMs. Here, we focus on the structure/function relationship between DC-SIGN and 
LFA-1 to obtain insight in their action that tunes both DC and T cell migration and activation 
to control immunity.
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Introduction
The immune system is in constant alert to defend itself against viruses, bacteria and other 
pathogens. Cell-cell interactions between dendritic cells (DC), T cells, as well as endothelial 
cells, that regulate the mobility of leukocytes through blood and lymph, are crucial to all 
immunological processes. DCs, the sentinels of the immune system, are the first immune cells 
to come in contact with invading pathogens. They efficiently capture and process antigen, 
migrate to draining lymph nodes to present pathogens as antigenic peptides to T cells (Hart, 
1997; Banchereau and Steinman, 1998). In this process migration is essential, since DCs have 
to travel from their nursery to the inflamed tissue where they sample antigen and subsequently 
move to the lymph nodes where T cells reside. Arriving in the lymph node DC-T cell 
clustering enables scanning of the presented foreign peptides by T cells and recognition of 
specific peptides triggers T cell activation. These primed T cells migrate via the blood to the 
site of infection where they perform their immune function (Sallusto and Lanzavecchia, 
1999). Migration of DC and T cells is a strictly coordinated event regulated by chemokines 
and cytokines, together with the expression of adhesion molecules on DCs, T cells, and 
endothelial cells. The presence and differential expression of the intercellular adhesion 
molecules (ICAM) on endothelial cells and their counter structures on DCs (DC-SIGN) or T 
cells (LFA-1), point to a central role for these structures in migration and DC-T cell 
activation. For a long time the ß2-integrin lymphocyte function-associated antigen-1 (LFA-1) 
has been considered to be the adhesion receptor for ICAM-1 (Rothlein et al., 1986; Marlin 
and Springer, 1987), ICAM-2 (Staunton et al., 1989; de Fougerolles et al., 1991), and ICAM- 
3 (Fawcett et al., 1992; de Fougerolles et al., 1993). Recently, a novel DC-specific adhesion 
receptor (DC-SIGN) has been identified, which binds with high affinity ICAM-2 and -3 
(Geijtenbeek et al., 2000b, 2000c). Intriguingly, despite the fact that DC-SIGN and LFA-1 
belong to structurally different families and bind different sites in the ICAMs, they share 
some similar characteristics such as the necessity of divalent cation-binding. This ensemble of 
highly regulated cell and tissue specific expression of DC-SIGN, LFA-1 and the ICAMs, 
together with the differences in affinities that DC-SIGN and LFA-1 exhibit for their counter 
structures under shear stress conditions, determine the contribution of each of these adhesion 
receptors at specific moments during the onset of an immune response.
The InterCellular Adhesion Molecules (ICAM)
The ICAMs are members of the immunoglobin (Ig)-superfamily, which form together with 
the cadherins, selectins, and integrins the adhesion receptor family (Springer, 1990; Hynes, 
1999). To date, five ICAMs have been identified that share characteristic features such as a 
structural identity of large extracellular Ig-like domains that are heavily glycosylated and a 
short cytoplasmic tail. ICAM-1 (CD54) has been first identified in 1986 through inhibition of 
leukocyte adhesion by monoclonal antibodies (Rothlein et al., 1986). The tissue distribution 
of ICAM-1 is very broad. Inflammatory cytokines strongly upregulate ICAM-1 expression on
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resting leukocytes, epithelial cells, as well as endothelial cells. ICAM-2 (CD102) however is 
constitutively expressed on the endothelium of blood and lymphatic vessels, as well as on 
high endothelial vascular (HEV) cells and leukocytes. ICAM-2 plays a central role in 
mediating lymphocyte recirculation as well as homing into secondary lymphoid tissues (de 
Fougerolles et al., 1991). ICAM-3 (CD50) is the major ICAM expressed by resting leukocytes 
and is important to initiate an immune response (de Fougerolles et al., 1993). ICAM-3 
expression is absent from endothelial cells and expression is not sensitive to inflammatory 
mediators. The other two members, ICAM-4 and ICAM-5, are expressed on the red cell 
lineage of hematopoietic cells and in the brain, respectively, but their physiological function 
in immunity remains vague (Bailly et al., 1994; Mizuno et al., 1997). Despite being part of a 
family, the homology between the Ig-like domains of the ICAMs is surprisingly low. This 
suggests that both their nature and binding characteristics do not have to be related. Their 
function in the immune system is to regulate cell adhesion through interactions with their 
receptors. ICAM-1, ICAM-2, and ICAM-3 interact with the ß2 integrin LFA-1 (although at 
different affinities) whereas ICAM-2 and ICAM-3 also interact with the novel identified 
adhesion receptor, the C-type lectin DC-SIGN (Fig. 1).
The ICAM receptors DC-SIGN and LFA-1
Expression. The extensively-studied ß2-integrin LFA-1 (aLß2; CD11a/CD18) is exclusively 
expressed by leukocytes, including T cells and DCs (Hynes, 1987; Humphries, 2000; 
Geijtenbeek et al., 2000b). LFA-1 mediates several adhesive interactions within the immune 
system, including DC-T cell, B-T cell, T cell-target cell interactions, as well as leukocyte 
interactions with the endothelium and transendothelial migration of leukocytes (Krensky et 
al., 1983; Martz, 1987; van Kooyk et al., 1993; Imhof and Dunon, 1995). The importance of 
LFA-1 in the immune system is clearly illustrated by the leukocyte adhesion deficiency 
(LAD) syndrome, which is caused by a defect in the ß2 subunit resulting in loss of LFA-1 
expression (Arnaout, 1990). Patients die at early age of recurrent bacterial infections due to 
impaired leukocyte adhesive functions.
The DC-specific C-type lectin DC-SIGN (CD209), originally cloned from a placental 
library through its capacity to bind to the HIV-1 envelope glycoprotein gp120 (Curtis et al., 
1992), was recently re-discovered as a cell adhesion receptor with a DC restricted expression 
(Geijtenbeek et al., 2000a, 2000b). In vivo, DC-SIGN is expressed by interdigitating cells in 
peripheral tissue as well as on mature DC present in lymphoid tissues such as lymph nodes, 
tonsils, and spleen (Geijtenbeek et al., 2000b). Two DC-SIGN positive DC precursor 
populations that differ in CD 14 expression were found to be present in peripheral blood 
(Geijtenbeek et al., 2000c). Generation of in vitro obtained DC demonstrate that DC-SIGN is 
rapidly upregulated on monocytes upon differentiation in vitro with the cytokines IL-4 and 
GM-CSF. Further in vitro maturation of DCs with TNFa reduces to some extent DC-SIGN 
expression (Geijtenbeek et al., 2000b). DC-SIGN is not expressed on Follicular DC or 
lymphoid derived DC nor on CD1a+ Langerhans cells in the epidermis. Expression of DC-
13
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SIGN in peripheral mucosal tissues has been detected in rectum, cervix, and uterus thereby 
illustrating the involvement of DC-SIGN in HIV transmission (Geijtenbeek et al., 2000a).
ICAM-3
Figure 1. The intercellular adhesion molecules and their receptors LFA-1 (CD11a/CD18) 
and DC-SIGN (CD209). LFA-1 (aLß2) is a heterodimeric type I  transmembrane protein. The 
I  domain of LFA-1 specifically binds to the first NH2-like domain of ICAM-1, ICAM-2, or 
ICAM-3 with respectively, high, medium, and low affinity (indicated by arrows). DC-SIGN, a 
type II transmembrane mannose binding C-type lectin, consist o f a CRD region that binds to 
the second NH2-like domain of ICAM-2 and ICAM-3, and contains seven complete and one 
incomplete tandem repeat. ICAM-1, -2, and -3 are type I  transmembrane glycoproteins 
belonging to the Ig-superfamily that have 5, 2, and 5 Ig-like domains, respectively For each 
Ig-like domain of ICAM-2 and -3, the percentage homology with the corresponding domains 
of ICAM-1 is indicated. MIDAS motif: metal ion dependent adhesion site. EF-hands: EF-hand 
like motifs, TM: transmembrane.
Structure. LFA-1, a type I transmembrane protein, is composed of an aL and a ß2 subunit 
(Fig. 1) (Hynes, 1987). It is composed of a large extracellular part and a relative small 
intracellular part without any known intrinsic signaling activities. Activation of LFA-1 and 
adhesion is regulated by the intracellular domain to which a number of signaling and
14
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cytoskeletal proteins associate (van Kooyk and Figdor, 2000; Liu et al., 2000; Bleijs et al., 
2001). Activation of LFA-1 on resting T cells is regulated through T cell receptor (TCR) 
triggering, which induces a conformational changes allowing avidity and affinity alterations 
in LFA-1 (van Kooyk et al., 1989; Figdor et al., 1990; Andrew et al., 1993; Constantin et al., 
2000; Lu et al., 2001b). The major ICAM binding site is formed by the 200 amino acid long I 
domain of LFA-1 found in the extracellular part of LFA-1 a  chain (Randi and Hogg, 1994).
Within this I domain harbors the metal ion dependent adhesion site (MIDAS), which upon
2+binding Mg directly coordinates ligand binding (Fig. 2) (Lee et al., 1995; McDowall et al., 
1998; Binnerts and van Kooyk, 1999).
In contrast, DC-SIGN is a type II transmembrane protein which contains a mannose 
binding C-type lectin-domain that includes carbohydrate-recognition domain (CRD) that
forms the ligand binding site (Curtis et al., 1992; Geijtenbeek et al., 2000b). Ligand binding
2+of DC-SIGN is activation independent but depends on the binding of two Ca ions to the
2+CRD. One of these bound Ca ions forms the core of the sugar binding site and directly 
coordinates ligand binding, whereas the second ion is required to stabilize the binding pocket 
(Fig. 2) (Drickamer, 1999). The CRD motif is a folded protein module, found in all C-type 
lectins, and characterized by the presence of several invariant and highly conserved residues. 
Interestingly, other C-type lectins cannot bind ICAM-2 and -3 indicating that also other amino 
acids within the C-type lectin domain must contribute to ligand binding. Thus, in spite of the
structural differences between LFA-1 and DC-SIGN, both receptors show similarities in that
2+  2+they require divalent cations Mg and Ca , for LFA-1 and DC-SIGN respectively, to bind 
ICAMs .
Ligand binding. Many adhesion blocking anti-LFA-1 antibodies have been mapped to the I 
domain. ICAM-1, -2, and -3 bind to distinct, but partly overlapping regions within the I 
domain, which enables LFA-1 to recognize and react to the different ligands (Binnerts and 
van Kooyk, 1999; Lu et al., 2001a, 2001b). LFA-1 binds with high affinity ICAM-1, less 
strong ICAM-2, and very weak ICAM-3 (Binnerts et al., 1994; Bleijs et al., 1999). This 
variation in affinity is likely due to differences between Ig-like domains of the ICAMs and to 
differences in the binding sites in LFA-1.
Adhesion blocking antibodies against DC-SIGN recognize the C-type lectin domain of 
DC-SIGN (Geijtenbeek, personal communication), and map closely to the CRD motif in DC- 
SIGN that coordinates binding of Ca2+ ions and ligand. DC-SIGN binds with very high 
affinity ICAM-2 as well as ICAM-3 (Geijtenbeek et al., 2000c). The observation that 
mannose-like carbohydrates can block DC-SIGN binding to ICAM-2 and -3, illustrates that 
DC-SIGN recognizes mannose carbohydrate structures. However, analysis by site-directed 
mutagenesis in ICAM-3 indicates that also protein based structures are required for binding 
the ICAMs (Gejjtenbeek, personal communication). Deletion mutagenesis of ICAM-3 
revealed that DC-SIGN interacts with the second domain of ICAM-3, whereas the first NH2- 
terminal Ig-like domains of all three ICAMs mediate binding to LFA-1 (Staunton et al., 1990; 
Holness et al., 1995; Gahmberg et al., 1997).
15
Chapter 1
The fact that two structurally distinct adhesion receptors such as DC-SIGN and LFA-1 
both recognize ICAM-2 and ICAM-3, suggests that the overall architecture of their binding 
domains could be similar. Comparison the overall amino acid sequence of the I-domain of 
LFA-1 with that of the CRD motif of DC-SIGN reveals little homology. However, some of 
the cation binding sequences are virtually identical positioned when comparing the I domain 
of LFA-1 and the CRD of DC-SIGN (Weis et al., 1998; Binnerts and van Kooyk, 1999; 
Drickamer, 1999). These findings indicate that the cation binding sites of LFA-1 and DC- 
SIGN are similar (Fig. 2), and explain why both molecules bind to ICAM-2 and ICAM-3.
The finding that both LFA-1/ICAM-1 and DC-SIGN/ICAM-2 interactions resist shear 
stress indicates that both interactions are important in T cell as well as and DC interactions 
with endothelial cells, regulating transendothelial migration under shear (Sigal et al., 2000; 
Geijtenbeek et al., 2000c; Constantin et al., 2000). By contrast, DC-SIGN/ICAM-3 
interactions, although of high affinity cannot resist any shear stress, illustrating major 
differences in receptor-ligand usage depending on shear-dependent cellular and shear- 
independent cellular contacts like DC-T cell interactions in lymphoid tissues.
Regulation of DC and T cell trafficking by DC-SIGN, LFA-1, and 
ICAMs
The continuous mobility of the immune cells back and forth between blood-tissue-lymph- and 
lymphoid tissues during homeostasis or inflammation, is a highly dynamic process regulated 
by many factors such as pathogen, cytokines/chemokines and adhesion receptors.
Step 1: Progenitor DCs migrate from the blood stream into the tissues under the influence 
of constitutively expressed cytokines and chemokines. Here they develop into immature 
dendritic cells which upon infection are guided and activated by the released of inflammatory 
cytokines and chemokines like SDF-1, MIP-1a, or RANTES. At the same time additional 
antigen presenting cells are recruited by expression of adhesion receptors and chemokines on 
the endothelium. (Sallusto and Lanzavecchia, 1999; Dieu-Nosjean et al., 1999; Geijtenbeek et 
al., 2000c). Transendothelial migration, also known as the multistep paradigm (Springer,
1994), can only occur when cells interact with the endothelial vessel wall under shear. This 
initial step to slow down the speed of the cells in the blood stream by tethering and rolling on 
the endothelium and is normally achieved by expression of selectins that recognize 
carbohydrate structures (Vestweber and Blanks, 1999). Tethering of progenitors DCs is 
mediated through the interaction of DC-SIGN with ICAM-2 expressed on endothelial cells 
which can resist shear stress (Fig. 3) (Nortamo et al., 1991; Geijtenbeek et al., 2000c). DC- 
SIGN/ICAM-2-mediated rolling and chemokine signals induce activation of integrins (LFA-
1) leading to an arrest of the DC. Upregulation of ICAM-1 expression on the endothelial cells 
by inflammatory mediators result in further adhesion strengthening (Geijtenbeek et al., 
2000c), indicating that for DC transendothelial migration sequential DC-SIGN/ICAM-2 and 
LFA-1/ICAM-1 interactions are both needed. Finally, the local production of chemokines will
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attract only those DCs that express the appropriate chemokine receptors, such as CCR1 and 
CCR5 (Figure 3, step 1).
Figure 2. Similar sequences are present at the MIDAS site in the LFA-11 domain and the 
CRD in DC-SIGN, that coordinate Mg2+ and Ca2+, respectively. The MIDAS motif 
containing residues Asp137, Ser139, Ser141, Thr206, and Asp239 are involved in coordinating the 
Mg2+ ion and directly ligand binding (ICAM-1, -2, and -3). The same architecture is present 
in the CRD of DC-SIGN. Residues Glu347, Asn349, Glu354, Asn365, and Asp366 organize the 
second Ca2+ ion and thereby coordinate ICAM-2 and -3 binding. The first Ca2+ ion stabilizes 
the structure ofthe C-type lectin domain.
17
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Figure 3. Dendritic cell (DC) and T cell trafficking regulated by the ICAMs. DCs precursor 
are attracted by cytokines and chemokines from blood to tissue. During migration progenitor 
DCs expressing DC-SIGN roll on the endothelium via DC-SIGN/ICAM-2, whereas they come 
to arrest by LFA-1/ICAM-1 interactions. Transendothelial migration takes place and the DCs 
capture antigen and start to migrate to the lymph node via the lymph vessel guided by 
chemokines. During migration DC mature and arrive in the lymph node where DCs adhere to
18
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the naive T cell via DC-SIGN/ICAM-3 interaction. The formation of low-avidity LFA- 
1/ICAM-1 interactions is thereby facilitated. After full TCR ligation, LFA-1 on the T cells is 
further activated and stabilizes the immunological junction through the high avidity LFA- 
1/ICAM-1 and CD2/LFA-3 interaction. Primed T cells migrate via the blood system to the 
infection site guided by released chemokines and cytokines. The shear stress dependent 
rolling of the T cell is initiated via selectins and subsequent LFA-1 activation and LFA- 
1/ICAM-1 interactions brings cells to arrest. Subsequent transendothelial migration of the T 
cells takes place to finally eradicate the infection.
Antigen uptake is associated with maturation of DC and with phenotypical alterations of 
DC that facilitate migration against inflammatory chemokine gradients -from peripheral tissue 
into lymphoid organs via the lymphatic vessels- , regulated by the production of chemokines 
of the CXC family (Sallusto and Lanzavecchia, 1999; Hartgers et al., 2000). In particular the 
chemokine receptors CXCR4 and CCR7 are upregulated on the mature DC in order to 
respond to the lymphoid tissues expressing chemokines SDF-1 and SLC (Sallusto et al., 1998; 
Banchereau and Steinman, 1998; Hartgers et al., 2000). To reach the lymphoid tissues DCs 
have to migrate through afferent high endothelial venule (HEV) to come into contact with 
naive T cells. ICAM-2 is highly expressed on HEV indicating that the transendothelial 
migration of DC into lymphoid tissue may occur in a similar DC-SIGN/ICAM-2 dependent 
fashion as described for the blood vessel
Step 2: Once in the lymph node, DCs present their antigens in the form of peptide-MHC 
complexes to the resting T cells. Full activation is provided by co-stimulatory molecules 
present on the DC, including LFA-3, CD80, and CD86 (Cella et al., 1997; Pierre et al., 1997; 
Hartgers et al., 2000). The organization of such an immunological contact site has taken an 
important role within the control of immunity. Recognition of the antigen by T cells requires 
the formation of specialized junctions, also indicated as supramolecular activation clusters 
(Monks et al., 1998) or immunological synapse (Grakoui et al., 1999). The initial contact 
between DC and resting T cells is mediated through DC-SIGN/ICAM-3 binding (Fig. 3, step
2) (Geijtenbeek et al., 2000b). This facilitates the formation of low-avidity interactions 
between LFA-1 on the T cells with ICAM-1 on the DC. The TCR/MHC complex together 
with CD2/LFA-3 are situated in the center of the immunological synapse and LFA-1/ICAM-1 
form the outer ring. Also DC-SIGN, is expressed diffusely over the cell surface of a DC, and 
ligand binding probably alter DC-SIGN distribution and reorganization similar to LFA- 
1/ICAM-1 or TCR/MHC molecules. After TCR ligation, LFA-1 on T cells is further activated 
and stabilizes the immunological junction through the high avidity LFA-1/ICAM-1 and 
CD2/LFA-3 interaction (van Kooyk et al., 1989; Shaw and Dustin, 1997). Many intracellular 
signaling molecules that regulate T cell activation, are localized in the synapse, such as PKC 
close to the TCR and talin forming the link between LFA-1 and the cytoskeleton (Sampath et 
al., 1998; Monks et al., 1998). LFA-1 activation may also be affected by ICAM-3 cross­
linking and signaling, since ICAM-3 has been extensively characterized as a signaling 
molecule (Campanero et al., 1993; Cid et al., 1994). Specialized lipid microdomains termed
19
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rafts can as well regulate immune responses as has been shown for LFA-1 (Krauss and 
Altevogt, 1999). The TCR and several signaling molecules are localized to lipid rafts and 
TCR cross-linking causes aggregation of raft-associated proteins, which suggest that rafts are 
important in controlling immune cell signaling (Janes et al., 2000; Pande, 2000). Additional 
research is required to reveal whether DC-SIGN is situated within the immunological synapse 
or lipid rafts.
Table I General features of DC-SIGN and LFA-1
DC-SIGN LFA-1
Expression Monocyte-derived Dendritic cells 
(Geijtenbeek et al., 2000b)
Dendritic cells (Hynes, 1987) 
Leukocytes (Hynes, 1987)
Ligands ICAM-1 (Rothlein et al., 1986)
in static condition ICAM-2 (Geijtenbeek et al., 2000b) ICAM-2 (Staunton et al., 1989)
ICAM-3 (Geijtenbeek et al., 2000b) ICAM-3 (Fawcett et al., 1992)
Ligands 
under shear flow
ICAM-2 (Geijtenbeek et al., 2000c) ICAM-1 (Sigal et al., 2000)
Structural and Type II transmembrane protein Type I transmembrane protein
functional C-type Lectin Integrin
characteristics Monomer Heterodimer
Constitutively active Inducible active
Carbohydrate-Recognition Domain Inserted-domain
Mannose-dependent Carbohydrate-independent
Ca2+-dependent (Geijtenbeek et al., Mg2+-dependent (Binnerts and van
2000b) Kooyk, 1999)
2nd Ig-like domain ICAM-2,-3 1st Ig-like domain ICAM-1,-2,-3
Step 3 : After full activation, lymph node T cells, primed to recognize antigen, proliferate, 
and enter the blood stream to migrate towards the site of action in the periphery (Fig. 3, step
3). Again similar to the DC initial rolling contact of the T cells with the endothelium is 
mediated by selectins, and chemokines are needed to arrest T cells through activation of LFA-
1 facilitating leukocyte transendothelial migration through high avidity interaction with 
ICAM-1 present on the activated endothelium (Springer, 1994).
Eventually, the cascade from DC recruitment leading to T cell activation and subsequent 
immune response is complete. Although LFA-1 and DC-SIGN play different roles in this 
process they act in concert to efficiently regulate these complex processes in which an array 
of receptor-ligand interactions take place. The divers expression of the ICAM molecules
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plays an important role by providing the necessary interactions at the right time and at the 
right place.
Concluding remarks
The adhesion receptors LFA-1 and DC-SIGN show similar binding activity; both bind ICAM-
2 and -3 (Table I). Though structurally unrelated, we show that both molecules require 
divalent cation binding to interact with the ICAMs and therefore both ligand binding domains 
contain strikingly similar cation binding pockets. The regulated expression of ICAM-2 on 
endothelium and ICAM-1 by cytokines, facilitates a well coordinated shear stress-resistant 
rolling and migration process of both DCs and T cells. In contrast, under conditions that lack 
shear stress DC-SIGN/ICAM-3 interactions play a major role in DC-T cell induced activation 
within the lymph node. Interestingly, besides binding to ICAM-2 and -3, DC-SIGN is capable 
to bind the gp120 envelope protein of HIV-1 thereby enhancing the infection of T cells 
(Geijtenbeek et al., 2000a). This knowledge opens new doors towards the development of 
therapeutics against HIV. However, one should keep in mind that interfering with the binding 
site for gp120 in DC-SIGN, the interaction of ICAM-2 or -3 could also be affected leading to 
immune defects that concern DC migration and T cell priming. Therefore, a fundamental 
understanding of the binding characteristics of the ICAMs to DC-SIGN as well as LFA-1 is 
crucial in order to develop specific therapeutic inhibitors.
Outline of this thesis
The ICAMs are important in regulating and directing the immune response. Their receptors, 
LFA-1 and DC-SIGN, bind differently to the ICAMs and have a restricted expression pattern. 
This thesis describes the role of the ICAMs in regulating LFA-1- and DC-SIGN-mediated 
adhesion under various conditions that are present in the immune system. Furthermore, the 
involvement of the cytoplasmic domain of LFA-1 in relation to LFA-1 activation is 
investigated.
In chapter 2 and 3 the function of the ICAMs is described in their ability to induce 
different cytokines upon LFA-1 binding and their role in activating the LFA-1 molecule. The 
activation of LFA-1 via the ß2 cytoplasmic tail is investigated in chapter 4. Besides static 
adhesion, shear stress dependent adhesive interactions involving LFA-1 and ICAM-1, such as 
in transendothelial migration, are presented in chapter 5, whereas chapter 6 the role of the ß2 
cytoplasmic tail in these rolling interactions is described in detail. The function of DC- 
SIGN/ICAM interaction in trafficking of dendritic cells is investigated in chapter 7. Finally, 
the results presented in this thesis are integrated in a general discussion in chapter 8.
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Distinct cytokine profiles dependent on ICAM-1, - 2, -3 binding
Abstract
The LFA-1 adhesion molecule is involved in cell adhesion events of leukocytes through 
binding to ICAM-1, ICAM-2, and ICAM-3. Whether binding to either of these ligands 
similarly affects co-stimulation of T cells and cytokine secretion is unknown. We 
demonstrated that LFA-1 co-stimulation under suboptimal concentrations of aCD3 mAbs 
resulted in high, intermediate and weak proliferation of T cells on ICAM-1, -2, and -3 
respectively, which correlates with the distinct affinities of LFA-1 for these ligands. 
Furthermore, we investigated whether binding to ICAM-1, -2, or -3 induced different cytokine 
profiles, thus regulating T helper cell function. GM-CSF and IFN-y were secreted in high 
amounts, whereas IL-2, IL-4, and IL-5 could not be detected. Interestingly, we observed that 
LFA-1/ICAM-1 co-stimulation of T cells resulted in high production of the Th2 cytokine IL- 
10 compared to ICAM-2 or ICAM-3. In contrast, ICAM-2 and ICAM-3 induced a much 
stronger secretion of the Th1 cytokine TNFa compared to LFA-1/ICAM-1 induced co­
stimulation, despite the lower proliferation rate. These results demonstrate that besides 
facilitating cell adhesion, LFA-1 serves as a potent co-stimulatory molecule by inducing 
different cytokine patterns depending on the ligand bound.
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Introduction
The leukocyte function-associated antigen (LFA-1) is a cell adhesion molecule, which 
belongs to the ß2-family of integrins, consisting of a non-covalently linked a-chain (CD11a) 
and ß-chain (CD 18) (Springer, 1990). LFA-1 is specifically expressed on leukocytes and 
plays an important role in cell adhesion and signaling in the immune system, such as 
leukocyte adhesion to endothelial cells, T cell mediated cytotoxicity, T helper cell and B cell 
responses (Krensky et al., 1983; Martz, 1987; van Kooyk et al., 1993; Imhof and Dunon,
1995). LFA-1 mediates these cellular interactions through binding to ICAM-1 (Marlin and 
Springer, 1987), ICAM-2 (Staunton et al., 1989), or ICAM-3 (Vazeux et al., 1992), which are 
members of the Ig-superfamily. Both ICAM-1 (CD54) and ICAM-3 (CD50) are composed of 
five Ig-like domains, while ICAM-2 (CD102) has only two Ig-like domains, and is differently 
expressed on cells of the immune system and on endothelial cells (Dustin et al., 1986; 
Acevedo et al., 1993; Staquet et al., 1995).
For proper binding of LFA-1 expressing leukocytes to its ligands, LFA-1 must be 
activated, which involves a conformational change in the a/ß heterodimer, thereby increasing 
the affinity and/or avidity for its ligands (Dustin and Springer, 1989; van Kooyk et al., 1989; 
Figdor et al., 1990; Lub et al., 1995). This process is referred to as ‘inside-out’ signaling (Lub 
et al., 1995). LFA-1 can be activated by stimulating leukocytes with phorbol esters that 
activate PKC (Rothlein and Springer, 1986), or directly by the addition of unique activating 
antibodies directed against the extracellular part of LFA-1 (van Kooyk et al., 1991; Robinson 
et al., 1992; Andrew et al., 1993; Landis et al., 1994). The activation of LFA-1 generates a 
Ca2+-dependent epitope, recognized by the NKI-L16 antibody (Keizer et al., 1988), and a 
Mn2+-inducable epitope, recognized by the M24 antibody. Cross-linking of the T cell 
receptor/CD3 complex with antibodies directed against CD3 also causes activation of LFA-1 
(van Kooyk et al., 1989).
Besides acting as an adhesion molecule, it is also well established that binding of LFA-1 
to its ligands or cross-linking of LFA-1 by antibodies can result in ‘outside-in’ signals, such 
as increased levels of intracellular calcium and intracellular pH, phosphorylation of PLC, and 
co-stimulatory signals (Wacholtz et al., 1989; van Seventer et al., 1990; 1992; Figdor et al., 
1990; Kanner et al., 1993). Several studies have demonstrated that LFA-1 co-stimulation by 
anti-LFA-1 antibodies in combination with suboptimal anti-CD3 antibodies leads to enhanced 
T cell proliferation (Pircher et al., 1986; van Noesel et al., 1988; Carrera et al., 1988; 
Wacholtz et al., 1989). Cross-linking of T cells by anti-LFA-1 and anti-CD3 antibodies 
enhances the expression of the cytokines IL-2, IL-3, IFN-y, GM-CSF, and TNFa (Pircher et 
al., 1986; Maraskovsky et al., 1992; Melero et al., 1993). In addition, several studies have 
investigated LFA-1 induced co-stimulation of T cells upon binding to purified ligands (van 
Seventer et al., 1990; de Fougerolles and Springer, 1992; Damle et al., 1992; Semnani et al., 
1994; Starling et al., 1995; van Kooyk et al., 1996). When T cells bound to coated ICAM-1, 
induced T cell proliferation and cytokine production has been observed (van Seventer et al., 
1991; Semnani et al., 1994). Also, binding of T cells to purified ICAM-2 leads to T cell co­
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stimulation. However none of these studies have compared the three LFA-1 ligands to analyze 
their capacity to facilitate LFA-1 co-stimulation and cytokine production.
In this study, we compared the co-stimulation of LFA-1 expressing T cells upon binding 
to immobilized ICAM-1, ICAM-2, or ICAM-3 in the presence of suboptimal concentrations 
of anti-CD3 antibodies, and we analyzed the production of various cytokines during culture. 
We demonstrate that T cell proliferation upon binding of LFA-1 to ICAM-1, ICAM-2, and 
ICAM-3 is a read-out of adhesive strength and is quantitatively different. Furthermore, we 
present evidence that depending on the ligand presented to LFA-1 different cytokine profiles 
are produced.
Materials and Methods
Antibodies
The monoclonal anti-LFA-1 antibodies used were SPV-L7 (IgG1, anti-CD11a), NKI-L15 
(IgG2a, anti-CD11a), NKI-L16 (IgG2a, anti-CD11a), NKI-L19 (IgG1, anti-CD18) (Keizer et 
al., 1985; Keizer et al., 1988), TS2/4 (IgG1, anti-CD11a) (Sanchez-Madrid et al., 1982), M24 
(IgG1, anti CD11a,b,c) and 60.3 (IgG1, anti-CD18) (Beatty et al., 1983). KIM185 (IgG1, anti- 
CD18) was used for activation of LFA-1 (Andrew et al., 1993). The mAb T3b was used to 
activate CD3 (Spits et al., 1983). The following ICAM blocking antibodies were used: RR1/1 
(Rothlein et al., 1986) directed against ICAM-1, A076 directed against ICAM-2 (6th 
International Leukocyte Workshop 1996), 186.269 and AZN-IC3.1 directed against ICAM-3 
(6th International Leukocyte Workshop 1996).
Immunofluorescence
Cells were incubated (30 min 4°C) in PBS containing 1% wt/vol. bovine serum albumin 
(Sigma Chemical Co.) and 0.01% NaZ3 (PBA), with appropriate dilutions of the different 
antibodies (10 ng/ml, 25 |il/well), followed by incubation with FITC-labeled goat F(ab’)2 
anti-mouse IgG antibody (GAM-FITC; Zymed, San Francisco, CA; 1:50 dilution in PBA) for 
30 min at 4°C. The relative fluorescence intensity was measured on a FACScan (Becton 
Dickinson, Mountain View, CA).
Adhesion assays
96-flat bottomed wells (Maxisorb, Nunc, Roskilde, Denmark) were coated with Goat anti­
human Fc antibodies (Jackson Immunoresearch Laboratories, Inc., Westgrove, PA; 4 |ig/ml 
50 |il/well) in TSM (150 mM NaCl, 10 mM Tris/HCl, 2 mM MgCl2, 1 mM CaCl2, pH 8.0) for 
1 h at 37°C. After blocking the wells with 1% BSA in TSM (100 ^l/well; 30 min at 37°C), 
wells were coated O/N at 4°C with equal amounts of ICAM-1Fc, ICAM-2Fc or ICAM-3Fc 
containing supernatants (1.33 nM, 50 |il/well), as analyzed by ELISA assays, from stable 
CHO-K1 transfectants generated by cotransfection of the ICAM-1 IgG1 Fc, ICAM-2 IgG1 Fc 
or ICAM-3 IgG1 Fc plasmids (20 |ig), with the PEE 14 plasmid (5 |ig), as described 
previously (Binnerts et al., 1996). Cells (40,000/well) were labeled in PBS with Calcein-A
31
Chapter 2
(25 |ig/107cells/ml; Molecular probes, Eugene, OR) for 30 min at 37°C and incubated on 
ICAM coated plates for 45 min at 37°C, in the presence or absence of the indicated mAb. 
Non-adherent cells were removed by three washes with 37°C wash buffer (TSM + 0.5% 
BSA), adherent cells were lysed with lysis buffer (50 mM Tris, 0.1% SDS) and fluorescence 
was quantified using the Cytofluorometer (Biorad, Richmond, CA). Results are expressed as 
the mean percentage of adhesion of triplicate wells.
Proliferation assays
96-flat bottomed wells (Maxisorb, Nunc, Roskilde, Denmark) were coated with suboptimal 
concentrations of anti-CD3 antibodies (T3b, 30 ng/ml, 50 ^l/well, 1 h 37°C), followed by 
Goat anti-human Fc (Jackson Immunoresearch Laboratories, Inc., Westgrove, PA; 4 |ig/ml 50 
|il/well, 1 h 37°C), 1% BSA (100 |il/well, 30 min at 37°C) and ICAM-1Fc, ICAM-2Fc or 
ICAM-3Fc proteins (0.33-5.33 nM, 50 |il/well, 1 h 37°C). Resting peripheral blood 
lymphocytes (PBL) obtained by Ficoll-Hypaque density centrifugation and subsequent 
depletion of monocytes by adherence to plastic, were added (100.000 cells/well) and cultured 
in RPMI 1640 (Gibco), 10% FCS (Gibco) and 1% antibiotics/antimycotics (Gibco) for three 
to five days at 37°C, 5% CO2. On day 3, 4, or 5, cells were pulsed for 19 h with [3H]- 
thymidine (1.52 Tbq/mmol, 0.5 |iCi/well; Amersham, Buckinghamshire, United Kingdom), to 
measure ICAM dependent proliferation. To determine whether induced proliferation was 
LFA-1- and ICAM-1-, ICAM-2-, or ICAM-3-specific, cells were cultured in the presence of 
function blocking antibodies at a concentration of 10 ng/ml.
Cytokine assays
24-Well plates were pretreated with 10% Toluene in ethanol and washed four times 
subsequently with ethanol and PBS. Wells were coated with suboptimal concentrations of 
anti-CD3 antibodies (T3b, 30 ng/ml, 1 ml/well, 1 h 37°C), followed by Goat anti-human Fc 
(Jackson Immunoresearch Laboratories, Inc.; 4 |ig/ml 1 ml/well, 1 h 37°C), 1% BSA (1 
ml/well, 30 min at 37°C) and ICAM-1Fc, ICAM-2Fc or ICAM-3Fc proteins (0.33-5.33 nM, 1 
ml/well, 1 h 37°C). Resting peripheral blood lymphocytes (PBL) obtained by Ficoll-Hypaque 
density centrifugation and subsequent depletion of monocytes by adherence to plastic, were 
added (106 cells/well). Culture supernatants were harvested 3, 4 or 5 days after stimulation of 
the cells. IL-2, IL-4, IL-5, IL-10, IFN-y, TNFa and GM-CSF were determined in standard 
ELISA assays (Agea et al., 1995; Piali et al., 1998).
Results
Adhesion of human T cells to ICAM-1, ICAM-2, and ICAM-3
We investigated the capacity of LFA-1 expressed on resting human peripheral blood 
lymphocytes to adhere to either immobilized ICAM-1Fc, ICAM-2Fc, or ICAM-3Fc (Fig. 1). 
As we earlier reported (Binnerts et al., 1994), resting T cells adhere poorly to ICAM-1Fc 
(19%) and even less to ICAM-2Fc or ICAM-3Fc (11%) when coated at same protein
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concentration of 1.33 nM as analyzed by ELISA assays (data not shown). Even higher 
concentrations of ICAMs coated do not enhance ICAM-3 binding (data not shown). 
Activation of LFA-1 by the activating CD18 mAb KIM185 results in a stronger adhesion to 
ICAM-1 (42%), ICAM-2 (31%) and ICAM-3 (21%). Addition of suboptimal concentrations 
of immobilized anti-CD3 mAbs does not significantly increase the adhesion of LFA-1 to 
ICAM-2 or ICAM-3, although LFA-1/ICAM-1 adhesion is slightly increased to 53%. These 
results demonstrate that mAb activated LFA-1 on T cells strongly adhere to ICAM-1, whereas 
non-activated LFA-1 on T cells weakly adhere to ICAM-1, ICAM-2 and ICAM-3.
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Figure 1. Adhesion o f resting T cells to ICAM-1Fc, ICAM-2Fc, or ICAM-3Fc coated 
plates. 96-Flat bottomed wells were coated with ICAM-1Fc, ICAM-2Fc, or ICAM-3Fc (1.33 
nM) with (■) or without (□) suboptimal concentrations o f anti-CD3 antibodies (30 ng/ml). 
Resting peripheral blood lymphocytes (40 x  103 cells/well) were incubated on the coated 
plates in the absence (-) or presence (+) of the LFA-1 activating antibody KIM185 (10 
fg/ml). Results are expressed as the mean % of LFA-1/ICAM specific adhesion of triplicate 
wells. Specific adhesion: percentage of bound cells -  percentage of cells bound in the 
presence of LFA-1 blocking antibodies (NKI-L15, 50 ffg/ml'). Data are representative of two 
experiments.
LFA-1 co-stimulation upon binding to ICAM-1, ICAM-2, and ICAM-3
Since we observed differences in adhesion of T cells to ICAM-1, ICAM-2 and ICAM-3, we 
analyzed the potential of resting T cells to proliferate upon binding to ICAM-1Fc, ICAM-2Fc, 
or ICAM-3Fc proteins under suboptimal concentrations of anti-CD3 antibodies as mentioned 
in the materials and methods section (Fig. 2A). Virtually no proliferation was observed of 
resting T cells when incubated for five days in the presence of suboptimal amounts (30 ng/ml) 
of coated anti-CD3 only (955±417 cpm), or when coated on 1.33 nM ICAM-1Fc (1193±210 
cpm), ICAM-2Fc (289±57 cpm) or ICAM-3Fc (335±248 cpm) alone. As positive control, 
maximal proliferation was achieved when T cells were activated by high amounts (2 ng/ml) 
of coated anti-CD3 (70030±6672 cpm).
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Figure 2. LFA-1 co-stimulation o f  resting T cells. 96-Flat bottomed wells were coated with 
1.33 nM (A+C) or 0.33-5.00 nM (B) of ICAM-lFc, ICAM-2Fc, or ICAM-3Fc together with 
suboptimal concentrations (30 ng/ml) o f anti-CD3 antibodies. As a control wells were coated 
only with ICAM-1Fc, ICAM-2Fc, ICAM-3Fc, or suboptimal concentrations o f anti-CD3. After 
culturing resting peripheral blood lymphocytes ( l0  cells/well) for three days at 37°C, 
proliferation was determined using [3H]-thymidine incorporation (A). To determine the 
specificity of proliferation (C), cells were incubated in the presence or absence of blocking 
antibodies (10 Jg/ml) against LFA-1 (NKI-L19), ICAM-1 (RR1/1), ICAM-2 (A076) or ICAM-
3 (186-269). Results are expressed as the mean % (SD<10%) o f maximal proliferation 
induced by 2 Jg/ml anti-CD3 antibodies (A+C: 70030±6672 cpm). Proliferation from 
triplicate wells is depicted. Data are representative of three experiments.
For ICAM-lFc, ICAM-2Fc and ICAM-3Fc the LFA-1 co-stimulatory effect was dose- 
dependent on the amount of coated ICAM molecules, ranging from 0.33-5.33 nM (Fig. 2B). 
At day 3 till day 5, co-stimulation upon ICAM-lFc binding induced a strong T cell 
proliferation (19319±6470 cpm), albeit lower than the maximal anti-CD3 induced 
proliferation. Similarly to the adhesion assay, T cell proliferation was high on ICAM-lFc,
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lower on ICAM-2Fc (6886±2438 cpm) and poor on ICAM-3Fc (3699±631 cpm), but still 
LFA-1/ICAM specific, since LFA-1 blocking antibodies could completely inhibit 
proliferation to background levels (Fig. 2C). Anti-ICAM-1 (RR1/1) blocked the anti-CD3 
induced LFA-1/ICAM-1 proliferation as expected. Similarly, anti-ICAM-2 (A076) and anti- 
ICAM-3 (186.269 or AZN-IC3.1) inhibited the LFA-1/ICAM-2 and LFA-1/ICAM-3 co­
stimulated proliferation, respectively. However, antibodies directed against ICAM-3 also 
inhibited LFA-1/ICAM-1 dependent proliferation (Fig. 2C). This indicates that LFA- 
1/ICAM-3 interactions are critical for ICAM-1 dependent proliferation of T cells, which is in 
agreement with our earlier findings that interaction of LFA-1 with ICAM-3 is required for 
LFA-1/ICAM-1 signal transduction (Chapter 3). Taken together, these data strongly suggest 
that the binding of LFA-1 to ICAM-1, ICAM-2 and ICAM-3 not only mediates T cell 
adhesion, but also induces LFA-1 co-stimulation as shown by enhanced T cell proliferation. 
Moreover, T cell proliferation upon LFA-1 co-stimulation greatly depends on the strength of 
adhesion to ICAM-1, ICAM-2 or ICAM-3.
Figure 3. LFA-1/ICAM-1 co-stimulation enhances LFA-1 expression and activation
Resting peripheral blood lymphocytes (10 cells/well) were cultured for five days on 24-well 
plates coated with 1.33 nM of ICAM-1Fc, ICAM-2Fc or ICAM-3Fc, together with suboptimal 
concentrations of anti-CD3 antibodies (bold line). As a control, wells were coated only with 
anti-CD3, ICAM-1Fc, ICAM-2Fc or ICAM-3Fc (thin line). Cells w^ ere stained with antibodies 
directed against the a  chain of LFA-1 (NKI-L7) or with an activation reporter antibody (NKI- 
L16) and GAM-FITC second antibody (dotted line). Data are representative of four 
experiments.
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LFA-1/ICAM-1 co-stimulation enhances expression and activation of LFA-1
While on resting T cells LFA-1 is inactive and initial adhesion to ICAM-1 in the presence of 
low amounts of anti-CD3 antibodies is poor (Fig. 1), we investigated whether culturing of 
resting T cells for 3 to 5 days on ICAM-1, -2 or -3 substrates in the presence of suboptimal 
concentrations of anti-CD3 affects LFA-1 activation. After 3, 4, and 5 days of co-stimulation, 
T cells were harvested and stained with antibodies against LFA-1, ICAM-1, ICAM-2, ICAM- 
3, CD3, CD4, and CD8. After 5 days of culture about 90% of the cells were CD3+ and 80% 
were CD4+. No significant differences were observed in expression of ICAM-1, ICAM-2, 
ICAM-3, CD3, CD4, and CD8 compared to T cells cultured on suboptimal amounts of anti- 
CD3 only (data not shown). In contrast, the NKI-L16 epitope, which reports the clustered 
status of LFA-1, and the NKI-L7 epitope (anti-CD11a), which stains the amount of LFA-1 
present on the cell membrane, were strongly upregulated when T cells were incubated for five 
days on plates coated with ICAM-1Fc in combination with suboptimal concentrations of anti- 
CD3 antibodies (Fig. 3). No clear altered expression of NKI-L16 and NKI-L7 was observed 
when T cells were cultured on either ICAM-2 or ICAM-3 together with anti-CD3 antibodies. 
This indicates that culturing T cells on ICAM-1 in the presence of suboptimal concentrations 
of anti-CD3 antibodies enhances LFA-1 expression levels and the clustering status of LFA-1 
on the cell membrane.
Figure 4. Photomicrographs o f T cells clustering upon LFA-1 co-stimulation. Resting 
peripheral blood lymphocytes (10 cells/well) were cultured for five days on 24-well plates 
coated with 1.33 nM of ICAM-1Fc (A), ICAM-2Fc (B) or ICAM-3Fc (C), together with 
suboptimal concentrations of anti-CD3. As a control, wells were coated with 4 Jg/ml Goat 
anti-human Fc antibodies without anti-CD3 and ICAMs (D) or coated only with 30ng/ml (E) 
or 2jg/ml anti-CD3 (F). Magnification 10x. One representative experiment out of three is 
shown.
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Based on these results we further analyzed the LFA-1 induced cluster formation of T 
cells. During proliferation large cell clusters were formed when T cells were cultured on co­
stimulated ICAM-1Fc coated plates, whereas smaller clusters were observed on ICAM-2Fc 
and ICAM-3Fc (Fig. 4). Incubation on ICAM-1Fc, ICAM-2Fc or ICAM-3Fc coated plates 
with the LFA-1 blocking antibody (NKI-L19) inhibited the cluster formation completely as 
well as proliferation (Fig. 2C). Stimulating T cells with high amounts of anti-CD3, inducing 
maximal proliferation, resulted in a few clusters that were not significantly larger than ICAM- 
1Fc induced clusters. Taken together, these results indicate that ICAM induced LFA-1 
mediated co-stimulation enhances LFA-1 clustering and T cell adhesion.
Secretion of different cytokines upon ligand binding-induced LFA-1 co-stimulation
To investigate the effects of the different ICAMs on LFA-1 co-stimulation, we measured the 
secretion of several T helper cell regulating cytokines. Again human PBL were incubated on 
ICAM-1Fc, ICAM-2Fc, or ICAM-3Fc coated plates in combination with suboptimal 
concentrations of anti-CD3 and after 3 to 5 days of culture, supernatant was harvested and IL- 
2, IL-4, IL-5, IL-10, IFN-y, TNFa, and GM-CSF were measured using an ELISA detection 
method. No detectable amounts of IL-2, IL-4, and IL-5 could be determined in the supernatant 
of all T cell cultures (data not shown). In contrast, significant amounts of IFN-y, TNFa, IL- 
10, and GM-CSF were produced (Table I). Because some differences were seen in cytokine 
levels between the various donors, although clearly distinct cytokine patterns could be 
observed, the relative cytokine secretion of T cells cultured on ICAM-1 are compared to 
ICAM-2 and ICAM-3 (Fig. 5). While LFA-1 co-stimulation upon binding ICAM-1, ICAM-2, 
or ICAM-3 resulted in equal amounts of IFN-y (2-20 ng) or GM-CSF (0.5-3 ng) large 
differences were observed in the secretion of IL-10 and TNFa. Significantly more IL-10 (4­
fold) was produced by T cells co-stimulated that grew on ICAM-1 than those that were bound 
to ICAM-2 or ICAM-3 (Table I, Fig. 5). In contrast, ICAM-2 and ICAM-3 induced co­
stimulation resulted in the secretion of high amounts of TNFa, while on ICAM-1 only low 
amounts (2 fold lower) of TNFa are found. These results indicate that despite the minimal T 
cell proliferation upon LFA-1/ICAM-2 and LFA-1/ICAM-3 co-stimulation and low affinity 
adhesive interaction, ICAM-2 and ICAM-3 are able to induce significantly more TNFa 
compared to ICAM-1. These data strongly indicate that distinct cytokines are produced when 
T cells are cultured on ICAM-1 (IL-10) compared to ICAM-2 or ICAM-3 (TNFa).
Discussion
We here demonstrate that LFA-1/ICAM-1 co-stimulation leads to the production of the Th2 
cytokine IL-10. In contrast, LFA-1 co-stimulation upon binding to ICAM-2 or ICAM-3 
predominantly leads to the production of the Th1 cytokine TNFa. Equal amounts of IFNy and 
GM-CSF are secreted when T cells were grown on ICAM-1, ICAM-2, or ICAM-3.
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Figure 5. Cytokine production upon LFA-1 co-stimulated T cells. Depicted is the relative 
secretion of GM-CSF, IFN-y, TNFa, and IL-10 of ICAM-1 versus ICAM-2 (D) or ICAM-3 
(B) (right bars), or ICAM-2 (D), ICAM-3 (B) versus ICAM-1 (left bars). 24-Wells plates 
were coated with ICAM-1Fc, ICAM-2Fc, or ICAM-3Fc (ranging from 0.33-5.33 nM) together 
with suboptimal concentrations of anti-CD3 antibodies. Supernatant was harvested after 
culturing resting peripheral blood lymphocytes (10 cells/well) for three to five days at 37°C, 
and cytokine production was determined in ELISA assays (see also Table I). Total number of 
measurements was for IL-10 and IFN-y: 33, and for TNFa and GM-CSF: 40. Data are mean 
± SEM (n=6). Asterisks indicate significantly more cytokine production on ICAM-1 versus 
ICAM-2/-3 or ICAM-2/-3 versus ICAM-1 (p<0.05).
Co-stimulation is referred to as an 'outside-in' signal, indicating that upon ligand binding 
LFA-1 is able to induce intracellular signals leading to proliferation (van Seventer et al., 
1990; Damle et al., 1992b; van Kooyk et al., 1996), cytokine production (van Seventer et al., 
1991; Semnani et al., 1994), activation of PLC, and an increase of intracellular calcium levels 
and pH (van Seventer et al., 1992). Previous studies have shown that co-stimulation can be 
induced by either anti-LFA-1 antibodies (van Noesel et al., 1988; Wacholtz et al., 1989) or 
purified recombinant ICAM-1, ICAM-2, or ICAM-3 proteins (van Seventer et al., 1990; 
Damle et al., 1992b; Starling et al., 1995; van Kooyk et al., 1996) in combination with 
suboptimal amounts of anti-CD3 antibodies. Our findings clearly demonstrate that purified 
ICAM-1 is the most potent ligand for both LFA-1 adhesion and proliferation induced by 
LFA-1 co-stimulation compared to ICAM-2 and ICAM-3. The proliferation induced upon
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binding ICAM-1, ICAM-2, and ICAM-3 is LFA-1 specific since anti-ICAM and anti-LFA-1 
blocking antibodies could inhibit the proliferation to background levels. Surprisingly, anti- 
ICAM-3 antibodies largely inhibited the LFA-1/ICAM-3 as well as the LFA-1/ICAM-1 
induced proliferation. In accordance with our earlier observations (Binnerts et al., in 
preparation), the interaction of ICAM-3 with LFA-1 seems to be critical for co-stimulation by 
ICAM-1. Since suboptimal anti-CD3 antibodies do not induce proliferation, we can exclude 
the involvement of ICAM-mediated proliferation of cell-cell interaction.
Differences in proliferation induced by ICAM-1, ICAM-2, and ICAM-3 is proportional to 
the strength of adhesion (Fig. 1). The stronger adhesion induces a higher proliferative 
response of T cells. However, the cytokine secretion profiles suggests that co-stimulation is 
not merely a result of the strength of adhesion, since ICAM-2 as well as ICAM-3 are able to 
induce high amounts of TNFa. This indicates that although the affinity of adhesion directs the 
strength of proliferation, other co-stimulatory events like cytokine production are independent 
of adhesion affinity. In contrast, Ohashi and colleagues (Bachmann et al., 1997) reported 
that LFA-1 does not deliver a co-stimulatory signal but only facilitates the triggering of the T 
cell receptor by promoting adhesion. Although this is in agreement with our hypothesis that 
proliferation is a consequence of the adhesive strength, it does not support our findings that 
LFA-1 is able to induce different cytokines upon binding to its ligands.
We investigated the secretion of IL-2, IL-4, IL-5, IL-10, IFN-y, TNFa, and GM-CSF in 
the supernatants of different LFA-1 co-stimulated T cells. Interestingly, we found that LFA-1 
co-stimulation upon binding to ICAM-1 leads to the highest secretion of the Th2 cytokine IL- 
10, whereas binding to ICAM-2 and ICAM-3 strongly induced the production of the Th1 
cytokine TNFa. Th2 cytokines (IL-4, IL-5, IL-6, IL-10) mediate humoral immune responses, 
mast cell and eosinophil stimulation to promote allergic responses, while Th1 cytokines (IL-2, 
IL-12, IFN-y, TNFa, GM-CSF) are in general associated with delayed type sensitivity and 
cell-mediated immunity (Mosmann and Sad, 1996). The Th2 cytokine IL-10 has potent 
immunomodulatory activities. Since IL-10 has been reported to inhibit T cell proliferation 
(Cohen et al., 1997), it is possible that the strong activation induced upon LFA-1/ICAM-1 co­
stimulation compared to that by ICAM-2 and ICAM-3, initiates the secretion of IL-10 to 
control T cell activation and proliferation. In contrast, the IL-10 production upon binding to 
ICAM-1 might also be due to the different thresholds for IL-10 activation and production, 
since LFA-1 has a high affinity for ICAM-1 and lower for ICAM-2 and ICAM-3. 
Furthermore, we show that larger amounts of the Th1 cytokine TNFa are secreted upon co­
stimulation by ICAM-2 and ICAM-3, but not by ICAM-1. The role of IL-10 and TNFa in the 
process of LFA-1 co-stimulation together with T helper cell differentiation needs to be further 
elucidated, as well as the T cell subsets producing these cytokines since total PBLs were used. 
In rheumatoid arthritis a balance exists between the production of the anti-inflammatory 
molecule IL-10 and the pro-inflammatory molecule TNFa. Il-10 is a major endogenous 
down-regulator of TNFa in the rheumatoid joint (Parry et al., 1997; Porter and Hogg, 1997). 
This suggests that binding of ICAM-1, ICAM-2 or ICAM-3 to LFA-1 may be involved in 
autoimmune diseases, such as rheumatoid arthritis. The secreted T helper cell cytokines IL-10
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Table I. Secretion of cytokines by costimulation of LFA-1 upon binding to ICAM-1, ICAM-2 or ICAM-3
E x p e r im e n t  1 E x p e r im e n t  2
C o a tin g 3 Proliferation Secretion o f Cytokines (pg)d C o a t in g Proliferation Secretion o g)(pesinekytok
O
dayb ccpm IL-10 TNF a IFN Y GM/CSF day cpm IL-10 TN Fa IFN Y GM/CSF
aCD3 0 pg/ml 3 1.1* 03±2*102 78 123 1715 277 aCD3 0 pg/ml 3 ND 810 36 3888 219
4 3.5*1 0 3±6*102 196 137 2663 306 4 1.3*103±6*102 7 22 2686 264
5 2.8* 0 3±3*102 253 133 5247 612 5 2.7*103±1*103 265 18 2895 201
30 pg/ml 3 1.5*1 03±3*102 150 394 5145 833 30 pg/ml 3 ND 430 ND 257 ND
4 4.5* 03±1*102 ND ND ND ND 4 2.3*10 3=8*102 158 58 443 343
5 3.3* 03±6*102 156 323 8241 1158 5 2.6*10 3=1*103 232 37 134 282
2 mg/ml 3 6.2*1 0 4±4*103 10104 2094 3819 3611 2 mg/ml 3 ND ND 547 2254 3436
4 9.0* 04±1*104 10201 1275 6231 2830 4 1.1*10±9*104 363 222 2323 3204
5 5.5* 03±7*103 1399 383 13901 1558 5 1.1*10±2*104 163 71 1797 2941
ICAM-1 0.67 nM 3 3.2*
'o
*1
HH
'o
525 1039 7444 1597 ICAM-1 0.67 nM 3 ND 3298 162 7549 1096
4 3.8* 04±6*103 1099 538 11537 1804 4 6.1*104±9*103 2585 40 5438 699
5 4.3* 04±9*103 519 573 13751 2124 5 1.1*105±6*103 870 33 4954 934
ICAM-1 2.67 nM 3 6.4*1 0 3±1*103 201 738 7021 1205 ICAM-1 3.33 nM 3 ND 2252 164 6975 1400
4 2.1*1 04±8*103 388 551 7010 1577 4 ND 1178 114 5832 1575
5 4.2* 04±2*104 190 452 11718 1914 5 ND 1693 54 5495 1566
ICAM-2 1.33 nM 3 1.9* 03±3*102 134 993 6915 1418 ICAM-2 0.67 nM 3 ND 481 206 4656 858
4 1.0* 0 4±2*103 162 1689 13488 1950 4 5.0*10 3=1*103 822 209 4903 732
5 7.8*1 03±2*103 241 1105 19429 2281 5 1.1*104±3*103 402 200 4395 1503
ICAM-2 5.33 nM 3 3.5* 03±6*102 106 1074 5247 1539 ICAM-2 3.33 nM 3 ND 441 235 5069 590
4 2.0* 04±4*103 145 1629 6630 2202 4 ND 635 232 4528 569
5 1.7*1 0 4±4*103 111 1263 13317 2997 5 ND 618 154 5106 728
ICAM-3 1.33 nM 3 1.6*1 0 3±9*102 84 1219 4920 1413 ICAM-3 0.67 nM 3 ND 526 185 4454 421
4 3.5*1 0 3±8*102 179 1964 10387 2062 4 3.6*103±1*103 453 222 4685 311
5 6.5*1 03±3*103 179 1017 17923 2700 5 6.9*10±5*103 566 157 2992 791
ICAM-3 5.33 nM 3 1.7* 03±5*102 167 1234 7432 1163 ICAM-3 3.33 nM 3 ND 606 328 2249 1006
4 5.0* 0 3±1*103 230 1766 5854 2192 4 ND 153 178 3381 573
5 7.6*
'o
*1
HH
'o
100 1029 15492 2223 5 ND 566 149 3157 707
24-wells plates were coated with 4 pg/ml Goat anti-human Fc antibodies with or without 30 ng/ ml anti-CD3 antibodies as a negative control, or as a positive control 
with 2 pg/ml anti-CD3 antibodies. ICAM-1Fc, ICAM-2Fc or ICAM-3Fc were coated at indicated concentrations together with suboptimal concentrations (30 ng/ml) of 
anti-CD3 antibodies.
b Resting peripheral blood lymphocytes (106 cells/well) were cultured for 3 to 5 days at 37°C before supernatant was harvested or proliferation was measured. 
c Proliferation measure by [3H]-thymidine incorporation (mean cpm ± SD, in triplo).
d Secreted IL-10, TNF a , IFNY and GM/CSF were determined in ELISA assay. ND: not determined. Data from two representative experiments among six are shown.
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Distinct cytokine profiles dependent on ICAM-1, - 2, -3 binding
This study shows for the first time that different cytokine levels are produced upon co- 
stimulating LFA-1 upon binding ICAM-1, ICAM-2, or ICAM-3. Probably, the LFA-1 
molecule is clearly able to generate different signals into the cell, which indicates that LFA-1 
can distinguish whether ICAM-1, ICAM-2 or ICAM-3 is bound. Interestingly, the binding 
site of ICAM-1, ICAM-2 and ICAM-3 within LFA-1 is distinct, although partly overlapping 
(Binnerts et al., 1994; Landis et al., 1994; van Kooyk et al., 1996; Binnerts et al., 1996). 
Several residues within the I domain in the a-chain of LFA-1 have been elucidated to be 
critical for ICAM-1 binding (Huang and Springer, 1995), whereas an epitope has been located 
to involve LFA-1 binding to ICAM-2 and ICAM-3, but not to ICAM-1 (van Kooyk et al., 
1996; Binnerts et al., 1996). This suggests that the binding sites for the ICAM molecules to 
LFA-1 are not identical. The binding to distinct sites within LFA-1 may therefore result in 
different conformational changes within the LFA-1 molecule that in turn may induce distinct 
intracellular signals. LFA-1 has a strong affinity for ICAM-1, less for ICAM-2 and weak for 
ICAM-3 (Fig. 1) (Damle et al., 1992b; de Fougerolles et al., 1994). In the case of LFA-1 co­
stimulation, it is unclear whether high affinity interactions can generate different signals 
compared to low affinity interactions. LFA-1 co-stimulation with only ICAM-1 induces an 
upregulation and activation of LFA-1 (Fig. 3) as shown by the mAb L7 and NKI-L16 (anti- 
CD11a). This suggests that ICAM-1 is able to induce clustering of the LFA-1 molecule, 
thereby increasing the avidity. This is also supported by the fact that dimers of ICAM-1 bind 
LFA-1. Additionally, larger cell clusters were observed on ICAM-1 than on ICAM-2 and 
ICAM-3 (Fig. 4). The difference in LFA-1 avidity and clustering could also be a mechanism 
by which LFA-1 signals upon ligand binding.
The molecular mechanisms between LFA-1/ligand binding and cytokine secretion are 
poorly understood. Outside-in signaling by LFA-1/ICAM-1 co-stimulation is known to induce 
prolonged inositol phospholipid hydrolysis and tyrosine phosphorylation of PLC-y (van 
Seventer et al., 1992; Kanner et al., 1993). A cascade of events could then initiate the 
expression and secretion of cytokines. It has been reported that both TNFa and IL-10 gene 
expression requires the early activation of protein tyrosine kinases (PTK), however 
downstream PTK they use distinct intracellular pathways (Serrador et al., 1997). This might 
suggest that the distinct binding of ICAM-1, -2, or -3 by LFA-1 induces distinct 
conformational changes in LFA-1 that initiate different intracellular signaling routes leading 
to the production of IL-10 or TNFa, respectively. Taken together, we demonstrate that co­
stimulation of LFA-1 upon binding to ICAM-1 leads to the production of a Th2 cytokine IL- 
10, whereas co-stimulation of LFA-1 upon binding to ICAM-2 or ICAM-3 leads to a high 
production of a Th1 cytokine TNFa. Despite the low T cell proliferation and adhesion to 
ICAM-2 and ICAM-3, high amounts of TNFa are produced. Thus co-stimulation of LFA-1 
upon binding to distinct ligands can lead to secretion of distinct cytokine profiles.
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Role of ICAM-3 in LFA-1/ICAM-1 adhesion and signaling
Abstract
Although ICAM-3 is implicated in both adhesion and signal transduction events of 
leukocytes, its low affinity for LFA-1 compared to other ligands of LFA-1 has puzzled many 
investigators. Here, we investigated the role of ICAM-3 in supporting LFA-1-mediated 
ICAM-1 binding and subsequently cell signaling. We observed that although ICAM-3 binds 
poorly to LFA-1 expressed on resting T cells, it specifically facilitates and increases LFA-1- 
mediated adhesion to the high affinity ligand of LFA-1, ICAM-1. We demonstrate that low- 
affinity binding of LFA-1 to ICAM-3 together with ICAM-1 alters the cell surface 
distribution of LFA-1 dramatically, inducing large clusters of LFA-1 that facilitate ICAM-1 
binding after LFA-1 activation. We found that LFA-1-mediated ICAM-1 cell-cell 
interactions, such as T cell proliferation, greatly depend on low affinity LFA-1/ICAM-3 
interactions that enhance stable LFA-1/ICAM-1 cell-cell contact. Taken together, these data 
demonstrate that low affinity LFA-1 binding to ICAM-3 regulates strong LFA-1/ICAM-1- 
mediated adhesion by driving LFA-1 into clusters to facilitate cell-cell interactions that take 
place in the immune system.
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Introduction
The integrin LFA-1 (CD11a/CD18) is a leukocyte adhesion receptor that coordinates different 
adhesive events in the immune system. LFA-1 plays an important role in the initiation of 
immune responses by establishing contact between antigen presenting cells and T cells, as 
well as in effector functions such as CTL/target interactions, T cell proliferation, and 
migration of leukocytes through endothelial cell layers into inflamed tissue (Krensky et al., 
1983; Martz, 1987; Springer, 1990; Figdor et al., 1990; Van Kooyk and Figdor, 1993; Van 
Kooyk et al., 1993, 1994; Mackay, 1995; Imhof and Dunon, 1995; Lub et al., 1995, 1997a,b; 
Stewart and Hogg, 1996; Kucik et al., 1996). LFA-1 (CD11a/CD18) belongs to the ß2 family 
of integrins, which share a common ß subunit (CD 18), but have distinct, but structurally 
homologous a  subunits. Other members of the ß2-family are Mac-1 (CD11b, aM/ß2), 
p150,95 (CD11c, aX/ß2), and aD (CD11d, aD/ß2) (Sanchez-Madrid et al., 1983; Springer, 
1990; Vandervieren et al., 1995). LFA-1 mediates cell-cell adhesion upon binding to one of 
the Ig-superfamily members ICAM-1 (Marlin and Springer, 1987; Staunton et al., 1988; 
Simmons et al., 1988), ICAM-2 (Staunton et al., 1989), or ICAM-3 (Vazeux et al., 1992; 
Fawcett et al., 1992; De Fougerolles et al., 1993), which have 5, 2, and 5 Ig-like domains, 
respectively. ICAM-1 is expressed on many cell types, including lymphocytes and activated 
endothelial cells in inflamed tissue (Dustin et al., 1986). ICAM-2 is present on lymphocytes, 
endothelial cells, and platelets (De Fougerolles et al., 1991; Diacovo et al., 1994), whereas 
ICAM-3 is only expressed on leukocytes, with the exception of endothelial cells in certain 
tumors (Acevedo et al., 1993). In contrast to ICAM-1, expression of ICAM-2 and ICAM-3 is 
not enhanced by cytokines (Acevedo et al., 1993; Cordell et al., 1994).
LFA-1-mediated cell adhesion requires activation of LFA-1 (Van Kooyk et al., 1989; 
Dustin and Springer, 1989; Hynes, 1992; Lub et al., 1995) and is dependent on the presence 
of divalent cations, such as Mg2+ and Ca2+ (Dransfield et al., 1992), an intact cytoskeleton, 
and a physiological temperature (Figdor et al., 1990). Activation can be induced by 
intracellular signals generated upon cross-linking of surface receptors like the TCR/CD3 
complex (Van Kooyk et al., 1989; Dustin and Springer, 1989), or upon addition of 
phorbolesters that directly activate protein kinase C (Rothlein and Springer, 1986). LFA-1 can 
also be activated directly by adding activating antibodies directed against the extracellular 
domains of the aL or ß2 subunit (Van Kooyk et al., 1991; Robinson et al., 1992; Andrew et 
al., 1993; Landis et al., 1993). Activation of LFA-1 and subsequent ligand binding is thought 
to result from conformational changes in the a/ß heterodimer that increase both the avidity 
and affinity of LFA-1 for its ligands (Binnerts and van Kooyk, 1999).
Several reports have illustrated that the cell surface distribution of LFA-1 is also
2+important for its adhesive function. Expression of a Ca -dependent epitope on LFA-1 has 
clearly been shown to correlate with the clustering status of LFA-1 on the cell surface and to 
facilitate ICAM-1 binding (Van Kooyk et al., 1994; Binnerts and van Kooyk, 1999). In 
addition, disconnecting LFA-1 from the actin cytoskeleton, through inhibitors, such as 
Cytochalasin D, or upon deletion of the a  and ß cytoplasmic tails, have been shown to result
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in clustering of LFA-1 on the cell membrane and to enhance its avidity and adhesive capacity 
(Stewart and Hogg, 1996; Kucik et al., 1996; Lub et al., 1997a,b; Van Kooyk et al., 1999).
It has been clearly demonstrated that engagement of LFA-1 on T cells by purified ICAM- 
1, -2, or -3 molecules can co-stimulate T cell proliferation; (De Fougerolles and Springer, 
1992; Starling et al., 1995; Van Kooyk et al., 1996; Bleijs et al., 1999). Several reports 
suggest that ICAM-3 may also function as signal transduction molecule. Cross-linking of 
ICAM-3 induces protein tyrosine phosphorylation, elevation of intracellular calcium levels, 
co-stimulation of T cells, morphological changes in T cells, and can lead to activation of ß1 
and ß2 integrins (Hernandez-Caselles et al., 1993; Campanero et al., 1993; Juan et al., 1994; 
Arroyo et al., 1994; Cid et al., 1994; Delpozo et al., 1994). Whether physiological 
engagement of ICAM-3 by LFA-1 is important for adhesion/cell signaling is still completely 
unknown.
Because ICAM-3 is the dominantly expressed ICAM molecule on resting lymphocytes, it 
was originally proposed to be the primary LFA-1 ligand during the initiation of an immune 
response (De Fougerolles and Springer, 1992). However, later reports showed that even LFA- 
1 expressed on activated T cells binds poorly to ICAM-3 when compared to ICAM-1 and 
ICAM-2 (De Fougerolles et al., 1994; Binnerts et al., 1994, 1996). Despite the low affinity 
binding of ICAM-3 to LFA-1, blocking antibodies directed against ICAM-3 have been shown 
to inhibit T cell proliferation in mixed lymphocyte reactions, suggesting that LFA-1/ICAM-3 
interaction is important in adhesion and cell signaling of resting T cells (Starling et al., 1995). 
In this study, we investigated whether ICAM-3 contributes directly to LFA-1-mediated 
adhesion of resting T cells, or is involved in the regulation of LFA-1 function on these cells. 
We obtained evidence that, although ICAM-3 binds poorly to LFA-1, low-affinity 
interactions of LFA-1 with ICAM-3 are required for LFA-1/ICAM-1-dependent adhesion and 
signal transduction during the initiation of an immune response.
Materials and Methods
Antibodies
The following antibodies were used: SPV-L7, NKI-L15 (Keizer et al., 1985), YTH81.5 
(Landis et al., 1994) and TS2/4 (Sanchez-Madrid et al., 1982), directed against CD11a, T3b 
directed against CD3 (Spits et al., 1983), REK-1 (Binnerts et al., 1994) and RR1/1 (Rothlein 
et al., 1986) directed against ICAM-1, CBR-IC2/2 (De Fougerolles et al., 1991) directed 
against ICAM-2, 186-269 and AZN-IC3.1 (6th International Leukocyte Workshop 1996) 
directed against ICAM-3, and TS2/9 (Sanchez-Madrid et al., 1982) directed against LFA-3. 
For activation of LFA-1, the LFA-1 activating mAbs KIM185 (Andrew et al., 1993) and 
MEM-48 (Binnerts et al., 1994), directed against CD 18 were used. LFA-1 activation was 
detected using the activation-dependent-epitope antibodies NKI-L16 against CD11a (Keizer 
et al., 1988) and M24 against CD11a,b,c kindly provided by Dr. N. Hogg (Dransfield and 
Hogg, 1989). For T cell subsets the following antibodies were used: RIV-6 against CD4
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(Leerling et al., 1990), wt82 against CD8 (Tax et al., 1984), anti-CD45RA and anti-CD45RO 
(Becton and Dickingson & Co., Oxnard, CA).
Cells
The T cell lines Peer and HSB-2 were cultured in Iscove's medium (Gibco, Life Technologies 
ltd, Paisley, Scotland) supplemented with 5% FCS and 1% antibiotics/antimycotics (Gibco). 
Resting T cells were obtained by centrifugal elutriation of PBMC from blood or bone marrow 
of healthy donors, as described (Figdor et al., 1984). The T cell fractions used contained over 
90% CD3 positive cells and were cultured in RPMI 1640 (Gibco), supplemented with 10% 
FCS and 1% antibiotics/antimycotics (Gibco). K562-LFA-1 transfectants were generated as 
described previously (Lub et al., 1997b) and were grown in RPMI/Iscove's (75:25) (Gibco) 
containing 7.5% FCS and Geneticin (Gibco; 2 mg/ml).
Adhesion assay
96-well (bottom wells) plates (Maxisorb, Nunc, Roskilde, Denmark) were coated with Goat 
anti-human Fc antibodies (4 ng/ml; 50 nl/well; Jackson immunoresearch laboratories, Inc., 
Westgrove, PA) in TSM (150 mM NaCl, 10 mM Tris/HCl, 1 mM MgCl2, 1 mM CaCl2, pH 
8.0), for 60 minutes at 37°C. After blocking the wells with 1% BSA in TSM (100 nl/well; 30 
minutes at 37°C), wells were coated O/N at 4°C with ICAM-1Fc or ICAM-3Fc containing 
supernatants at the indicated concentrations, from stable CHO-K1 transfectants generated by 
co-transfection of the ICAM-1 IgG1 Fc, ICAM-3 IgG1 Fc or CD14Fc (Fawcett et al., 1992) 
plasmids (20 ng), with the pEE14 plasmid (5 ng), as described (Van Kooyk et al., 1999). 
Cells (4x104/well) were labeled in PBS with Calcein-A (25 ng/107 cells/ml; Molecular probes, 
Eugene, OR) for 30 minutes at 37°C and incubated on ICAM coated plates for 45 minutes at 
37°C, in the presence or absence of the indicated mAb. Non-adherent cells were removed by 
three washes with 37°C wash buffer (TSM + 0.5% BSA), adhering cells were lysed with lysis 
buffer (50 mM Tris, 0.1% SDS), and fluorescence was quantified using the Cytofluorometer 
(Biorad, Richmond, CA). Results are expressed as the mean percentage of adhesion of 
triplicate wells.
Immunofluorescence analysis
Cells (0.1x106) were incubated with appropriate dilutions of mAb (10 ng/ml; 25 nl/well) in 
PBS containing 0.5% bovine serum albumin and 0.01% NaZ3 (PBA), for 30 minutes at 4°C. 
After one wash with cold PBA, cells were incubated with FITC-labeled Goat anti-mouse 
secondary antibodies (Zymed, San Francisco, CA; 1:50 dilution in PBA), for 30 minutes at
4°C. Fluorescence was measured using a FACScan® (Becton and Dickingson & Co., Oxnard, 
CA) after another PBA wash.
Confocal microscopy
As described for the adhesion assay, 96-well (flat bottom) plates (Maxisorb, Nunc, Roskilde, 
Denmark) were coated with Goat anti-human Fc antibodies (60 minutes at 37°C), 1% BSA in 
TSM (30 minutes at 37°C), followed by ICAM-1Fc, ICAM-3Fc, or CD14Fc containing
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supernatants at the indicated concentrations for 1 hour at 37°C. Freshly isolated resting T cells 
(4x104/well) were incubated on ICAM coated plates for 45 minutes at 37°C. Cells were fixed 
with 0.5% paraformaldehyde for 15 minutes. Fixed cells were stained with TS2/4 mAb 
(10ng/ml) for 30 minutes at 4°C, followed by incubation with FITC-labeled Goat anti-mouse 
secondary antibodies (Zymed, San Francisco, CA; 1:50 dilution in PBA), for 30 minutes at 
4°C. Cells were attached to poly-L-lysine coated glass slides, after which cell surface 
distribution of LFA-1 was determined by Confocal Laser Scanning Microscopy (CLSM) at 
488 nm with a krypton/argon Laser (Bio-Rad, Hercules, CA). The same instrument settings 
were used throughout the experiments.
Co-stimulation assay
96-well (flat bottom) plates (Maxisorb, Nunc, Roskilde, Denmark) were coated with 
suboptimal concentrations of anti-CD3 antibodies (T3b, 30 ng/ml; 50 nl/well, 1 hour 37°C), 
followed by Goat anti-human Fc antibodies (Jackson immunoresearch laboratories, Inc., 
Westgrove, PA; 4 ng/ml, 50 nl/well, 1 hour 37°C), 1% BSA (100 nl/well, 30 minutes, 37°C) 
and ICAM-1Fc proteins (200 ng/well; 50 nl/well, 1 hour at 37°C). Resting T cells were added 
(1x105 cells/well in RPMI 1640 (Gibco) + 10% FCS) and cultured for three days. On day 3, 
cells were pulsed for 16 hours with [3H]-thymidine (1.52 TBq/mmol, 0.5 nCi/well, 
Amersham, Buckinghamshire, UK), to measure ICAM-1-dependent proliferation. Cells were 
cultured in the presence of the indicated function blocking antibodies at a concentration of 10 
ng/ml.
Results
ICAM-3 is unable to support LFA-1 mediated adhesion of resting T cells
To determine the role of ICAM-3 in adhesion of T lymphocytes, we compared the capacity of 
LFA-1-expressing resting T cells with activated T cells to bind to ICAM-1Fc or ICAM-3Fc 
proteins (Fig. 1). As resting T cells, PBL and the Peer T cell line were used, whereas the 
HSB-2 T cell line is more activated, as the cells grow in clusters due to the active state of the 
integrins. Maximal adhesion of activated HSB-2 T cells to ICAM-1Fc could be observed at 
all ICAM-1Fc concentrations (25-500 ng/ml), without prior activation of LFA-1 (Fig. 1A), 
indicating that LFA-1 is quite active on HSB-2 T cells. In contrast, HSB-2 T cells did not 
spontaneously bind ICAM-3. Upon further activation of LFA-1 with the activating antibody 
KIM185, HSB-2 T cells bound to ICAM-3 Fc (50%) (Fig. 1B), although to a lesser extent 
than to ICAM-1Fc proteins (70%), since a 12 fold higher concentration of ICAM-3Fc was 
required for maximal adhesion.
When adhesion of resting T cells was examined, they were found to adhere less well to 
ICAM-1Fc when compared to activated T cells (Fig. 1C), since adhesion required activation 
of LFA-1, and higher ICAM-1Fc concentrations (200 ng/ml) were needed for maximal 
adhesion (60%). In contrast, even upon activation of LFA-1, resting T cells could not adhere 
to ICAM-3Fc (<8%), at all concentrations tested (Fig. 1D). Similarly, resting T cell lines,
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Figure 1. Adhesion o f resting and activated T lymphocytes to ICAM-1Fc and ICAM-3Fc.
Calcein labeled activated HSB-2 T cells (A, B), resting T lymphocytes (C, D), Peer T cells (E, 
F), or LFA-1-transfected K562 cells (G, H) were incubated on plates coated with anti-human 
Fc mAb and ICAM-1Fc (A, C, E, G) or ICAM-3Fc (B, D, F, H) proteins at concentrations 
ranging from 25-500 ng/ml, for 45 min at 37°C, in the absence (diamonds) or presence of the 
phorbolester PMA (50 nM) (squares), or the LFA-1 activating mAb KIM185 (10 Jg/ml) 
(triangles). After washing away non-bound cells, fluorescence was quantified. Results are 
expressed as the mean % of LFA-1/ICAM-1 specific adhesion, o f triplicate wells. Specific 
adhesion: percentage of bound cells minus percentage of cells bound in the presence of a 
LFA-1 blocking antibody (NKI-L15). Data are representative of three experiments.
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such as Peer T cells, but also LFA-1 expressing transfectants, such as K562-LFA-1 did not 
bind to any concentration of ICAM-3Fc coated (Fig. 1F, 1H), while LFA-1 expressed by 
these cells was capable to bind ICAM-1 (Fig. 1E, 1G). The fact that resting T cells bind less 
well ICAM-1Fc or ICAM-3Fc than activated T cells was not due to the fact that they express 
lower levels of LFA-1 on the cell surface (Table I). These results clearly indicate that while 
activated T cells bind to both ICAM-1 and ICAM-3, resting T cells only bind to ICAM-1 and 
fail to bind ICAM-3, even after strong activation of LFA-1 by an activating antibody.
Table I. LFA-1 expression levels
Cells
Relative fluorescence intensity
Control TS2/4
HSB-2 3 (2)1 131 (100)
PBL 4 (1) 132 (96)
Peer 3 (1) 137(100)
K562-LFA-1 3 (2) 200 (98)
1 Percentage positive cells
Low-affinity interaction of LFA-1 with recombinant ICAM-3 enhances LFA-1-mediated 
adhesion to ICAM-1
We next investigated whether low-affinity interactions of LFA-1 with ICAM-3 could regulate 
LFA-1-mediated adhesion to the high affinity LFA-1 ligand ICAM-1. Therefore, we 
analyzed adhesion of resting T cells, such as Peer T cells, to wells coated with a combination 
of ICAM-1Fc and ICAM-3Fc proteins, or wells coated with only ICAM-1Fc or ICAM-3Fc. 
Figure 2A shows that although coated ICAM-3Fc was unable to support adhesion of Peer T 
cells, interaction of LFA-1 with immobilized ICAM-3Fc enhanced LFA-1-mediated adhesion 
of Peer T cells to ICAM-1Fc upon activation of LFA-1 with the activating antibodies MEM- 
48 or KIM185. The observed ICAM-3 dependent increase in adhesion was specific, since 
coating of a combination of ICAM-1Fc with CD14Fc on the plate did not increase LFA-1 
mediated ICAM-1 adhesion (data not shown). To exclude the involvement of other ß2 
integrins or ICAM-3 signaling on Peer T cells, we used K562-LFA-1 transfectants that only 
expressed LFA-1 and no ICAM-3. Figure 2B again demonstrates that interaction of LFA-1 
with ICAM-3Fc only did not lead to any cell binding. However, when ICAM-3Fc was 
immobilized together with ICAM-1Fc, adhesion was specifically enhanced to ICAM-1Fc 
(30% increase) when stimulated with KIM185 or MEM-48. PMA did not induce any adhesion 
of K562-LFA-1 or Peer T cells since LFA-1 expressed in these cells is not responsive to PMA 
(Lub et al., 1997b).
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Figure 2. Solid phase ICAM-3Fc enhances adhesion o f Peer T cells or K562-LFA-1 
transfectants to ICAM-1Fc. Flat bottom wells pre-coated with anti-human Fc antibodies and 
ICAM-lFc (25 ng/ml), were coated with ICAM-3Fc at 50 ng/ml (closed bars). As a control, 
wells were coated with ICAM-1Fc (25 ng/ml) (open bars) or ICAM-3Fc (50 ng/ml) (hatched 
bars) alone. Resting Peer T cells (A) or K562-LFA-1 transfectants (B) were incubated on the 
coated plates in the absence or the presence of the phorbolester PMA (50 nM), or the LFA-1 
activating antibodies MEM-48 or KIM185 (10 jig/ml). Results are expressed as the mean % 
of LFA-l/ICAM-1 specific adhesion of triplicate wells calculated as in Fig. 1. Data are 
representative of three experiments.
Only little amounts of coated ICAM-3Fc were required to enhance LFA-1-mediated adhesion 
to ICAM-1Fc, since maximal increase of adhesion was already observed at an ICAM-3Fc 
concentration of 50 ng/ml (Fig. 3A). No increase of adhesion was observed in the presence of 
blocking antibodies directed against ICAM-3, confirming that the observed increase of 
adhesion to ICAM-1 was ICAM-3 dependent (Fig. 3B). Together, these data show that low- 
affinity interactions of LFA-1 with ICAM-3 can regulate LFA-1/ICAM-1 binding in resting T 
cells.
Enhanced clustering of LFA-1 upon low-affinity interaction with recombinant ICAM-3
Since clustering of LFA-1 on the cell surface has been shown to enhance LFA-1-mediated 
adhesion to ICAM-1 (Van Kooyk et al., 1994; Lub et al., 1995) we investigated whether low- 
affinity LFA-1/ICAM-3 interactions enhanced binding to ICAM-1 through reorganizing 
LFA-1 on the cell surface of resting T cells. Using Confocal Laser Scan Microscopy, we 
observed that the surface membrane distribution of LFA-1 on resting T cells, stained with the 
non-activating mAb TS2/4, is dramatically altered upon ICAM-3 binding (Fig. 4). We found 
that LFA-1 is homogeneous distributed on resting T cells upon interaction with uncoated
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plates (Fig. 4A) or coated with ICAM-1Fc or ICAM-3Fc alone (Fig. 4B, 4C). In contrast, 
when resting T cells came in contact with both immobilized ICAM-1Fc and ICAM-3Fc (Fig. 
4E, 4F), the organization of LFA-1 on the cell surface is dramatically altered into a more 
clustered distribution. The number of LFA-1 molecules was not increased since surface 
expression experiments (FACS analysis) resulted in equal staining of LFA-1 in all 
experimental settings (table II), nor was LFA-1 activated as determined by activation-epitope- 
dependent mAb NKI-L16 and M24 (table II). In addition, binding of PBLs to ICAM-1, 
ICAM-3, or ICAM-1+ICAM-3 is not due to enrichment for any T cell subsets such as CD4, 
CD8, CD45RA, or CD45RO as shown in table II. Furthermore, the induced clustering of 
LFA-1 was ICAM-3 specific, since coating of CD14Fc together with ICAM-1Fc did not 
induce a clustering of LFA-1 on the cell membrane, as the LFA-1 distribution was similar as 
on T cells that came in contact with non-coated wells (Fig. 4D). This indicates that the low- 
affinity interaction of LFA-1 with ICAM-3 and ICAM-1 primes LFA-1 to form clusters. 
Further activation of LFA-1 by activating antibodies can than enhance the adhesion of T cells 
to ICAM-1.
ICAM-1Fc ICAM-3Fc ICAM-1Fc + 
ICAM-3Fc
Figure 3. Immobilized ICAM-3Fc specifically enhances adhesion o f K562-LFA-1 
transfectants to ICAM-1Fc. Flat bottom wells pre-coated with anti-human Fc antibodies and 
ICAM-lFc (25 ng/ml), were coated with ICAM-3Fc at a range of concentration of 0-500 
ng/ml (A), or 50 ng/ml (B). K562-LFA-1 transfectants (A) were incubated on the coated plates 
in the absence (diamonds) or the presence of the phorbolester PMA (50 nM) (squares), or the 
LFA-1 activating antibodies MEM-48 (circles) or KIM185 (10 fJg/ml) (triangles). In (B), 
K562-LFA-1 cells were incubated in the presence or absence of blocking antibodies directed 
against ICAM-3 (186-269) or LFA-1 (NKI-L15). Cells were unstimulated (hatched bars) or 
stimulated with the LFA-1 activating antibodies MEM-48 (open bars) or KIM185 (10 /Jg/ml) 
(closed bars). As a control, wells were coated with ICAM-1Fc (25 ng/ml) or ICAM-3Fc (50 
ng/ml) alone. Results are expressed as the mean % of LFA-1/ICAM-1 specific adhesion of 
triplicate wells calculated as in Fig. 1. Data are representative o f three experiments.
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Figure 4. Low-affinity interaction with ICAM-3 enhances LFA-1 clustering on ICAM-1.
Flat bottom wells were coated with only anti-human Fc antibodies (A), or precoated with 
anti-human Fc antibodies followed by 40 ng/ml ICAM-1Fc (B), 50 ng/ml ICAM-3Fc (C), 30 
ng/ml ICAM-1 and 50 ng/ml CD14Fc (D), or 30 ng/ml ICAM-1Fc and 50 ng/ml ICAM-3Fc 
(E), or 40 ng/ml ICAM-1Fc and 50 ng/ml ICAM-3Fc (F). Resting T cells were incubated on 
the ICAM coated wells for 45 minutes at 37oC. Cells were harvested and stained with the non­
activating anti-LFA-1 mAb TS2/4 (10 Jg/ml) and FITC-labeled secondary antibodies. 
Fluorescence distribution was determined by Confocal Laser Scanning Microscopy at 488 
nm. The instrument settings were the same for the distinct panels. One representative 
experiment out of five is shown.
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Table II. Expression patterns of PBL after adhesion to ICAM-1 / ICAM-3 substrate
Relative fluorescence intensity 2
Coating 1 Control VPS -L7 3 NKI-L16 M24 M24 Mn2+ CD4 CD8 CD45RO CD45RA
medium 2 (3) 274 (99) 88 (99) 23 (10) 124 (98) 119 (45) 372 (36) 110 (73) 107 (78)
ICAM-1 3 (1) 852 (99) 60 (96) 7 (2) 103 (98) 2 o 5 0)(441 3)(76 100 (76)
ICAM-3 3 (3) 872 (99) 66 (94) 8 (3) 84 (96) 0)(630 0)(4041 4)(78 97 (69)
ICAM-1+ICAM-3 3 (3) 282 (99) 70 (96) 7 (8) 92 (98) 117 (51) 403 (40) 112 (71) 103 (72)
1 PBL were allowed to adhere to wells coated with medium, 40 ng/ml ICAM-1, 50 ng/ml ICAM-3, or 40 ng/ml 
ICAM-1 and 50 ng/ml ICAM-3 for 45 min at 37oC.
2 Mean fluorescence and (percentage positive cells).
3 Antibodies used: SPV-L7, anti-CD11a; NKI-L16 and M24 are LFA-1 activation-dependent-epitope antibodies; 
M24 with 2mM Mn2+; RIV-6 for anti-CD4; wt82 for anti-CD8; anti-CD45RO and anti-CD45RA.
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ICAM-1Fc +CD3 
+ anti CD11a 
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+ anti ICAM-1 
+ anti ICAM-3
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Figure 5. Co-stimulation o f resting T cells by recombinant ICAM-1Fc is inhibited by anti- 
ICAM-3 mAb. (A) After culturing resting T cells for three days at 37°C on plates coated with 
ICAM-lFc proteins, suboptimal amounts of anti-CD3 antibodies (white bars), or both (black 
bars), proliferation was determined using [3H]-thymidine incorporation. To determine the 
specificity of proliferation, cells were incubated in the presence or absence of blocking 
antibodies (10 pg/ml) directed against LFA-1 (NKI-L15), ICAM-1 (REK-1), ICAM-2 (CBR- 
IC2/2), ICAM-3 (186-269), or the anti-CD11a I  domain antibody YTH81.5 that selectively 
inhibits LFA-1 interaction with ICAM-3. (B, C) Photomicrographs ofco-stimulated T cells on 
ICAM-1 coated plates incubated for three days in the absence (B) or presence (C) of anti- 
ICAM-3 blocking antibodies (10 pg/ml). Magnification 10x. Proliferation from triplicate 
wells is depicted. Data are representative of three experiments.
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LFA-1/ICAM-3 interactions are critical for ICAM-1-induced T cell proliferation
Since these results indicate that low-affinity interactions of LFA-1 with ICAM-3 enhance 
LFA-1/ICAM-1 dependent adhesion, we subsequently investigated the role of ICAM-3 in 
LFA-1/ICAM-1 dependent T cell proliferation. To this end we analyzed co-stimulation of T 
cells induced by adding T cells by coated ICAM-1Fc proteins and suboptimal amounts of 
anti-CD3 antibodies (Fig. 5A). Incubation of resting T cells on these ICAM-1Fc and anti-CD3 
coated plates resulted in strong proliferation, that was LFA-1 and ICAM-1 dependent, since it 
was prevented by addition of blocking antibodies directed against CD11a or ICAM-1. 
Surprisingly, LFA-1/ICAM-1 dependent proliferation was completely inhibited by the 
addition of blocking antibodies directed against ICAM-3, or addition of anti-CD11a I domain 
antibodies that selectively blocked LFA-1 binding to ICAM-3 (YTH81.5) (Binnerts et al.,
1996). Blocking the LFA-1/ICAM-2 interaction had no effect on the LFA-1/ICAM-1-induced 
T cell proliferation. Formation of large cell clusters of proliferating cells that are induced 
upon LFA-1/ICAM-1 co-stimulation (Fig. 5B) is completely blocked by the addition of 
blocking anti-ICAM-3 antibodies (Fig. 5C). Together, these results clearly show that weak 
intercellular interactions mediated by LFA-1 expressed by T cells and ICAM-3 present on T 
cells, are necessary for LFA-1/ICAM-1-dependent co-stimulation of resting T lymphocytes.
Discussion
ICAM-3 has been described as an adhesive and signaling counter-receptor for LFA-1, 
although the function of ICAM-3 as an adhesion ligand for LFA-1 remains poorly defined. 
We therefore investigated the role of ICAM-3 on LFA-1/ICAM-1-dependent cell adhesion in 
a purified protein adhesion assay as well as in cell-cell interactions that take place within the 
immune system such as T cell proliferation.
We found that purified ICAM-3 is unable to support adhesion of resting T lymphocytes, 
indicating that ICAM-3 does not directly contribute to the LFA-1-mediated adhesion of these 
cells. However, low-affinity interaction of LFA-1 with recombinant ICAM-3 or cell-bound 
ICAM-3 enhances LFA-1-dependent adhesion to ICAM-1 and proliferation. By confocal 
microscopy studies, we demonstrated that ICAM-3 in combination with ICAM-1 enhances 
clustering of LFA-1 on the cell surface of resting T cells, thereby enhancing the avidity of 
LFA-1/ICAM-1 interactions. We demonstrated that low-affinity LFA-1/ICAM-3 dependent 
intercellular interactions are critical for co-stimulation of resting T cells induced by 
recombinant ICAM-1. This indicates that interaction of the LFA-1/ICAM-3 binding does not 
directly contribute to intercellular adhesion of T cells but rather induces subtle conformational 
changes in LFA-1, such as redistribution of LFA-1 on the cell surface, that allow optimal 
adhesion to ICAM-1 and subsequent signaling.
Low-affinity LFA-1/ICAM-3 interactions enhance LFA-1 function, but are not sufficient 
to induce adhesion of LFA-1 to ICAM-1, since enhancement of adhesion is only observed 
upon activation of LFA-1 with LFA-1 activating antibodies, anti-CD3, or antigen (Fig 2,5,6). 
It is possible that binding of ICAM-3 to LFA-1 induces a ligand-dependent conformational
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change in LFA-1 that facilitates its subsequent interaction with ICAM-1. Although it has been 
shown that fixation of LFA-1 molecules in an ICAM-1 bound state facilitates subsequent 
interaction with other ICAM-1 or ICAM-3 molecules (Cabanas and Hogg, 1993; Buckley et 
al., 1997), it is hard to envisage how LFA-1 molecules can maintain a conformation induced 
by weak interaction with ICAM-3 once this ligand dissociates from LFA-1. Alternatively, 
upon engagement of LFA-1 by ICAM-3, LFA-1 may transmit signals into the cell that 
enhance LFA-1 function. Upon ligand binding, ß1 and ß3 integrins organize into structures 
called focal adhesions that strengthen integrin adhesion by linking them to the cytoskeleton. 
These focal adhesions contain a variety of cytoskeletal proteins and signaling molecules 
(Burridge and Fath, 1989; Clark and Brugge, 1995; Craig and Johnson, 1996). Whether ß2 
integrins form similar focal adhesions is not well established. However, it has been shown 
that the ß2 cytoplasmic tail can link to the cytoskeletal proteins a-actinin and filamin 
(Pavalko and LaRoche, 1993). It is tempting to speculate that upon engagement of LFA-1 by 
ICAM-3, proteins involved in ß2-mediated signal transduction associate with the cytoplasmic 
domains of LFA-1, thereby facilitating stable interaction of LFA-1 with ICAM-1.
Certainly, the expression levels of LFA-1 are not different on activated versus resting T 
cells. However, the distribution of LFA-1 on activated T cells, such as HSB-2, is extremely 
different than that on resting T cells (data not shown). We earlier reported that the clustered 
distribution of LFA-1 on activated T cells, versus the homogeneous distribution of LFA-1 on 
the surface of resting PBL reflects the adhesive state of LFA-1 (Figdor et al., 1990; Van 
Kooyk et al., 1994). Clustering of LFA-1 seems to regulate LFA-1 activation dynamically 
since it has been reported by various groups that avidity alterations in LFA-1 enhance LFA- 
1/ICAM-1 adhesion. It has been demonstrated that during activation of resting T cells in 
culture, LFA-1 organizes into clusters on the cell surface and facilitate LFA-1/ICAM-1 
interactions (Van Kooyk et al., 1991, 1994; Kucik et al., 1996). Similarly, also disconnection 
of LFA-1 from the cytoskeleton network by agents that disrupt the actin cytoskeleton, such as 
Cytochalasin D, or by deletion of the cytoplasmic tails, has been shown to result in a 
constitutively active LFA-1 receptor, that is redistributed into clusters on the cell surface (Lub 
et al., 1997a; Van Kooyk et al., 1999). This clearly demonstrates the importance of avidity 
changes that stimulate adhesive properties of LFA-1. In this study, we show that also the cell 
surface redistribution of LFA-1 can dramatically alter upon ICAM-3 ligand binding (low 
affinity interaction of ICAM-3 in combination with ICAM-1), and results in an increase of the 
avidity of LFA-1/ICAM-1 interactions. This finding gives ICAM-3 a new function being not 
only a low affinity adhesion ligand for LFA-1, but regulating LFA-1 avidity by altering the 
surface distribution of LFA-1 on resting T cells.
ICAM-3 induced LFA-1-mediated binding to ICAM-1 has been reported in the past, 
however, in these studies ICAM-3 adhesion was achieved by activating anti-ICAM-3 
antibodies that induce T cell aggregation (Campanero et al., 1993). In these studies, it is still 
questionable whether LFA-1/ICAM-1 interactions were the result of initial ICAM-3 binding 
or by ICAM-3-mediated signaling through cross-linking ICAM-3 with an antibody. Several 
groups have reported that antibody cross-linking of ICAM-3 induces co-stimulation, elevation 
of intracellular calcium levels, activation of Src family kinases, tyrosine phosphorylation of
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Figure 6. Model for the role ofICAM-3 in LFA-1 adhesion and signaling between T and/or 
B cells. Depicted is the interaction of an LFA-1 expressing effector cell with a target cell that 
expresses both ICAM-1 and ICAM-3. Low-affinity interaction of LFA-1 on the T cell with 
ICAM-3 on the target cell (1), induces redistribution/clustering of LFA-1 (2), to prime LFA-1 
for activation. When upon anti-CD3 triggering or antigen recognition intracellular signals 
enhance the affinity of LFA-1 for ICAM-1 (3), stable LFA-1/ICAM-1 cell-cell interaction will 
be induced (4). Ultimately, signals transmitted by LFA-1 upon ICAM-1 binding result in the 
induction of T cell proliferation, cytotoxicity and expression of genes (5).
intracellular proteins, and morphological changes in T cells (Hernandez-Caselles et al., 1993; 
Campanero et al., 1993; Juan et al., 1994; Arroyo et al., 1994; Cid et al., 1994; Delpozo et al., 
1994). It remains possible that low-affinity LFA-1/ICAM-3 interactions are sufficient to elicit 
ICAM-3-dependent signal transduction in lymphocytes. So far, ICAM-3-dependent signaling 
has only been studied upon cross-linking with anti-ICAM-3 antibodies. Whether binding of 
ß2 integrins to ICAM-3 results in ICAM-3-dependent signal transduction remains to be seen. 
We here show that ICAM-3-induced LFA-1/ICAM-1 binding occurs equally well upon initial 
interaction of LFA-1 to ICAM-3 expressed on cells or presented as purified protein (ICAM- 
3Fc), clearly demonstrating that this interaction is independent from ICAM-3-induced 
signaling.
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Our results indicate that ICAM-3 plays a pivotal role in the regulation of various 
leukocyte intercellular interactions. Despite the low affinity of LFA-1 for ICAM-3, the high 
expression of ICAM-3 on resting leukocytes, compared to ICAM-1 or ICAM-2, makes it an 
ideal initial counter-receptor for LFA-1. Accordingly, it has been demonstrated that adhesion 
of resting T lymphocytes to LFA-1 occurs primarily via ICAM-3 (De Fougerolles and 
Springer, 1992). In a second step, the initial interaction of ICAM-3 with LFA-1 on the 
opposite cell can affect the redistribution of LFA-1 into clusters, facilitating LFA-1-mediated 
adhesion to ICAM-1, which establishes a more stable cell-cell interaction. This putative role 
of ICAM-3 can be essential to initiate T cell proliferation after TCR engagement, mixed 
lymphocyte reactions, in lysis of target cells by NK cells, and T-B cell interactions.
In summary, our results show for the first time that physiological low-affinity interactions 
between LFA-1 and ICAM-3 strengthen LFA-1-dependent ICAM-1 adhesion. Based on our 
results, we propose a novel model for the interaction of resting T cells with target cells such 
as T or B cells (Fig. 6). In this model, low-affinity interactions of LFA-1 expressed on the T 
cell occur with ICAM-3 and ICAM-1 on the counter cell, which is not measurable in adhesion 
assays. This low-affinity ICAM-3 binding redistributes LFA-1 on the cell surface by 
reorganization of LFA-1 into clusters, making it ready to bind ICAM-1. When intracellular 
signals arrive the clustered LFA-1, such as via or through anti-CD3 triggering or antigen 
recognition, these signals activate LFA-1. The clustered and activated LFA-1 can then bind its 
high affinity ligand ICAM-1, allowing the T cell to bind to the counter cell and to enable 
proliferation and proper delivery of the cytolytic hit. Since ICAM-3 is restricted to cells of 
hematopoietic origin, it is tempting to speculate that the main function of ICAM-3 in the 
interactions between T and B cells is to enhance the adhesive interaction of LFA-1 with 
ICAM-1 through redistribution of LFA-1.
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ß2 cytoplasmic domain in LFA-1 signaling
Abstract
The leukocyte specific ß2 integrin LFA-1 (aL/ß2) mediates activation-dependent adhesion to 
ICAM-1. In leukocytes, LFA-1 requires activation by intracellular messengers in order to 
bind ICAM-1. We observed malfunctioning of LFA-1 activation in leukemic T cells and 
K562 transfected cells. This defective inside-out integrin activation is only restricted to ß2 
integrins, as ß1 integrins expressed in K562 readily respond to activation signals, such as 
PMA. To unravel these differences in inside-out signaling between ß1 and ß2 integrins, we 
searched for amino acids in the ß2 cytoplasmic domain that are critical in the activation of 
LFA-1. We provide evidence that substitution of a single amino acid (L732R) in the ß2 
cytoplasmic DLRE motif, creating the DRRE motif, is sufficient to completely restore PMA 
responsiveness of LFA-1 expressed in K562. In addition, an intact TTT motif in the C- 
terminal domain is necessary for the required PMA responsiveness. We observed that 
restoration of the PMA response did not alter LFA-1 affinity nor the phosphorylation status of 
LFA-1. In contrast, strong differences were observed in the capacity of LFA-1 to form
clusters which indicates that inside-out activation of LFA-1 strongly depends on cytoskeletal
2+induced receptor reorganization that was induced by activation of the Ca -dependent protease 
calpain.
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Introduction
The lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; aL/ß2) is a member of 
the leukocyte integrin family. LFA-1 expression is leukocyte specific and mediates adhesive 
interactions between cells. The ß2 integrin LFA-1 consists of a common ß2 subunit that is 
non-covalently associated with an aL subunit (Springer, 1990). By binding to the intercellular 
adhesion molecule (ICAM)-1, LFA-1 is important in mediating cellular interactions in the 
immune system such as cytotoxic T cells and natural killer cell-mediated cytotoxicity, helper 
T lymphocyte responses, and leukocyte adhesion (Krensky et al., 1983; Martz, 1987; van 
Kooyk et al., 1993; Imhof and Dunon, 1995).
LFA-1 has to be activated via outside-in or inside-out signals in order to efficiently bind 
ICAM-1. Outside-in signaling has been identified by LFA-1 activating antibodies (Andrew et 
al., 1993) or immobilized ligands resulting in cell spreading, rise in intracellular Ca2+ and pH, 
phosphorylation of proteins, and co-stimulatory signals (Wacholtz et al., 1989; Figdor et al., 
1990). Inside-out signals are initiated upon triggering of specific cell surface molecules, 
generating intracellular signals that induce a high affinity and/or avidity state of LFA-1 
(Dustin and Springer, 1989). Both conformational changes (affinity) in the presence of Mg2+ 
and altered surface distribution of LFA-1 into clusters (avidity) upon Ca2+ binding results in 
strong ligand binding (Rothlein and Springer, 1986; Figdor et al., 1990; van Kooyk et al.,
1994).
Although the aL and ß2 cytoplasmic domains of LFA-1 are relatively short and do not 
contain any intrinsic kinase activity, they are important for affinity and avidity regulation. 
Previous studies have shown that LFA-1 adhesiveness is controlled by the cytoplasmic 
domain of the ß2 subunit, since truncation of the cytoplasmic ß2 domain, but not the aL 
domain, eliminates LFA-1 binding to ICAM-1 (Hibbs et al., 1991a). Complete deletion of the 
ß2 cytoplasmic domain results in clustering and spontaneous activation of LFA-1. This 
constitutively active LFA-1 deletion mutant strongly binds to ICAM-1. The phorbol ester 
PMA that activates PKC cannot further increase the adhesion to ICAM-1 of this constitutive 
active LFA-1, in contrast to wild-type LFA-1 (Lub et al., 1997a). It has been proposed that the 
aL cytoplasmic domain of LFA-1 is involved in post-ligand binding events, since deletion of 
the cytoplasmic aL domain does not affect binding to ICAM-1 (Hibbs et al., 1991a). Also 
cytoskeleton restraints play a crucial role in regulating LFA-1 avidity, since clustering of 
LFA-1 is induced on resting PBLs after treatment with cytochalasin D (Lub et al., 1997b). 
Interestingly, this is not the case for ß1 integrins, indicating that ß2 and ß1 integrins differ in 
their ability to cluster into specialized lipidic membrane microdomains, also termed rafts 
(Pande, 2000). Replacement of the ß2 cytoplasmic domain for that of ß1 (aL/ß2/ß1) creating 
a chimeric LFA-1 molecule containing a ß1 cytoplasmic domain provided us with additional 
evidence. The chimeric LFA-1 (aL/ß2/ß1) showed a clustered cell surface distribution when 
expressed in the erythroleukemic cell line K562. Furthermore, PMA activation of the 
chimeric LFA-1 molecule increased the adhesion to ICAM-1. This in contrast to wild-type
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LFA-1, that when expressed in K562 is not clustered and is defective for PMA-induced 
activation (Lub et al., 1997a).
Several regions within the ß2 cytoplasmic domain are thought to be important in 
regulating LFA-1. Alanine substitutions of conserved threonines (TTT) in the ß2 cytoplasmic 
domain reduce ICAM-1 binding and a serine residue is phosphorylated upon PKC activation 
by PMA (Hibbs et al., 1991b). There are different consensus sequences known in the ß2 
cytoplasmic domain that can associate with intercellular components, such as cytohesin-1 
(Kolanus et al., 1996), Rack1 (Liliental and Chang, 1998), and a-actinin (Pavalko and 
LaRoche, 1993).
The observation that, despite their homology, ß2 and ß1 integrins are differently 
regulated by inside-out signals, prompted us to identify residues within the ß2 cytoplasmic 
domain that are involved in the PMA induced LFA-1 mediated ligand binding. To this end we 
substituted ß2 amino acids for those of the ß1 cytoplasmic domain that are critical for PMA 
induced adhesion in K562 cells. We observed that a single ß2/ß1 amino acid substitution is 
sufficient to completely restore the PMA responsiveness by enhancing LFA-1 avidity, but not
the affinity. In addition, we observed that activation of LFA-1 by PMA is dependent on
2+cytoskeletal rearrangements that seem to be mediated by the Ca -dependent protease calpain.
Materials and Methods
Monoclonal antibodies
The monoclonal antibodies (mAbs) SPV-L7 (IgG1), NKI-L15 (IgG2a), and NKI-L16 (IgG2a) 
reactive with the a  chain of LFA-1 were raised as described previously (Keizer et al., 1988). 
The non-blocking mAb TS2/4 (IgG1) reactive with aL (Sanchez-Madrid et al., 1982), mAb 
60.3 (IgG1) directed against ß2 (Beatty et al., 1983), and mAb KIM185 (IgG1) used to 
activate ß2 integrins (Andrew et al., 1993), were kindly provided by Drs E Martz , N. Hogg, J. 
Harlan, and M. Robinson, respectively. The blocking mAb SAM-1 (IgG1) was directed 
against the a5 chain of VLA-5 (Keizer et al., 1987).
DNA constructs
The 4.2 kb a  chain of LFA-1 was cloned in the XbaI site of the pCDM8 vector, that directs 
expression of aL from the CMV AD169 immediate early promoter (pCDL1). The 3' end of 
ß2 was cloned as an EcoR1-BglII fragment in the pRc/CMV vector (containing a neomycin 
resistance gene; Invitrogen Corporation, San Diego, CA). Within this sequence is a unique 
ApaI site at position 1980. The C-terminal end was rebuilt from this site using 10 overlapping 
oligonucleotides and amplification by PCR to obtain the appropriate hybrids. For the ß2/ß1 
chimeric protein, amino acid 752 of ß1 cytoplasmic domain was joined to the amino acid 732 
of ß2. The deletion mutant of LFA-1 was made by truncation of the ß2 cytoplasmic domain 
from amino acid 724 (Lub et al., 1997a). All point mutations in the ß1 and ß2 cytoplasmic 
domain were generated by the oligonucleotide-directed pAlter® mutagenesis system
73
Chapter 4
(Promega, Madison, WI) according to the protocol. The following oligonucleotides were 
used: L732R-ß2, CTGAGCGACCGCCGGGAGTAC; Y735F-ß2, CTCCGGGAGTTCAG- 
GCGCTTTG; S756C-ß2, CCCCTTTTCAAGTGCGCCACCACGACG; T758V-ß2, TTCAA- 
GAGCGCCGT C ACGACGGT CAT GAAC; F766Y-ß2, AACCCCAAGTATGCTGAGAG; 
R732L-ß1, AT A ATT CAT GACC T A AGGGAGTTTGC ;. For the deletion mutants the 
following oligonucleotides were used: A731-ß2, CACCTGAGCGACTAACGGGAGTACA- 
GG; A732R-ß2, TGAGCGACCGCTGAGAGTACAGGC; A732L-ß2, AGCGACCTCTGAG- 
AGTACAGG. Both double mutants L732R+S756C-ß2 and L732R+T758V-ß2 were created 
using L732R-ß2 as template and subsequent mutagenesis with the appropriate 
oligonucleotides for the S756C-ß2 and T758V-ß2 point mutation. All mutations were verified 
by nucleotide sequencing of the region encoding the cytoplasmic domain.
Cell culture and transfection
Stable LFA-1 expressing K562 transfectants were established by electroporation of 107 cells 
in 0.8 ml PBS at 280V and 960^F with the wild-type aL (in pCDM8) together with wild-type 
ß2 subunit (in pRc/CMV), truncated ß2 subunit, chimeric ß2 subunit, or point mutated ß2 
subunit (Lub et al., 1997a). K562-LFA-1 transfectants were cultured in RPMI 1640 medium 
(Life Technologies ltd, Paisley, Scotland), supplemented with 10% fetal calf serum (Bio 
Whitaker, Verviers, Belgium), 1% antibiotics/antimycotics (Life Technologies, Inc., Grand 
Island, NY). After 48 hrs the neomycin analogue, geneticin (2 mg/ml; Life Technologies ltd, 
Paisley, Scotland) was added to the culture medium. The different transfectants were sorted 
three or more times to obtain a homogeneous population of cells expressing high levels of 
LFA-1. Positive cells were stained with FITC-conjugated TS2/4 mAb and isolated using a 
Coulter Epics Elite cell sorter (Coulter, Hialeah, FL).
Immunofluorescence analysis
Expression of LFA-1 on the transfectants was determined by immunofluorescence. Cells 
(2.105) were incubated (30 min, 4°C) in PBS, containing 0.5% wt/vol BSA (Boehringer, 
Mannheim, Germany) and 0.01% sodiumazide (10 mM; Merck, Hohenbrunn, Germany), with 
appropriate dilutions of either an anti-integrin mAb or an isotype matched control antibody, 
followed by incubation with (FITC)-labeled goat (Fab')2 anti-mouse IgG mAb (Zymed 
laboratories, San Francisco, CA) for 30 min at 4°C. The relative fluorescence intensity was 
measured by FACScan analysis (Becton Dickinson & Co., Oxnard, CA).
Fluorescent beads adhesion assay
For cell adhesion to ICAM-1 cells were resuspended in TSA (TSM (20 mM Tris-HCl pH 8.0, 
150 mM NaCl, 1mM CaCl2, 2 mM MgCl2), 0.5% BSA (w/v); 5x106 cells/ml). Cells (50.000) 
were pre-incubated with/without LFA-1-blocking mAb (20 pg/ml) for 10 min at RT in a 96- 
wells V-shaped bottom plate. Carboxylate-modified TransFluoSpheres (488/645 nm, 1.0 pm; 
Molecular Probes) were coated with adhesion ligands (ICAM-1 Fc) as described earlier 
(Geijtenbeek et al., 1999). The ligand-coated TransFluoSpheres (20 beads/cell) and different
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A ß2 extracellular dom ain TM  cytoplasm ic dom ain ß 2
ß2 KALIHLSDLREYRRFEKEKLKS QWNND N P L F KSATTTVM N P K F A ES
L73 2 R-ß2 KALIHLSDR REYRRFEKEKLKSQ WNN DN PLFKSATTTVMN PKFAES
Y7 3 5F -ß 2  KALIHLSDLREF RRFEKEKLKS Q WNN DNPLFKSATTTVMN PKFAES
S7 5 6 C -ß2  KALIHLSDLREFRRFEKEKLKSQ WN N DN PL FK CATTTVMNPKFAES
T7 5 8V-ß2 KALIHLSDLREYRRFEKEKLKS Q WN N DN PL FKS AVTTVMN PKFAES
F7 6 6Y-ß2 KALIHLSDLREYRRFEKEKLKS Q WN N DN PLFKSATTTVMN P KYAES
A 7 3 2 L  ß2  KALI HLS DL
A 7 3 2 R - ß 2  KALIHLSDR
A 7 3 1 - ß 2  KALIHLSD
B ß2 extracellular dom ain TM  cytoplasm ic dom ain ß 1
ß 1 KLL MIIHDRRE FAKFE KE KMNAKWDT GE N P I Y KSAVTTVVN P K Y EGK 
R7 3 2 L -ß1  KLL MIIHDL REFAKFEKEKM NAK W DTGEN PIYKSAVTTVVN P KYEGK 
A 7 3 1 - ß 1  KLL MIIHD
Figure 1. Schematic diagram of ß1 and ß2 subunit point mutants. Wild-type ß1 (A) and ß2
(B) subunits are composed of a large extracellular part, a transmembrane region (TM), and a 
cytoplasmic domain. Mutations in the cytoplasmic domain of ß2 amino acids substituted for 
ß1 residues (A) and visa versa (B) are in bold. Depicted is the one letter amino acid code.
integrin stimuli (100 nM PMA (Calbiochem, La Jolla, CA) or LFA-1-activating mAb 
(KIM185, 10 pg/ml)) were added and the suspension was incubated for 30 min at 37°C. 
Optional, cells were pretreated with 5 |ig/ml cytochalasin D (Sigma) for 15 min at 37°C or 
with 20-100 |ig/ml calpeptin (Calbiochem, La Jolla, CA) for 30 min at 37°C. The cells were 
washed with TSA and incubated for 10 min at RT with FITC-conjugated anti-TS2/4-antibody. 
The cells were washed with TSA and resuspended in 100 pl TSA. The LFA-1 transfectants 
that expressed similar levels of LFA-1, as determined by staining for TS2/4-FITC (minimal 
30% of the cells with a mean fluorescence intensity of 70-80), were gated and analyzed for 
LFA-1 mediated adhesion measured by flowcytometry using the FACScan. Values are 
depicted as integrin specific adhesion i.e. cell adhesion percentage minus cell adhesion 
percentage in the presence of an integrin blocking mAb.
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Soluble ICAM-1Fc binding
Transfectants were resuspended in TSA (5x106 cells/ml). Cells (50.000) were pre-incubated 
with/without LFA-1-blocking mAb (20 pg/ml) for 10 min at RT in a 96-wells V-shaped 
bottom plate. Different concentrations of purified soluble ICAM-1Fc were added together 
with medium or the LFA-1-activating mAbs KIM185 (15 pg/ml), and the suspension was 
incubated for 30 min at 37°C. The cells were washed with TSA and incubated for 30 min at 
RT with FITC-conjugated goat-anti-human Fc specific Ab (Jackson Immunoresearch Labs, 
West Grove, PA). Cells were washed with TSA and resuspended in 100 pl TSA. The 
percentage of positive cells was measured by flowcytometry using the FACScan. Values are 
depicted as percentage of positive cells i.e. cell adhesion percentage minus cell adhesion 
percentage in the presence of an integrin blocking mAb. Alternatively, the concentration of 
sICAM-1Fc that gives half-maximal adhesion (ED50) is depicted.
Confocal Microscopy
Cells were fixed with 0,5% paraformaldehyde. Fixed cells were stained with TS2/4 mAb (10 
|ig/ml) for 30 min at 37 °C, followed by incubation with (FITC)-labeled goat (Fab')2 anti­
mouse IgG mAb (Zymed laboratories, San Francisco, CA) 30 min at RT. Cells were attached 
to poly-l-lysine coated glass slides, after which cell surface distribution of integrins was 
determined by Confocal Laser Scanning Microscopy (CLSM) at 488 nm with a krypton/argon 
Laser (Biorad 1000, Hercules, CA). The CLSM settings were: lens, 60x; gain, 1300; pinhole,
1.5 |im; and magnification, 2.0x. The same instrument settings of the CLSM were used 
throughout the distinct experiments.
Results
Substitution of the ß2 by the ß1 cytoplasmic domain restores PMA responsiveness in 
K562 cells transfected with LFA-1
LFA-1 is a cell adhesion receptor that is exclusively expressed on leukocytes. Activation of 
LFA-1 is required for efficient binding to its ligand ICAM-1. Addition of the phorbol ester 
PMA has been shown to activate LFA-1 on leukocytes (Rothlein and Springer, 1986). When 
wild-type LFA-1 is transfected into the erythroleukemic cell line K562 (K562-aL/ß2) (Fig. 1 
and 2), the ß2 activating antibody KIM185 can activate LFA-1 and induce LFA-1-mediated 
adhesion to ICAM-1, however an inside-out activator of LFA-1, such as PMA, cannot 
activate LFA-1 (Fig. 3A; Lub et al., 1997a). This lack of PMA responsiveness of LFA-1 is not 
caused by a general defect of intracellular signal molecules since other endogenous expressed 
integrins like VLA-5 can be activated by PMA to bind its ligand fibronectin. Our finding that 
expression of chimeric LFA-1 containing the ß1 cytoplasmic domain (aL/ß2/ß1) can 
completely restore the PMA responsivess of LFA-1 in K562 cells, prompted us to search for 
single amino acids that differ between the ß1 and ß2 cytoplasmic domain.
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Anti-CD11a Anti-CD18 Anti-CD11a Anti-CD18
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K-aL/ß2
aL/L732R-ß2
aL/Y735F-ß2
aL/S756C-ß2
aL/T758V-ß2
aL/F766Y-ß2
aL/ß2/ß1
aL/R732L-ß1
aL/A732L-ß2
aL/A732R-ß2
aL/A731-ß2
Relative fluorescence intensity
Figure 2. Expression of LFA-1 on LFA-1 transfected K562 cells. K562 transfected with 
LFA-1 were stained with specific antibodies directed against CD11a (SPV-L7), CD18 (60.3), 
or an isotype-matching control antibody The mean fluorescence is indicated in the graphs. 
One out of five experiments is shown.
Substitution of leucine for the ß1 arginine in the DLRE motif of the ß2 cytoplasmic 
domain restores PMA responsiveness of LFA-1 in K562 cells
To analyze in detail the regions in the ß1 cytoplasmic domain that are responsible for the 
PMA responsiveness of ß2/ß1 chimeric LFA-1 molecule transfected in K562, several point 
mutations were created in the ß2 cytoplasmic domain. Amino acids of the ß2 cytoplasmic 
domain were substituted for the residues present in the ß1 cytoplasmic domain (Fig. 1). K562 
cells were transfected with aL chain together with the ß2 chain containing cytoplasmic 
domains of ß1 or ß2 as described in materials and methods. The expression levels of K562 
cells transfected with the LFA-1 chimeras and point mutants was determined by FACS 
analysis using anti-CD11a and anti-CD 18 antibodies (Fig. 2). The mutations in the ß2 
cytoplasmic domain did not affect the a/ß heterodimerization based on the expression of a/ß
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heterodimer dependent MHM23 epitope and immunoprécipitation of LFA-1 from all mutants 
confirmed that mutant LFA-1 was expressed as a/ß heterodimers (data not shown).
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Figure 3. Binding ofLFA-1 mutants expressed in K562 cells to ICAM-1-coated fluorescent 
beads measured by ilowcytometry. (A) Adhesion of K562-aL/ß2 and aL/ß2/ß1 cells to ICAM- 
1 or fibronectin. Cells were incubated in medium, PMA (100 nM), the activating anti-ß1 mAb 
TS2/16 (10 Jg/ml), or the activating anti-ß2 mAb KIM185 (10 fJg/ml) together with ligand- 
coated TransFluoSpheres for 30 min at 37°C as described in section Material and Methods. 
Depicted is the percentage (± SD) of either VLA-5 or LFA-1 specific adhesion to fibronectin 
or ICAM-1, respectively. Specific adhesion is percentage of cells binding - percentage of cells 
binding in the presence of a LFA-1 blocking mAb (NKI-L15) or a VLA-5 blocking antibody 
(SAM-1). (B) Adhesion of ß2 cytoplasmic domain point mutants. Depicted is the mean 
percentage (± SD) of LFA-1 specific adhesion to ICAM-1 of the gated cells that expressed 
equal amounts of LFA-1 (mean fluorescent intensity 70 - 80) as determined by staining with 
the FITC conjugated non-blocking anti-LFA-1 antibody (TS2/4). Data are representative of 
three experiments. Inset: Adhesion of mutant aL/L732R-ß2 to various soluble ICAM-1Fc 
concentrations with or without activation by PMA. One of two independent experiments is 
shown, SD < 10%.
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The capacity of the LFA-1 mutants to adhere to ICAM-1 was determined using an 
ICAM-1 coated fluorescent-beads adhesion assay (Geijtenbeek et al., 1999) in the absence or 
presence of PMA or the LFA-1 activating antibody KIM185 (Fig 3B). This adhesion assay 
allows analysis of only those cells that have similar expression levels of LFA-1. Only cells 
with a mean fluorescence of 70 -  80 were analyzed for ICAM-1-coated fluorescent beads 
binding. All LFA-1 mutants were able to adhere to ICAM-1 for at least 45% when activated 
by KIM185, indicating that the LFA-1 molecules are functionally expressed on the K562 
cells. The level of LFA-1-mediated adhesion to ICAM-1 without any activation is low 
(<8%), except for the mutant aL/L732R-ß2 (15%). Mutation of potential tyrosine and 
serine phosphorylation sites within the ß2 chain to ß1 residues (aL/Y735F-ß2 and aL/S756C- 
ß2) do not restore the PMA responsiveness (Fig. 3B). The same holds true for the threonine at 
position 758, which has been reported to be involved in cell spreading, and the phenylalanine 
at position 766 which affects ligand binding (Hibbs et al., 1991b). Of all mutants only 
substitution of leucine for the ß1 amino acid arginine (aL/L732R-ß2) in the DLRE motif of 
the ß2 cytoplasmic domain results in a significant increase in adhesion to ICAM-1 upon PMA 
stimulation. Since the adhesion of unstimulated aL/L732R-ß2 cells is already high (18%), 
which might facilitate PMA activation, we investigated adhesion to decreasing ICAM-1 
concentrations to a level in which the default adhesion of aL/L732R-ß2 was similar to that of 
wild-type LFA-1 (Fig. 3B inset). At low ICAM-1 concentration, PMA could still enhance the 
adhesion of mutant aL/L732R-ß2, indicating that the PMA responsiveness is truly induced by 
the point mutation and not by inherent stronger adhesion. In addition, similar as aL/L732R- 
ß2, mutant aL/S756C-ß2 has also a default adhesion of 10%, but does not respond to PMA. 
To investigate whether this single mutation is crucial for PMA responsiveness, we mutated in 
the ß2/ß1 chimera the arginine present in the DRRE motif of the ß1 cytoplasmic domain to a 
leucine (aL/R732L-ß1). However, in mutant aL/R732L-ß1 the PMA responsiveness was not 
abolished, suggesting that this arginine residue within the full ß1 cytoplasmic domain is not 
essential for PMA responsiveness, and thus that the PMA activation of ß1 integrins is 
differently regulated than ß2 integrins. The PMA induced adhesion of the latter mutant 
seems somewhat lower than in mutant ß2/ß1 chimera. However, comparing the relative 
PMA induciability between the PMA responsive mutants demonstrates that there are no 
significant differences (Table I). Taken together, these results indicate that the created DRRE 
motif in the ß2 cytoplasmic domain is essential for PMA mediated activation of ß2 integrin 
LFA-1.
Avidity but not affinity changes correlates with PMA induction of ß2 cytoplasmic 
mutants
To investigate whether the restored PMA responsiveness of the aL/L732R-ß2 mutant is due 
to a change in avidity and/or affinity we performed confocal microscopy to detect avidity 
alterations and soluble ICAM-1 binding studies as affinity measurements. Analysis of the 
LFA-1 cell surface distribution by confocal microscopy shows that substitution of the ß2 
cytoplasmic domain for the ß1 domain leads to clustering of LFA-1 on the cell surface (Lub et
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al., 1997a), whereas wild-type LFA-1 expressed in K562 cells shows homogeneous 
distribution of LFA-1 (Fig. 4A). All point mutants in the ß2 cytoplasmic domain have a 
homogeneous LFA-1 distribution (Fig. 4C, 4D, and data not shown), with the exception of the 
PMA responsive LFA-1 mutant aL/L732R-ß2 that exhibits clusters of LFA-1 (Fig. 4B). 
Surprisingly, LFA-1 is clustered in all of the ß1 cytoplasmic domain point mutants 
investigated, whereas the reversed mutation aL/R732L-ß1 has a homogeneous LFA-1 
distribution (data not shown) despite the fact that the mutant is able to bind to ICAM-1 upon 
stimulation by PMA. These results suggest that the clustered status of the ß2 integrin LFA-1 
in aL/ß2/ß1 and aL/L732R-ß2 may facilitate the PMA responsiveness of LFA-1.
Table I. Relative PMA induction
K-aL/ß2 aL/ß2/ß1 aL/L732R-ß2 aL/R732L-ß1
Exp. 1 1,8- 67.3 66.0 59.1
Exp. 2 2.2 36.5 42.5 54.8
Exp. 3 4.3 69.2 51.2 53.0
Exp. 4 10.8 57.4 44.8 81.3
Exp. 5 2.2 57.5 37.3 15.5
Exp. 6 11.9 20.3 25.0 35.5
Exp. 7 21.9 59.7 35.7 50.7
Exp. 8 12.1 49.2 36.8 45.5
mean2
SD
9.3
7.09
52.1
16.48
42.4
12.23
49.4
18.94
1 Percentage PMA induction calculated from absolute adhesion values:
((PMA - medium) / (KIM185 - medium)) * 100%
2 Student T-test: K-aL/b2 p-value < 0.0001. No significant differences between 
aL/ß2/ß1, aL/L732R-ß2, and aL/L732R-ß1
Whether also the affinity of LFA-1 for ICAM-1 is altered in the aL/L732R-ß2 mutant that 
responds to PMA, we determined the concentration of soluble ligand (ICAM-1Fc) that 
yielded half-maximal direct ligand binding activity (ED50). High affinity of LFA-1 for 
ICAM-1 results in a low concentration of ICAM-1Fc needed to obtain 50% of maximal 
binding. Strong binding of ICAM-1Fc was observed after stimulation of LFA-1 with the 
activating mAb KIM185 (Table II). Binding of ICAM-1Fc to the mutants was LFA-1- 
dependent since LFA-1 blocking antibodies completely inhibited adhesion (data not shown). 
When the concentration of ICAM-1Fc that yielded half-maximal binding was calculated, we 
observed an ED50 of approximately 2 |ig/ml for soluble ICAM-1Fc binding to LFA-1 of 
K562-aL/ß2, aL/ß2/ß1, aL/L732R-ß2, aL/S756C-ß2, and aL/T758V-ß1. Mutant aL/Y735F- 
ß2 has a slightly, but not significant (p=0.136), lower affinity (ED50: 4.9±0.14 |ig/ml)
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compared to wild-type LFA-1 (ED50: 3.0±1.53 |ig/ml). Activation of aL/L732R-ß2 with 
PMA (ED50: 6.0±1.63 |ig/ml) does not significantly (p=0.248) increases the affinity 
compared to unstimulated cells (ED50: 4.5±2.25 |ig/ml) as shown in figure 3B (inset). 
Together, these findings indicate that not affinity but avidity changes are responsible for the 
PMA responsiveness of mutant aL/L732R-ß2 to bind ICAM-1.
Figure 4. Surface distribution ofLFA-1 mutants in K562 cells by Confocal Laser Scanning 
Microscopy (CLSM). Cells were fixed (0.5% paraformaldehyde) and subsequently stained 
with the anti-LFA-1 mAb TS2/4 and GAM-(Fab')2-FITC second antibodies. Wild-type LFA-1 
(A) is found homogeneous on the cell surface similar as aL/S756C-ß2 (C), aL/T758V-ß2 (D), 
and aL/L732R+T758V-ß2 (E). LFA-1 is localized in large clusters on aL/L732R-ß2 (B), and 
aL/L732R+S756C-ß2 (F) as indicated by arrows. The instrument settings of the CLSM were 
the same for the four different panels: Lens, 60x; gain, 1300; pinhole, 1.5 jim; and 
magnification, 2.0x. One out ofthree experiments is shown.
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Table II. Affinity of LFA-1 for sICAM-1
K562 transfectants
concentration sICAM-1Fc (^g/ml) ED502
20 10 2 1 0.2 0.1 0 3mean SD
K-aL/ß2 32.01 37.8 20.2 16.1 2.8 1.6 1.7 3.03 |ig 1.53
aL/ß2/ß1 28.0 35.8 17.1 8.0 2.1 1.0 0.9 2.53 ^g 1.07
aL/L732R-ß2 32.9 47.7 30.9 17.0 3.7 3.4 4.4 2.50 ^g 1.21
aL/Y735F-ß2 27.2 22.0 3.6 1.0 0.6 0.8 1.1 4.90 ^g 0.14
aL/S756C-ß2 25.8 26.9 16.0 10.7 4.2 3.0 3.2 2.16 |ig 1.06
aL/T758V-ß2 24.9 22.2 12.9 4.8 2.5 1.9 2.2 2.10 |ig 0.36
aL/L732R+S756C-ß2 64.2 68.3 40.4 24.3 5.7 3.5 1.1 1.87 ^g 0.70
aL/L732R+T758V-ß2 76.6 69.4 29.9 10.4 2.7 1.1 1.1 3.32 ^g 1.79
1 Percentage adhesion to sICAM-1Fc.
2 Half maximum binding
3 Mean ED50 +/- SD of at least 3 independent experiments
Importance of the ß2 cytoplasmic domain for PMA responsiveness of LFA-1
To determine whether only L732R in the ß2 domain was enough to generate PMA induced 
adhesion, we deleted the ß2 cytoplasmic domain directly after the wild-type leucine at 
position 732 in the DLRE motif, or at the similar position in the mutant aL/L732R-ß2, or 
after the aspartic acid at position 731 (Fig. 1A and 2). Deleting the cytoplasmic domain 
immediately after position 731 or 732 completely abolished the PMA induced adhesion to 
ICAM-1 (Fig. 5A), whereas the LFA-1 activating antibody KIM185 induced ICAM-1 binding 
equally well (50%). These results demonstrate that next to the ß1 residue L732R in the ß2 
cytoplasmic domain also other residues within the C-terminal part of the ß2 cytoplasmic 
domain are necessary for the acquired PMA responsiveness of mutant L732R-ß2.
758Threonine is important for PMA responsiveness of L732R-ß2 in K562 cells
To investigate which amino acids C-terminal of position 732 in the ß2 cytoplasmic domain 
are necessary together with L732R for PMA induced LFA-1 activation, double mutants were 
created that contained both L732R and serine and threonine mutations located C-terminal of 
L732R (Fig. 1). Serine and threonine residues have been shown to be important in LFA-1 
phosphorylation and function (Hibbs et al., 1991b; Valmu and Gahmberg, 1995). These two 
double mutants, designated aL/L732R+S756C-ß2 and aL/L732R+T758V-ß2, were stained 
for functional expression of LFA-1 (data not shown) and the LFA-1-mediated adhesion to 
ICAM-1 was studied using the ICAM-1 coated fluorescent-bead adhesion assay (Fig. 5B). To 
our surprise, the double mutant aL/L732R+T758V-ß2 disrupted the L732R induced PMA 
response from 35% to 5%. Mutation of the potential serine phosphorylation site (S756C) did
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not alter the PMA responsiveness of double mutant aL/L732R+S756C-ß2 (37%). These data 
suggest that the acquired PMA responsiveness of mutant aL/L732R-ß2 depends on the 
threonine residue at position 758, but not the serine residue at position 756.
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Figure 5. Adhesion of LFA-1 deletion mutants expressed in K562 cells to ICAM-1-coated 
fluorescent beads measured by flowcytometry. (A) LFA-1 expressing K562 cells were pre­
incubated in medium, PMA (100 nM), or the activating anti-ß2 mAb KIM185 (10 fJg/ml) for 
30 min at 37°C in the absence or presence of the LFA-1 blocking mAb NKI-L15. (B) Adhesion 
of LFA-1 double mutants transfected into K562 cells. Depicted is the mean percentage (± SD) 
of LFA-1 specific adhesion to ICAM-1 of the gated cells that expressed equal amounts of 
LFA-1 (mean fluorescent intensity 70 - 80) as determined by staining with the FITC 
conjugated non-blocking anti-LFA-1 antibody (TS2/4). In (A) SD < 10%. Integrin specific 
adhesion: Percentage of cells binding - percentage of cells binding in the presence of an 
integrin blocking mAb (NKI-L15). One representative experiment out of four is shown.
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The ß2-cytoplasmic domain contains several phosphorylation sensitive serine and 
threonine residues that are phosphorylated upon phorbol ester stimulation (Valmu and 
Gahmberg, 1995). Since the aL/L732R-ß2 mutant could restore the PMA response, whereas 
the double mutant aL/L732R+T758V-ß2 blocked this responsiveness, we investigated the 
importance of serine or threonine phosphorylation of the ß2-cytoplasmic domain due to PMA 
activation. Both mutants and wild-type LFA-1 in K562 cells are serine and threonine 
phosphorylated on the aL- and ß2-cytoplasmic domain with or without PMA stimulation 
(data not shown), suggesting that the lack of PMA responsiveness of mutant 
aL/L732R+T758V-ß2 is not caused by an impaired phosphorylation on serine or threonine 
residues in the LFA-1 molecule.
To further investigate whether affinity and/or avidity changes regulate the PMA response 
of the double mutants, we determined the affinity of ICAM-1 by measuring the soluble 
ICAM-1Fc concentration needed to yield half-maximal binding activity (Table II). Although 
the double mutants aL/L732R+S756C-ß2 and aL/L732R+T758V-ß2 differed in PMA 
responsiveness, no significant changes could be observed for the ED50 (1.9±0.70 |ig/ml 
ICAM-1 and 3.3±1.79 |ig/ml ICAM-1, respectively). However, analysis of the cell surface 
distribution of LFA-1 revealed that LFA-1 was homogeneously distributed on double mutant 
aL/L732R+T758V-ß2 (Fig. 4E), whereas the PMA responsiveness of mutant 
aL/L732R+S756C-ß2 (Fig. 4F) showed a clustered LFA-1 surface distribution. This 
demonstrates a strong correlation between a clustered LFA-1 cell surface distribution and the 
capacity to respond to PMA.
PMA mediated activation of L732R-ß2 involves cytoskeletal rearrangements
It has been reported that activation of LFA-1 in leukocytes is tightly regulated by the 
organization of the cytoskeleton. As LFA-1 clustering strongly correlates with PMA 
responsiveness we studied which cytoskeleton associated proteins are involved in 
reorganization of LFA-1. We therefore investigated by inhibiting actin assembly whether low 
concentrations of cytochalasin D could allow integrin clustering and adhesion of non-PMA 
responsive LFA-1 transfectants. To our surprise, cytochalasin D could not restore the PMA 
response (Fig. 6) or enhance clustering of LFA-1 (data not shown) as was observed in 
leukocytes (Lub et al., 1997b). In contrast, mutant aL/L732R-ß2 exposed to cytochalasin D 
resulted in a constitutively active LFA-1 molecule and cell adhesion was not further increased 
by PMA. This indicates that the clustered aL/L732R-ß2 might still be associated with the 
cytoskeleton.
2+Recently, increased levels of intracellular Ca could enhance LFA-1 mediated adhesion
2+through induction of avidity changes in LFA-1 due to the activation of a Ca -dependent 
protease calpain that disrupts the cytoskeletal association with LFA-1 (Stewart et al., 1998). 
Activation of calpain can be blocked by reagent calpeptin. To investigate whether our LFA-1 
transfected K562 cells regulate their cell surface distribution by the activation of calpain, we 
inhibited adhesion to ICAM-1 with calpeptin at concentrations previously demonstrated to 
block calpain activity (Stewart et al., 1998). Surprisingly, calpeptin completely abrogated the
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PMA responsiveness of mutant aL/L732R-ß2, whereas a lower concentration of calpeptin (20 
|ig/ml) could not fully block the PMA induced adhesion (Fig. 6). These results indicate that 
PMA acts via calpain to promote activation of LFA-1 through partial dissociation from the 
cytoskeleton facilitating clustering of LFA-1 molecules.
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Figure 6. Cytoskeletal rearrangements are important for the LFA-1 mediated adhesion 
upon PMA stimulation. Wild-type LFA-1 and point mutant aL/L732R-ß2 transfected into 
K562 cells were pre-incubated with 5 Jg/ml cytochalasin D or 100 Jg/ml calpeptin. Cells 
were subsequently stimulated with medium, PMA (100 nM), or the activating anti-ß2 mAb 
KIM185 (10 Jg/ml) for 30 min at 37°C in the absence or presence of the LFA-1 blocking mAb 
NKI-L15. aL/L732R-ß2 cells were also preincubated with 20 Jg/ml (dotted bars), 60 Jg/ml 
(hatched bars), or 100 Jg/ml (black bars) calpeptin before stimulation with PMA. Depicted is 
the mean percentage (± SD) of LFA-1 specific adhesion to ICAM-1 of the gated cells that 
expressed equal amounts of LFA-1 (mean fluorescent intensity 70 - 80) as determined by 
staining with the FITC conjugated non-blocking anti-LFA-1 antibody (TS2/4). Integrin 
specific adhesion is calculated as explained in figure 5. Data are representative for three 
experiments.
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Discussion
Using a cell transfection system in which inside-out signaling of the ß2 integrin LFA-1 could 
be modified by substitution of the ß2 for the ß1 cytoplasmic domain, we searched for single 
amino acids in the ß2 cytoplasmic domain that regulate inside-out signaling. We identified 
one amino acid at position 732, in which a leucine is substituted for an arginine, that could 
restore the PMA responsiveness of LFA-1 completely. PMA inside-out signaling also 
depends on a threonine located more C-terminal at position 758. Of all LFA-1 mutants that 
respond to PMA, avidity alterations and not affinity changes or ß2 phosphorylation seemed 
important for proper function. We propose a model for this PMA responsiveness regulated by 
position 732 and 758 and avidity changes regulated by activation of a Ca2+-dependent 
protease calpain which releases LFA-1 from the cytoskeleton thereby allowing the formation 
of a signaling complex leading to active LFA-1.
Integrin-dependent adhesion is strongly induced upon inside-out signaling when PKC is 
activated through addition of PMA or via T cell receptor triggering. It remains still obscure 
how 'inside-out' signaling by PMA results in LFA-1 activation. The newly identified single 
amino acid mutation (L732R) responsible for PMA activation of LFA-1 is situated in the ß2 
DLRE motif which is conserved throughout the other integrins, but distinct in one amino acid 
(DRRE) in ß1 and ß7 integrins. PMA can activate ß1 integrins, but not ß2 and ß7 in K562 
cells, suggesting that besides the DRRE motif also lymphocyte specific elements are involved 
(Lub et al., 1997a). In addition, creating the DLRE motif in the ß1 cytoplasmic domain 
(aL/R732L-ß1) did not abolish the PMA responsiveness, indicating that the PMA activation 
of ß1 integrins is differently regulated compared to ß2 integrins. The DLRE motif has been 
proposed to bind the GFFKR motif in the a  chain and both these cytoplasmic domains serve 
to constrain LFA-1 into a default low affinity state (Hughes et al., 1996). Mutations in the 
TTT region (position 758-760) into alanines residues of the ß2 cytoplasmic domain have been 
shown to reduce the default adhesion to ICAM-1 and the phorbol ester mediated LFA-1 
phosphorylation when expressed in COS cells or B lymphoblastoid cells, but do not abrogate 
the binding to ICAM-1 in response to PMA (Hibbs et al., 1991b). In contrast, we observed 
with the double mutant aL/L732R-T758V-ß2 that substitution of the threonine into the ß1 
residue valine in K562 cells completely decreased the PMA induced adhesion restored by the 
L732R mutation and altered the LFA-1 surface distribution. The phosphorylation level of 
these threonines after stimulation with PMA is strongly increased upon pretreatment with 
okadaic acid which inhibits serine and threonine phosphatases (Valmu and Gahmberg, 1995). 
Threonine-phosphorylated CD18 molecules have been shown to associate with the 
cytoskeleton (Valmu et al., 1999) and play an important role in the formation of stressfibers 
and specialized microdomains, such as rafts (Peter and O'Toole, 1995; Krauss and Altevogt, 
1999; Pande, 2000). However, in our system we could not identify any role of threonine 
phosphorylation and the PMA responsiveness of LFA-1, although the threonines themselves 
are a prerequisite for the PMA response together with the mutation L732R. In line with the 
threonine phosphorylation, we observed also no differences in serine phosphorylation, even in
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double mutant aL/L732R-S756C-ß2 which was still able to adhere to ICAM-1 upon 
stimulation with PMA. This further questions the relevance of this serine residue in 
phosphorylation and ICAM-1 binding as shown in other studies (Hibbs et al., 1991b). The 
tyrosine-based NPKY motif in the ß1 cytoplasmic domain has been implicated in regulating 
integrin function (Reszka et al., 1992). However, substitution of the phenylalanine for the ß1 
tyrosine (F766Y-ß2) in this motif did not restore PMA sensitivity. Taken together, 
phosphorylation of the ß2 cytoplasmic domain is not a prerequisite for the acquired PMA 
responsiveness.
Cytohesin, a member of guanine nucleotide exchange factors for ADP-ribosylation factor 
G-proteins, specifically interacts with the ß2 cytoplasmic domain directly after the 
transmembrane region (position 723-725) thereby controlling T cell receptor or phorbol ester 
induced activation of LFA-1 (Kolanus et al., 1996). Cytohesin expression is involved in 
maintaining LFA-1 in a high avidity state. Since cytohesin is expressed in K562 cells and 
associates with LFA-1 (Geiger et al., 2000), it is likely that the high avidity state of our DRRE 
mutant is a direct result of cytohesin binding. Double staining of LFA-1 and cytohesin in the 
ß2 point mutants did not demonstrate differences in colocalization of LFA and cytohesin (data 
not shown). Upon PMA activation many proteins are phosphorylated and activated via PKC 
such as the ß2-linked proteins Rack1, MacMARCKS, and L-plastin. Phosphorylated Rack1 
binds PKC allowing subsequent recruitment of Rack1 to the KALI-region in the ß2 
cytoplasmic domain which is the same binding region for cytohesin (Kolanus et al., 1996; 
Liliental and Chang, 1998). The WD repeats 5-7 of Rack1 interact with ß integrins, leaving 
the other repeats free for binding to PKC and possible cytohesin. Thus Rack1 merely 
functions as a scaffold protein to recruit PKC and other ß2 regulators to the site of action. 
MacMARCKS is a PKC substrate phosphorylated upon PMA activation which leads to an 
increase in the lateral diffusion of ß2 integrins and enhanced LFA-1-dependent cell clustering 
(Zhou and Li, 2000). We could not demonstrate by confocal microscopy any differences in 
cytosolic localization of MacMARCKS after activation with PMA (data not shown). Hence, it 
remains unclear whether MacMARCKS directly binds the ß2 cytoplasmic domain or Rack1. 
The leukocyte specific actin bundling protein L-plastin proved to be important in enhanced 
integrin avidity through PKC and PI-3 kinase (Jones et al., 1998). Upon PMA activation, 
calcium is released from intracellular stores and binds to the EF-handtype calcium-binding 
domain of L-plastin thereby inhibiting actin-bundling activity. Thus MacMARCKS as well as 
L-plastin play a crucial role in the association of the integrin with the cytoskeleton and 
subsequently integrin activation. Besides PKC, PI-3 kinase and the small GTPase Rap1 
modulate LFA-1 avidity in leukocytes (Reedquist et al., 2000; Katagiri et al., 2000). Both 
Rap1 and the PI-3 kinase, but not PKC mediated activation, upregulated the NKI-L16 epitope, 
indicating increased LFA-1 avidity (Katagiri et al., 2000).
The actin cytoskeleton plays a critical role integrin activation and signaling by acting as a 
platform to bring different components close together leading to a signaling complex. The ß 
cytoplasmic domain has been demonstrated to be associated with the cytoskeletal components 
a-actinin (Pavalko and LaRoche, 1993), vinculin (Pardi et al., 1995), filamin (Sharma et al.,
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Figure 7. Model for dynamic avidity regulated inside-out signaling of LFA-1. (A) Schematic 
model of the LFA-1 ß2 cytoplasmic domain that regulates avidity changes and PMA 
responsiveness. LFA-1 is kept in an inactive state by cytoskeletal restraints attached to the 
cytoplasmic domain of LFA-1. Wild-type LFA-1 expressed in K562 cells (K562-aL/ß2) is non­
clustered and cannot be activated by PMA to bind ligand. The threshold for PMA to activate 
LFA-1 is insufficient because an efficient signaling complex or microdomain cannot be 
formed due to the absence of clusters of LFA-1. However, substitution of the leucine at 
position 732 for the ß1 amino acid arginine together with an intact TTT motif induces LFA-1 
to reorganize into clusters and thereby restores the PMA responsiveness of LFA-1. PMA 
triggers PKC and subsequently activates, phosphorylates, and recruits a cascade of 
substrates such as cytohesin (Geiger et al, 2000), Rack1 (Liliental and Chang, 1998), 
MacMARCKS (Zhou and Li, 2000), paxillin (Li et al., 1996), L-plastin (Jones et al., 1998), 
PI-3 kinase (Katagiri et al., 2000), and increases intracellular Ca2+ levels (Dustin and 
Springer, 1989). Calcium can activate specific proteases such as calpain that releases LFA-1 
from the cytoskeleton (Stewart et al., 1998). Presumably, talin is cleaved from the 
cytoskeleton (Sampath et al., 1998), resulting in mobile LFA-1 and reorganization of the 
cytoskeleton network. Cytochalasin D disrupts the cytoskeleton and bypasses the PMA 
induced activation. This allows LFA-1 to recruit signaling components that re-establishing 
the contact with the cytoskeleton leading to the formation of a signaling complex able to 
efficiently bind ligand. Because LFA-1 is in a default clustered status in the L732R-ß2 mutant, 
these signaling components are concentrated near the LFA-1 cytoplasmic domain leading to 
a signaling complex able to activate LFA-1 threshold for PMA induced 'inside-out' signaling. 
(B) Amino acid sequence of the ß2 cytoplasmic domain with the binding sites (underlined) for 
cytohesin, Rack1 and a-actinin. The threonine residues at position 758-760 together with the 
phenylalanine (766) are required for ligand binding. The mutated lysine creating the DRRE 
motif and the essential threonine at position 758 restore the PMA responsiveness of LFA-1 
expressed in K562 cells.
1995) or talin (Burn et al., 1988). Treatment of cells with cytochalasin D, that disrupt the 
cytoskeleton network, results in activation of LFA-1 that coincides clustering of LFA-1, 
indicating that the cytoskeleton restraints keep integrins inactive (Lub et al., 1997b). 
However, cytochalasin D had no effect on activation or clustering of wild-type LFA-1 
expressed in K562 cells, indicating a different mechanism of cytoskeletal organization. In 
contrast, the PMA responsive mutant aL/L732R-ß2 could be spontaneously activated by 
cytochalasin D. The release of LFA-1 from the cytoskeleton in lymphocytes is also thought to 
be regulated by the cysteine protease calpain that is activated by local Ca2+ fluxes (Stewart et 
al., 1998). Indeed, we have evidence that the PMA induced activation of LFA-1 is mediated 
by calpain, since inhibition with calpeptin abrogated the PMA responsiveness of mutant 
aL/L732R-ß2. Calpeptin also has been reported to induce stressfiber formation in fibroblasts 
due to its inhibitory action on protein tyrosine phosphatases (PTPases) upstream of the small 
GTPase Rho (Schoenwaelder and Burri dge, 1999). It is rather unlikely that this additional
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effect of calpeptin on PTPases also occurs during the integrin mediated adhesion of the non­
adherent K562 cells that do not induce stressfiber formation. Proteins identified as potential 
calpain targets include talin, filamin, and a-actinin. Talin forms the bridge between the ß2 
integrin and the actin filaments. Upon activation, LFA-1 is released from the cytoskeleton as a 
result of proteolysis of talin, probably by calpain, leading to freely mobile integrin as 
postulated by Sampath and colleagues (1998). Next a-actinin binds the ß2 cytoplasmic 
domain between the residues 736-746 directly C-terminal of the DLRE motif thereby 
stabilizing the cytoskeletal-integrin interaction necessary for strong adhesion. We speculate 
that this ß2-specific event is impaired in K562 whereas the DRRE mutant partly restores the 
lateral mobility of LFA-1 resulting in increased LFA-1 avidity. The a-actinin binding motif is 
also important for endoplasmic reticulum retention, assembly, and transport to the cell surface 
of LFA-1 (Pardi et al., 1995). Peptides from the ß1 cytoplasmic domain reveal that pp125FAK 
and paxillin bind the membrane proximal KLLMITHDRREFA motif which includes the 
DRRE motif (Schaller et al., 1995). In ß2 integrins, paxillin is tyrosine phosphorylated by 
MacMARCKS and both colocalize in the membrane ruffles of spreading macrophages (Li et 
al., 1996).
The acquired PMA signaling of our LFA-1 mutants in K562 cells coincides with a 
change in a clustered LFA-1 cell surface distribution. Much attention is recently drawn on 
specialized lipidic membrane microdomains also termed rafts. They function as platforms for 
signaling molecules and are involved in the regulation of LFA-1 function and adhesion 
through avidity changes (Krauss and Altevogt, 1999; Pande, 2000). Whether the PMA 
responsive LFA-1 mutant is differently organized in rafts compared to wild-type LFA-1 
remains so far unsolved. Our results suggest that increased avidity facilitates PMA induced 
adhesion to ICAM-1, rather than affinity changes. Clustering of LFA-1 molecules likely leads 
to a higher concentration of signaling components involved in LFA-1 signaling such as 
cytohesin, Rack1, paxillin, or MacMARCKS as shown in a model in figure 7. Furthermore, 
activation of LFA-1 by PMA is dependent on calpain which cleaves cytoskeletal components. 
This is likely a crucial event because one can imagine that dislodgment from the cytoskeleton 
facilitates binding of signaling molecules leading to a reorganization of the cytoskeleton and 
activation of LFA-1. We have shown that this process can be overruled by adding 
cytochalasin D. However, PMA seems ineffective in cells with a homogeneous distribution of 
LFA-1. In case of the mutants with a clustered LFA-1 distribution, the threshold for triggering 
the PMA signaling cascade is lower since the concentration of signaling molecules directly or 
indirectly connected to the cytoplasmic domain of LFA-1 are higher. Therefore we cannot 
exclude that PMA indeed has an effect on LFA-1 in K562 cells, albeit small and not 
detectable with our assays. By using the soluble ICAM-1 binding assay we can detect 
relatively small changes in LFA-1 affinity. However, all our mutants showed an equal ability 
to bind soluble ICAM-1, indicating no affinity differences. Previous reports suggest that 
affinity changes play an important role in regulating integrin mediated adhesion, although we 
earlier showed that this is not true for ß2 integrins (Lobb et al., 1995; van Kooyk et al., 1999). 
Activation of LFA-1 by EGTA or Mg2+ leads to enhanced expression of the M24 epitope, 
indicating that Mg2+ binding induces conformational changes in LFA-1 leading to enhanced
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ICAM-1 binding (Dransfield et al., 1992). Since we observed no changes in affinity and M24 
expression of the mutants, we conclude that the acquired PMA responsiveness has no effect 
on the extracellular conformational changes of LFA-1.
In summary, we present in this study evidence that substitution of a single amino acid in 
the ß2 DLRE motif together with an intact C-terminal TTT sequence is sufficient to restore 
PMA induced LFA-1 adhesion to ICAM-1. The gained PMA signaling is likely due to the 
presence of a dense LFA-1 intracellular signaling complex since these mutants have a 
clustered surface distribution of LFA-1. The activation of LFA-1 is dependent on 
rearrangements of the cytoskeleton through a mechanism involving a Ca2+-dependent protease 
calpain. This work clearly demonstrates that the function of LFA-1 is strictly regulated and 
involves leukocyte specific signaling element.
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LFA-1 mediated rolling on ICAM-1
Abstract
The LFA-1 integrin is crucial for the firm adhesion of circulating leukocytes to ICAM-1- 
expressing endothelial cells. In the present study, we demonstrate that LFA-1 can arrest 
unstimulated PBL subsets and lymphoblastoid Jurkat cells on immobilized ICAM-1 under 
subphysiological shear flow and mediate firm adhesion to ICAM-1 after short static contact. 
However, LFA-1 expressed in K562 cells failed to support firm adhesion to ICAM-1 but 
instead mediated K562 cell rolling on the endothelial ligand under physiological shear stress. 
LFA-1-mediated rolling required an intact LFA-1 I-domain, was enhanced by Mg2+, and was 
sharply dependent on ICAM-1 density. This is the first indication that LFA-1 can engage in 
rolling adhesions with ICAM-1 under physiological shear flow. The ability of LFA-1 to 
support rolling correlates with decreased avidity and impaired time-dependent adhesion 
strengthening. A ß2 cytoplasmic domain-deletion mutant of LFA-1, with high avidity to 
immobilized ICAM-1, mediated firm arrests of K562 cells interacting with ICAM-1 under 
shear flow. Our results suggest that restrictions in LFA-1 clustering mediated by cytoskeletal 
attachments may lock the integrin into low-avidity states in particular cellular environments. 
Although low-avidity LFA-1 states fail to undergo adhesion strengthening upon contact with 
ICAM-1 at stasis, these states are permissive for leukocyte rolling on ICAM-1 under 
physiological shear flow. Rolling mediated by low-avidity LFA-1 interactions with ICAM-1 
may stabilize rolling initiated by specialized vascular rolling receptors and allow the 
leukocyte to arrest on vascular endothelium upon exposure to stimulatory endothelial signals.
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Introduction
The recruitment of leukocytes into sites of inflammation and lymphoid tissues involves 
leukocyte interactions with vascular endothelium under shear flow. These interactions are 
initiated by weak reversible recognition of endothelial ligands followed by firm adhesion 
mediated by members of the integrin family and their respective Ig family ligands (Springer, 
1994). ß2 Integrins are the major cell-cell adhesion receptors on leukocytes, and they 
participate in versatile adhesive processes of these cells within the vasculature (Springer, 
1994). These processes include the arrest of immune cells on vessel walls at sites of 
inflammation or lymphoid tissues, transendothelial migration, and final localization at sites of 
Ag presentation (Dustin et al., 1992; Springer, 1994). LFA-1 (aL/ß2) is the major ß2 integrin 
on lymphocytes that mediates binding to ICAMs, Ig family integrin ligands expressed on 
venular endothelia and on APC, effector immune cells, and activated platelets (Dustin and 
Springer, 1991; Campanero et al., 1993; Diacovo et al., 1996; Katada et al., 1996). ICAM-1 
(CD54) is the major LFA-1 ligand; it is ubiquitously found on most leukocytes and 
endothelial cells, where it is up-regulated during inflammation. ICAM-1 is a bent rod and 
contains five Ig-like domains oriented head to tail (Staunton et al., 1990). Domain 1 of 
ICAM-1, the most membrane-distal, contains the primary site of contact for LFA-1 (Marlin et 
al., 1990).
LFA-1 has been postulated to require activation to support firm adhesion to its different 
ICAM ligands (Dustin and Springer, 1989; van Kooyk et al., 1989). High-avidity LFA-1 
binding to endothelial ICAM-1 is triggered on circulating leukocytes after they have 
established weak rolling adhesions on the vessel wall through selectins, CD44, or VAP-1 
(Springer, 1994; Butcher and Picker, 1996). However, several integrins like a4ß1 and a4ß7 
occur in constitutively adhesive states on circulating leukocytes and can also support rolling 
adhesions on their respective endothelial ligands (Jones et al., 1994; Alon et al., 1995a; Berlin 
et al., 1995; Johnston et al., 1996). The inability of ß2 integrins to participate in similar rolling 
interactions between leukocytes and vascular endothelium has been attributed to the critical 
dependence of their adhesiveness on prior activation of chemoattractant receptors coupled to 
heterotrimeric G-proteins on circulating leukocytes (Bargatze et al., 1995; Campbell et al., 
1998; Campbell et al., 1999).
Controlled flow assays performed in laminar flow chambers have been useful in the 
characterization of transient and weak adhesive interactions between cells and surface- 
immobilized ligands or Abs (Chen et al., 1997). Using these assays to generate low-range 
detachment forces, relatively weak adhesions between integrins on resting cells and 
immobilized ligands can be detected and quantified (Carr et al., 1996; Weber et al., 1997; 
Chen et al., 1999). Testing LFA-1 adhesiveness to ICAM-1 in the human leukemia cell Jurkat 
as a prototypic T cell model, we show in this paper that LFA-1 can spontaneously form weak 
but specific adhesion to immobilized ICAM-1. Subsets of PBL were also found to develop 
LFA-1 adhesions of considerable strength upon short contact with ICAM-1-coated surfaces. 
Under identical conditions, stable adhesion to ICAM-1 of K562 cells transfected with LFA-1
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was not observed. Nevertheless, when exposed to physiological shear stresses, LFA-1- 
expressing K562 cells established persistent rolling on ICAM-1. These results extend 
previous findings, which showed that the isolated I-domain of LFA-1 can engage in rolling 
interactions with high-density ICAM-1 and ICAM-3 (Knorr and Dustin, 1997). This is the 
first indication that the intact LFA-1 integrin, when placed in a permissive cellular 
environment, can support rolling adhesions on physiological densities of ICAM-1 under 
physiological shear flow. Furthermore, this study provides evidence that cell-type-dependent 
differences in LFA-1 avidity states, but not intrinsic affinity properties, control LFA-1 ability 
to support rolling adhesions on ICAM-1 under physiological shear flow.
Materials and Methods
Abs and reagents
All mAbs were used as purified IgGs. The function-blocking anti-LFA-1 mAb NKI-L15 and 
the non-blocking mAbs SPV-L7 and NKI-L16, directed against the a  subunit of LFA-1, were 
produced as previously described (Keizer et al., 1988). TS1.22, a function-blocking anti-LFA- 
1 mAb directed against the I-domain of the integrin subunit (Huang and Springer, 1995), and 
mAb R 6.5, an anti-ICAM-1 mAb directed against the LFA-1 recognition site on the first Ig- 
like domain of ICAM-1 (Smith et al., 1989), were the generous gift of Dr. T. Springer, 
(Center for Blood Research, Harvard Medical School, Boston, MA). TS2.4, a non-blocking 
anti-LFA-1 mAb (Huang and Springer, 1995), was kindly provided by Dr. E. Martz. HP 1/2, a 
very late Ag-4 (VLA-4)-specific mAb (Sanchez-Madrid et al., 1986), was a kind gift of Dr. R. 
Lobb (Biogen, Cambridge, MA). The anti-ß2 mAb KIM185 was used to activate LFA-1 
(Andrew et al., 1993). Purified mouse IgG (Zymed, South San Francisco, CA) was used as a 
control Fluorescein isothiocyanate-conjugated goat anti-mouse IgG and goat F(ab')2 anti­
mouse IgG (Zymed), or goat anti-human Fc (Jackson Immunoresearch, West Grove, PA) 
were used as secondary Abs in FACS analysis and immunofluorescence microscopy. 
Recombinant soluble ICAM-1 (sICAM-1), encompassing the entire extracellular domain of 
human ICAM-1 was purchased from R&D Systems (Minneapolis, MN). ICAM-1-Fc, 
consisting of the entire extracellular portion of human ICAM-1 fused to human IgG Fc 
(Dransfield et al., 1992), was the generous gift of Dr. L. Klickstein (Brigham and Women's 
Hospital, Boston, MA). A VCAM-1-Fc fusion protein, consisting of the two N-terminal 
domains of human VCAM-1, fused to human IgG Fc was a gift of Dr. R. Lobb. BSA- 
(fraction V), protein A-, Ca2+-, and Mg2+-free HBSS and Ficoll-Hypaque 1077 were obtained 
from Sigma (St. Louis, MO). Human serum albumin (HSA; fraction V) and PMA were 
purchased from Calbiochem (La Jolla, CA).
Cells
K562 cells stably expressing LFA-1 (Lub et al., 1997b) were maintained in RPMI 
1640/Iscove's medium (3:1 v/v) supplemented with 5% heat-inactivated FCS (Biological 
Industries, Beit Hahemek, Israel), 1% penicillin/streptomycin (Bio Lab, Jerusalem, Israel),
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and 2 mg/ml G418 (Calbiochem) to selectively maintain the transfected population. The ß2 
deletion mutant L2/724 generated by truncation of the ß2 cytoplasmic tail at amino acid 
position 724 close to the transmembrane region (Lub et al., 1997b) was stably expressed in 
K562 cells maintained as above. The Jurkat T lymphoblastoid cell line was maintained in 
RPMI 1640 supplemented with 10% heat-inactivated FCS (Sigma), 2 mM L-glutamine, and 
1% antibiotics. Human peripheral blood lymphocytes (obtained from healthy donors) were 
isolated from citrate-anticoagulated whole blood by dextran sedimentation and density 
separation over Ficoll-Hypaque (Carr et al., 1996). The mononuclear cells thus obtained were 
washed and further purified on nylon wool and by further panning on serum-coated dishes. 
The resulting purified PBL were more than 90% CD3-positive T lymphocytes. PBL were 
maintained in RPMI 1640 supplemented with 10% heat-inactivated FCS for 15-18 h after 
isolation and purification until use.
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Figure 1. Expression of LFA-1 on K562-LFA-1, Jurkat, and PBL. Cells were stained with 
the anti-LFA-1 mAb TS1.22 and then with FITC-labeled goat anti-mouse and were analyzed 
by FACS (open histograms). Negative control staining with murine IgG is shown in the filled 
histograms.
Flowcytometry
A total of 106 cells were incubated for 1 h on ice in 20 [ig/ml of the LFA-1 mAb TS1.22 and 
control mAb 4B9 in a solution of PBS with 1% BSA and 0.05% sodium azide (FACS buffer). 
Cells were washed three times in FACS buffer and incubated for 15 min on ice with 5 ^g/ml 
FITC-conjugated goat anti-mouse IgG (Zymed) in FACS buffer. Cells were washed three 
times and analyzed by FACSort flow cytometer (Becton Dickinson). ICAM-1-Fc binding to 
cells was determined by immunofluorescence by incubating 50,000 cells in TSA binding 
medium (20 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM Ca2+, 2 mM Mg2+, and 5 mg/ml 
BSA) with or without LFA-1 blocking mAb (20 fig/ml) for 10 min at room temperature (RT) 
in a 96-well V-bottom plate. Different concentrations of purified soluble ICAM-1-Fc were 
added, and the suspension was incubated for 30 min at 37°C. The cells were washed with 
TSA and incubated for 30 min at RT with FITC-conjugated goat-anti-human Fc-specific Ab, 
and then they were washed again, and the percentage of positively stained cells was measured 
by FACScan. Net binding values were depicted as: (percentage of positive cells stained in the 
absence of the LFA-1 blocking mAb (NKI-L15)) - (percentage of cells stained in the presence
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of the LFA-1 blocking mAb). The concentration of sICAM-1Fc that gave half-maximal net 
ICAM-1-Fc staining was determined for the different experimental groups.
Fluorescent beads adhesion assay
Cells were resuspended in TSA binding medium (5*106 cells/ml). A total of 50,000 cells were 
preincubated with or without LFA-1-blocking mAb (20 |ig/ml) for 10 min at RT in a 96-well 
V-bottom plate, alone or in the presence of 100 ng/ml PMA. Ligand-coated TransFluoSpheres 
(1 ^m; Molecular Probes, Eugene, OR) were incubated with different experimental groups (at 
a ratio of 20 beads/cell) for 30 min at 37°C. The cells were washed with TSA, and LFA-1- 
mediated bead adhesion was measured by flowcytometry using FAC Scan as previously 
described (Geijtenbeek et al., 1999). Values are depicted as integrin-specific adhesion, i.e., 
(percentage of cells binding to beads in the absence of the LFA-1 blocking mAb (NKI-L15)) - 
(percentage of cells binding to beads in the presence of the LFA-1 blocking mAb).
Confocal microscopy
Cells were fixed with 0.5% paraformaldehyde and stained with TS2/4 mAb (10 |ig/ml) for 30 
min at 37°C before incubation with FITC-labeled goat F(ab')2 anti-mouse IgG mAb for 30 
min at RT. Cells were attached to poly-l-lysine-coated glass slides, and cell surface 
distribution of integrins was determined by confocal laser scanning microscopy (CLSM) at 
488 nm with a krypton/argon laser (Bio-Rad 1000; Bio-Rad, Hercules, CA).
Laminar flow assays
Preparation of adhesive substrates. Recombinant sICAM-1 was dissolved in coating medium 
(PBS buffered with 20 mM bicarbonate (pH 8.5)) and directly coated to a polystyrene plate 
(60 X 15 mm petri dish; Becton Dickinson, Lincoln Park, NJ) for 2 h at 37°C. The plate was 
washed three times with PBS and blocked with HSA (20 mg/ml in PBS) overnight at 4°C. 
ICAM-1-Fc-coated substrates were prepared as previously described (Fuhlbrigge et al., 1996). 
Protein A (20 |ig/ml in coating medium) was spotted onto a polystyrene plate, and the 
substrate was washed and blocked with HSA (20 mg/ml in PBS). The protein A-coated 
substrate was overlaid overnight at 4°C with 0.5-10 |ig/ml of ICAM-1-Fc in PBS 
supplemented with HSA. The adsorbed chimeric ICAM-1 was shown to bind the protein A- 
coated substrate exclusively through its Fc region, as verified by the ability of excess human 
IgG to compete off all ICAM-1-Fc adsorption onto the substrate. LFA-1-specific mAbs were 
coated (5 |ig/ml in PBS/HSA) on surfaces precoated with protein A and overlaid with IgG-Fc- 
specific rabbit anti-mouse (5 |ig/ml in PBS/HSA). The density of functional sICAM-1 coated
125on the substrate was determined by saturation binding of I-labeled anti-ICAM-1 mAb, R 
6.5. The site density of ICAM-1-Fc adsorbed to the protein A substrates was determined from
125overlay experiments with I-labeled ICAM-1-Fc. Labeled fusion protein or ICAM-1 mAb 
were prepared by the chloramine T method (Hunter and Greenwood, 1962), using a ratio of
12550 |ig protein to 0.5 mCi of carrier-free [ I]Na (Amersham, Buckinghamshire, U.K.). 
Determination of cell adhesion to ICAM-1 in stasis and under fíow. A polystyrene coated 
with an adhesive ligand was assembled in a parallel-plate laminar flow chamber (260-^m
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gap) and mounted on the stage of an inverted phase contrast microscope (Diaphot 300; Nikon, 
Tokyo, Japan) as previously described (Lawrence and Springer, 1991; Alon et al., 1995a). 
Cell images were videotaped with a long-integration LIS-700 CCD video camera (Applitech, 
Holon, Israel) and a Panasonic AG-6730 SVHS video recorder (Panasonic, Osaka, Japan). 
Cultured cells were washed twice with cation-free H/H medium (HBSS containing BSA (2 
mg/ml) and 10 mM HEPES (pH 7.4)) containing 5 mM EDTA, resuspended in H/H medium, 
and kept at RT until use. Cells were suspended at RT in binding medium (H/H supplemented 
with 1 mM each of Ca2+ and Mg2+; also referred to as physiological binding medium). 
Alternatively, cells were suspended in H/H supplemented with 2 mM Mg2+, alone or with 0.5 
mM EGTA (Mg2+/EGTA). Suspended cells (106 cells/ml) were perfused through the flow 
chamber and allowed to settle on the plate for different periods in the absence of flow or were 
perfused through the chamber for 1 min at a constant low shear flow (0.25 dyn/cm2, unless 
otherwise indicated) before being subjected to an incremental increase in shear stress. Shear 
flow was generated and automatically controlled with an automated syringe pump (Harvard 
Apparatus, Natick, MA) attached to the outlet side of the flow chamber. The wall shear stress 
was increased step-wise every 5 s (by a programmed set of flow rates) until it reached 10 
dyn/cm2. At the end of each 5-s interval at a particular shear stress, the number of cells that 
remained bound (stationary or rolling; see below) was determined relative to the number of 
cells originally settled in stasis or relative to the number of cells that had accumulated at low 
shear flow on the ICAM-1-coated field. Cellular interactions were determined on two 
representative fields of view (each typically 0.34 mm2 of area). For Ab inhibition studies, 
cells (107/ml) were preincubated (5 min; 4°C) in H/H medium with LFA-1 blocking mAb (20 
|ig/ml). The cells were diluted 1:10 into binding medium without washing out the Abs, and 
the suspension was perfused into the flow chamber. To selectively block high-affinity LFA-1 
on compared cells, cells were suspended in binding medium containing soluble ICAM-1-Fc 
(0.5-1 |ig/ml) or control VCAM -1-Fc for 5 min at 24°C and then perfused through the flow 
chamber without diluting out the soluble ligands. For metabolic energy inhibition 
experiments, cells (2x107/ml) were treated (10 min; 22°C) with 0.1% sodium azide (Sigma) 
and 50 mM 2-deoxyglucose (2-DOG; Sigma) in H/H medium and then diluted (1:5) with 
binding medium and immediately perfused into the flow chamber.
Determination of rolling fractions and rolling velocities. Cells interacting with ICAM-1 were 
defined as arrested if they adhered to the substrate and remained motionless throughout the 
shear-flow interval examined. Cellular motions were defined as rolling if they persisted for at 
least 4 s at a mean velocity >2 |im/s that was reduced at least 20-fold compared with a freely 
flowing cell at a given shear stress. Some cells that arrested after tethering to high-density 
ICAM-1 under low shear flow began rolling when subjected to elevated shear stresses. The 
rolling fraction at a given shear stress was defined as: [(no. of rolling cells) x 100]/(no. of 
rolling cells + no. of stationary cells). The mean rolling velocities of cell populations at a 
given shear stress were determined by measuring the displacements of 15-20 cells over 5 -s 
shear intervals.
Image analysis. Quantitative analysis of cell displacements was performed with the WSCAN- 
Array-3 imaging software (Galai, Migdal-Ha'emek, Israel). Video frame images were
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digitized using a Matrox Pulsar frame grabber (Matrox Graphics, Dorval, Quebec, Canada) 
and processed by software running on an Atlas Pentium MMX-200 work station. The 
program output provided the coordinates of the center point of each cell with time, and 
analysis was performed with a dedicated software run under Matlab 5.2 (developed in 
collaboration with the lab of Prof. David Malah, Signal and Image Processing Lab, Technion, 
Haifa, Israel). Selected video images were also digitized on a G3 Macintosh using a 
Media100 frame grabber, and cellular motions were tracked using the DIAS imaging software 
(Solltech, Oakdale, IA).
Results
LFA-1 expressed in K562 cells supports rolling adhesions on ICAM-1 under 
physiological shear flow
To assess the magnitude of adhesiveness spontaneously developed by LFA-1 during brief cell 
contact with ICAM-1, we used a controlled flow assay to study weak LFA-1-dependent 
adhesion of various cell types to ICAM-1 substrates. LFA-1-mediated adhesion of the T cell 
leukemia line Jurkat was compared with that of K562 cells transfected with LFA-1 cDNA 
(K562-LFA-1 cells). The level of LFA-1 expressed on both cell types was comparable, 
although it was somewhat more heterogeneous in the K562 transfectants (Fig. 1). Substrates 
were coated with a recombinant human ICAM-1-Fc fusion protein by overlaying the protein 
on plastic precoated with protein A. Unstimulated Jurkat and K562-LFA-1 cells failed to 
develop firm adherence to immobilized ICAM-1 in conventional tip plate adhesion assays 
(data not shown). Nevertheless, when allowed to briefly settle on ICAM-1-coated substrates 
assembled in a flow chamber, significant fractions of both cell types developed considerable 
LFA-1-specific adhesion to ICAM-1 even without stimulation (Fig. 2A). Adhesion of both 
cell types was entirely LFA-1-dependent because it was blocked in the presence of the LFA- 
1-blocking mAb TS1.22 or by integrin inhibition in the presence of EDTA (Fig. 2A and data
not shown). VLA-4-expressing K562 cells failed to adhere to identical ICAM-1 substrates
2+  2+(Fig. 2A). Replacement of Ca by Mg , which induces a high-affinity state on LFA-1 
without dependence on intracellular signaling events, increased LFA-1 adhesiveness to 
ICAM-1 in both cell types to a comparable degree (Fig. 2A). The fraction of Jurkat cells that 
spontaneously adhered to ICAM-1 was markedly higher than that of K562-LFA-1 cells, both 
in medium containing Ca2+ and Mg2+ and in medium containing Mg2+ alone. Strikingly, when 
K562-LFA-1 cells adhered to ICAM-1 were subjected to a physiological shear stress higher 
than 1 dyn/cm , the majority of cells started to roll on the ICAM-1 substrate in a persistent 
manner, reminiscent of selectin-mediated rolling assayed in similar flow assays (Fig. 2, B and 
C). Rolling required a threshold of ICAM-1 density because it diminished on substrates 
coated at densities below 80 sites/^m (data not shown). The median strength of LFA-1- 
transfected K562 cell adhesions i.e., the shear stress causing the detachment of half of
originally adherent cells, also varied with ICAM-1 density. The median strength dropped
2 2 2 from 2.5 dyn/cm on ICAM-1-Fc coated at 750 sites/^m to a median strength of 1 dyn/cm
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Figure 2. LFA-1-mediated adhesion to ICAM-1 in different unstimulated LFA-1- 
expressing cells. A, K562-LFA-1 cells or Jurkat cells were introduced into the flow chamber 
in the indicated medium and allowed to settle for 1 min on a substrate coated with ICAM-1- 
Fc as described in Materials and Methods. The substrate contained 375 sites/pm2 of ICAM-1- 
Fc molecules/pm2 (750 ICAM-1 sites/pm2). Cells were then subjected to a shear stress of 0.25 
dyn/cm2 for 10 s before incremented shear stresses were applied, as indicated in the figure. 
Each increment lasted for 5 s, and the number of cells remaining adherent to ICAM-1 at the 
end of each interval of incremented shear was determined in two representative fields. The 
mean values ± range are shown in the figure. Reduction in the number of LFA-1 K562 cells 
remaining bound in the field was a result of cell detachment from the substrate and not of 
cells rolling out of the field of view. No adhesion of K562-LFA-1 or Jurkat cells was detected 
on substrates coated with protein A or with HSA alone. One of six similar independent 
experiments. B, Effect of shear stress and cation composition in the binding medium on the 
ability of LFA-1-expressing cells to roll on ICAM-1. Fractions of adherent cells within each 
cell type that maintained steady rolling on the ICAM-1 substrate at the indicated shear 
stresses are depicted. Rolling fractions were determined in two representative fields at a
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shear stress of 1.5 dyn/cm2 or 3.5 dyn/cm2. Average values ± range are shown. C, Images of 
K562-LFA-1 cells rolling on ICAM-1-Fc coated at 950 ICAM-1 sites/pm2 at a shear stress of
3.5 dyn/cm . The figure shows superposition of sequential images of cells captured from 
videotaped cellular motions at 0.28-s intervals. Cell images analyzed by the imaging software 
DIAS (see Materials and Methods) are represented as filled superimposed circles. 
Representative cells rolling with either a persistent or a jerky pattern are shown in medium 
containing either Ca2+ and Mg2+ (top panel) or Mg2+ alone (bottom panel). The arrow in the 
top panel indicates the position of a representative rolling cell at the position where it began 
to detach from the ICAM-1-coated substrate. The velocity of freely flowing cells at a shear 
stress of 3.5 dyn/cm2 was >400 pm/s.
on ICAM-1-Fc coated at 190 sites/^m2. Mg2+ was obligatory for LFA-1-mediated rolling of 
K562 cells on ICAM-1 because, in the presence of Ca2+ alone, LFA-1 adhesiveness was 
abolished on any ICAM-1 substrate tested (Fig. 2A). Replacement of Ca2+ with Mg2+ 
rendered essentially all adherent K562 cells rolling on the ligand (Fig. 2B). Recently, ICAM-1 
dimerization has been shown to strengthen LFA-1-mediated adhesions (Miller et al., 1995). 
ICAM-1 dimerization within the ICAM-1-Fc chimera did not appear obligatory for efficient 
LFA-1-mediated rolling because LFA-1 adhesiveness to monovalent ICAM-1, sICAM-1, 
directly immobilized on the substrate was comparable to LFA-1 adhesiveness to the dimeric 
ICAM-1-Fc when both were present at high site densities (Fig. 3). Notably, the ability of 
K562-LFA-1 cells to roll on ICAM-1 did not depend on a prior contact with immobilized 
ICAM-1. Cells tethered at shear flow to high-density ICAM-1 substrates (Fig. 3) continued to 
efficiently roll on the substrates, similarly to cells statically adhered and then subjected to 
shear flow (Fig. 2).
Rolling velocity through LFA-1 is modulated by cations and is only moderately 
increased by elevated shear stresses
Agonists of VLA-4 affinity to VCAM-1, such as Mn2+ or Mg2+, have been shown to slow 
integrin-mediated rolling (Alon et al., 1995a). Therefore, we asked how LFA-1 rolling on
ICAM-1 is regulated by divalent cations. Although rolling adhesions of K562-LFA-1 cells
2+increased in the presence of Mg2+ alone (Fig. 2, A and B), the velocities of cells rolling on
ICAM-1 in the presence of this cation alone were not significantly different from those
2+  2+measured in physiological concentrations of Ca and Mg (Fig. 4A). LFA-1 binding to
2+  2+ ICAM-1 in the presence of Mg can be increased by chelation of residual Ca in the
2+presence of EGTA, because Ca exclusion stabilizes LFA-1 in a conformation with high 
affinity for ICAM-1 (Stewart et al., 1996). Indeed, in the presence of Mg2+/EGTA, the 
fraction of adherent K562-LFA-1 cells rolling on ICAM-1 was sharply reduced (Fig. 4B,
inset), and the cells that could still roll on ICAM-1 did so at 5- to 7-fold slower velocities than
2+in the presence of Mg alone (Fig. 4B). Increasing LFA- affinity to ICAM-1 in the presence
2+of Mg /EGTA thus resulted in the majority of K562-LFA-1 cells developing firm adherence 
to ICAM-1 substrates. Elevation of ICAM-1 density caused all cells to arrest on ICAM-1 in
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the presence of Mg /EGTA (data not shown). Thus, increasing LFA-1 affinity restricts 
rolling interactions and leads to arrest of K562 cells interacting with ICAM-1 under shear 
flow. A characteristic of rolling adhesions mediated by selectins and a4 integrins is that 
rolling velocity increases with increasing shear forces (Lawrence and Springer, 1991; Alon et 
al., 1995a). A remarkable feature of LFA-1-mediated rolling demonstrated by our 
experiments was the invariance of rolling velocity with elevated shear stress (Fig. 4, A and 
B). To rule out the possibility that cells with higher resistance to detachment from ICAM-1, 
and therefore higher avidity of LFA-1 and slower rolling dynamics, were enriched within the 
population of cells remaining rolling on ICAM-1 at elevated shear stresses, single cells were 
analyzed for their displacement with time at continuously incremented shear stress. 
Surprisingly, rolling velocities of individual K562-LFA-1 remained constant (Fig. 4C, open 
symbols) or increased only moderately with elevated shear stress (Fig. 4C, closed squares). 
This peculiar dynamic behavior was seen only in cell subsets that exhibited higher resistance 
to detachment by elevated shear stresses. Thus, highly adhesive LFA-1-expressing K562 cells 
could overcome the destabilizing effects of elevated shear stress, which lead to faster rolling 
and enhanced detachment in the more weakly adhered K562-LFA-1 cells.
Figure 3. Effect of ICAM-1 type and site density on K562-LFA-1 accumulation and rolling 
efficiency. Rolling attachments formed by K562-LFA-1 cells on different ICAM-1 substrates 
under shear flow. Cells were perfused in the presence of 2 mM Mg2+ and allowed to 
accumulate at 0.25 dyn/cm2 for 60 s. The shear stress was increased to 0.5 dyn/cm2 for 5 s. 
The number of cells remaining adherent at the end of this interval is depicted by the hatched 
bars, and the fraction of adherent cells rolling on ICAM-1 at 0.5 dyn/cm2 is shown in 
parentheses on top of each bar graph. Cells remaining bound at 0.5 dyn/cm2 were subjected 
to incremented shear stresses of 0.75, 1.0, and 1.5 dyn/cm2, with each incremented shear 
lasting for 5 s. The number of cells remaining adherent at 1.5 dyn/cm2 (average ± range of 
two representative fields) is depicted by the filled bars, and the fraction of rolling cells at this 
shear stress is shown in parentheses on each bar. One of four similar experiments.
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Figure 4. Effect ofcations and shear stress on LFA-1-mediated rolling dynamics on ICAM-
1. A, Velocities of K562-LFA-1 cells rolling on ICAM-1-Fc coated at 950 ICAM-1 sites/cm2 in 
physiological medium or medium containing 2 mM M g+. Cells were tethered to the substrate 
at low shear stress of 0.25 dyn/cm for 1 min and then subjected to incremented shear stresses 
as described in Fig. 2. Displacement of rolling cells was determined over 5-s periods at the 
indicated shear stresses. Velocities were determined only for persistently rolling cells that 
remained adherent throughout the entire shear stress interval, indicated below each bar. 
Each bar shows the mean rolling velocity (and SEM) for 15 -20 cells. B, Velocities of K562 - 
LFA-1 cells rolling on ICAM-1-Fc coated at 750 ICAM-1 sites/cm2 in Mg2+ or Mg2+/EGTA. 
The fractions of adherent cells rolling at each indicated shear stress are shown in the inset. C, 
Displacement in the direction of flow of representative K562-LFA-1 cells rolling on high- 
density ICAM-1-Fc (at 1900 ICAM-1 sites/cm2) in physiological medium at incremented 
shear stresses. Cells were allowed to accumulate for 1 min on the ICAM-1 substrate at 0.25 
dyn/cm and then were subjected to incremented shear stresses as described in Fig. 2. The 
wall shear stress was increased at the indicated time points of the observation period. Cell 
positions were determined at 0.2-s intervals by WSCAN Array-3 image analysis software, as 
explained in Materials and Methods. Only cells remaining bound over the entire assay period 
(up to a shear stress of 8.25 dyn/cm2) were analyzed. Results shown in AC are representative 
of three independent experiments.
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LFA-1 tail-deletion mutant expressed in K562 cells exhibits high avidity to ICAM-1 
concomitant with loss of rolling
To study how increased LFA-1 avidity to ICAM-1 can modulate interactions between this 
integrin ligand pair under shear flow, we compared the dynamic properties of wild-type (wt) 
LFA-1 and an LFA-1 cytoplasmic tail deletion mutant. The ß2 subunit tail deletion mutant 
aLß2/724 exhibits constitutive high avidity to ICAM-1 and high expression of the activation 
epitope M24 concomitant with ligand-independent clustering (Lub et al., 1997b; van Kooyk et 
al., 1999), yet it binds soluble ICAM-1-Fc with affinity similar to that of wt LFA-1 (van 
Kooyk et al., 1999). K562 cells expressing the deletion mutant at levels identical to those of 
K562-LFA-1 cells (not shown) accumulated on both high- and low-density ICAM-1 at 
strikingly higher levels than did K562-LFA-1 under shear flow (Fig. 5A). The deletion 
mutant-expressing cells immediately arrested upon tethering to ICAM-1 and remained 
arrested on the ligand without ability to roll even when exposed to elevated shear stresses that 
caused their detachment from ICAM-1 (Fig. 5A). The resistance to detachment from ICAM-1 
of LFA-1 mutant-expressing cells was markedly higher than that of K562-LFA-1 cells on 
both bivalent (high-density) or monovalent (low-density) ICAM-1 (Fig. 5). No rolling was 
supported by the mutant LFA-1 on ICAM-1 at any ligand concentration or shear stress tested, 
in contrast to highly efficient rolling mediated by wt LFA-1 (Fig. 5 A). These findings are 
consistent with the notion that enhanced LFA-1 avidity to ICAM-1 results in immediate 
adhesion strengthening under shear flow at the expense of reversible rolling interactions. 
Thus, even in a cellular environment permissive for LFA-1-mediated rolling like that of K562 
cells, interference with the cytoskeletal association of LFA-1 through tail deletion abrogates 
the ability of the integrin to support rolling adhesions under physiological flow.
Modulation of LFA-1 avidity in T cells does not produce rolling reactivity
Metabolic energy is essential for optimal integrin function (O'Toole et al., 1994). Energy 
depletion of Jurkat cells by sodium azide and 2-deoxyglucose enhances VLA-4-mediated 
rolling on VCAM-1 at the expense of firm adhesion associated with reduction of integrin 
affinity to ligand (Chen et al., 1999). Therefore, we asked whether a similar energy depletion 
treatment of resting T cells would enhance their LFA-1 rolling on ICAM-1. However, 
metabolic energy depletion of Jurkat cells and PBL by azide/2-deoxyglucose greatly 
decreased LFA-1 adhesion to ICAM-1 without promoting LFA-1 rolling (Fig. 6). Phorbol 
esters like PMA are strong agonists of integrin adhesion in leukocytes (Faull et al., 1994; 
Alon et al., 1995a; Lawrence et al., 1995; Laudanna et al., 1996; Lub et al., 1997a). PMA 
treatment enhances LFA-1 adhesiveness in T cells by augmenting integrin clustering rather 
than affinity to ligand (Kucik et al., 1996; Stewart et al., 1998). Therefore, we set out to 
determine whether PMA stimulation of T cell LFA-1 can render a fraction of LFA-1- 
expressing cells capable of rolling on ICAM-1 under shear flow. PMA stimulation of PBL 
increased the number of PBL that arrested on ICAM-1 under low flow by 3-fold, but did not 
render any subset of treated cells capable of rolling on ICAM-1 (Fig. 6B).
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Figure 5. LFA-1 tail deletion mutant expressed in K562 cells exhibits increased avidity to 
ICAM-1 and loss of rolling. Accumulation under ñow on ICAM-1 and resistance to 
detachment by elevated shear stresses of K562 cells transfected with wt or ß2 tail deletion 
mutant of LFA-1. K562 cells expressing either wt LFA-1 or the LFA-1 cytoplasmic tail mutant 
L2/724 were allowed to accumulate for 1 min on either ICAM-1-Fc (950 ICAM-1 sites/pm2; 
A) or sICAM-1 (100 sites/pm2; B) at 0.25 dyn/cm2 and then were subjected to incremented 
shear stresses as described in Fig. 2. The different ICAM-1 forms were coated as described in 
Materials and Methods. The number of cells originally accumulated and the number of cells 
remaining adherent at the end of each shear stress interval were determined in two fields of 
view. Rolling fractions of wt and tail deletion LFA-1 mutant at a shear stress of 0.5 dyn/cm 
are shown in parentheses. One of three independent experiments.
LFA-1 avidity to ICAM-1 is lower in K562 cells than in T cells despite conserved affinity 
and constitutive clustering
The markedly stronger adhesion developed by T cell LFA-1, together with its inability to 
support rolling, suggests that LFA-1 avidity to ICAM-1 is higher in Jurkat T cells, as well as 
in PBL, than in K562 cells. Consistent with such a possibility, Jurkat cells could bind ICAM-
1-coated beads better than K562 cells could in physiological medium in the absence of shear 
flow, even without cell stimulation (Fig. 7A). Thus, markedly enhanced adhesiveness of 
Jurkat cell LFA-1 to surface-bound ICAM-1 could be observed even in shear-less conditions. 
Integrin-mediated adhesion to physiological ligands is dynamically regulated after ligand 
binding (Dransfield et al., 1992; Lub et al., 1997a; Yauch et al., 1997; Stewart et al., 1998). 
LFA-1 adhesion strengthening is diffusion-limited and depends strongly on contact time with 
the immobilized ligand (Kucik et al., 1996). Consistent with the inherent defect in adhesion 
strengthening of wt LFA-1 on K562 cells, K562-LFA-1 transfectants could not develop firm 
adhesion to ICAM-1 even after prolonged contact with ligand (Fig. 7B). When statically
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Figure 6. Effect of PMA stimulation and energy depletion of T cells on LFA-1 
adhesiveness to ICAM-1 under shear flow. Resting, energy-depleted (azide-treated), or 
PMA-activated Jurkat (A) or PBL (B) were perfused into the chamber at low shear stress of 
0.25 dyn/cm2 in physiological binding medium containing 1 mM each of Ca2+ and Mg2+. Cells 
were allowed to accumulate for 1 min on ICAM-1-Fc coated at 1900 ICAM-1 sites/pm2. 
Accumulated cells were subjected to incremented shear stresses as described in Fig. 2, and 
the number of cells remaining adherent at the end of each shear stress interval was 
determined. Values in B represent the mean of two fields of view. Insets, rolling fractions of 
untreated or treated cells at a shear stress of 1.5 dyn/cm2, determined as in Fig. 2B. The 
rolling fraction of K562-LFA-1 cells under identical experimental conditions is shown for 
comparison. One of three independent experiments.
110
LFA-1 mediated rolling on ICAM-1
adhered to low- or high-density ICAM-1, only a small fraction of K562 cells developed 
detectable adhesion to ICAM-1 during 1 min of contact, and a 3-fold longer contact period 
with the ligand did not increase the fraction of K562-LFA-1 cells firmly adherent to ICAM-1 
(Fig. 7B). Notably, even though Jurkat cell adhesion developed over 1 min of contact was 
much higher than that of the K562-LFA-1 cells, it could be further enhanced by a 3-fold or 
10-fold prolonged contact period with ICAM-1, in contrast to K562-LFA-1 adhesion (Fig. 7B 
and data not shown). These experiments collectively suggest that Jurkat LFA-1 and PBL 
develop firmer adhesion to surface-bound ICAM-1 than do K562-LFA-1 cells because of 
higher constitutive avidity of LFA-1 and higher contact-dependent adhesion strengthening of 
the integrin expressed in these T cells compared with K562 cells.
Figure 7. LFA-1 avidity to ICAM-1 is higher in resting Jurkat T cells than in K562 cells. A,
Binding of ICAM-1-coated beads to K562-LFA-1 and Jurkat cells. Cells were suspended in 
the presence of the indicated agonists for 10 min with fluorescent beads coated with ICAM-1 
at a cell:bead ratio of1:20. After washing off unbound beads, the fraction of cells with bound 
beads was determined by FACS. Background bead binding was determined by including an 
LFA-1 blocking mAb in the reaction suspension and was less than 5%. Results are expressed 
as the mean percentage of cells with bound beads from two independent experiments, each 
conducted in triplicate. Mean values ±  SD of LFA-1-specific adhesion are depicted. PMA was 
present at 100 ng/ml, and the LFA-1 activating mAb KIM185 was used at 5 pg/ml. ND, not 
determined because of cell aggregation induced by the mAb. B, Development of adhesion over 
contact time by LFA-1 in K562 cells and Jurkat. Cells were allowed to settle in physiological 
binding medium for 1 or 3 min in stasis on sICAM-1 coated at 200 sites/cm2 and then 
subjected to detachment by shear force of 0.25 dyn/cm2 for 10 s and then 0.5 dyn/cm2 for an 
additional 5 s. The fraction of originally settled cells remaining bound at the end of the assay 
is shown for cells settled for different periods. Results represent the mean ± range of two 
fields of view. Results are representative of three independent experiments.
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The reduced constitutive avidity of LFA-1 in the K562 cell system could reflect reduced 
intrinsic affinity to soluble ligand as well as lower constitutive clustering. ICAM-1-Fc bound 
saturably to K562-LFA-1, Jurkat cells, and subsets of PBL with comparable half-saturation 
concentrations (10 nM; data not shown), suggesting that the affinity of LFA-1 to ICAM-1 in 
solution is of the same order in both cell types. Direct binding measurements of soluble 
integrin ligands to their cell-surface receptors may discriminate against low-avidity LFA-1 
subsets because of rapid dissociation of ligand from these subsets caused by removal of 
unbound ligand by cell washing. Therefore, we took an alternative approach to assess in situ 
the role of LFA-1 affinity in T cell and K562-LFA-1 cell adhesion to ICAM-1 under flow. 
Because high-affinity LFA-1 states are preferentially occupied by soluble ICAM-1 (Stewart et 
al., 1996), we measured the extent of inhibition exerted by this soluble ligand on LFA-1- 
dependent cell adhesion to immobilized ICAM-1. ICAM-1-Fc inhibited in a dose-dependent 
manner both the accumulation on and resistance to detachment from ICAM-1 of PBL and of 
K562-LFA-1 cells interacting with ICAM-1 under shear flow (Fig. 8). The similar ICAM-1- 
Fc dose dependence of LFA-1 adhesion seen with both cell types suggested that LFA-1 
molecules with comparable levels of affinity contributed to LFA-1 adhesiveness in both PBL 
and K562-LFA-1 cells. In light of the conserved affinity of LFA-1 toward ICAM-1 in both 
resting Jurkat cells and K562 cells, we next tested whether Jurkat cells exhibit higher 
constitutive clustering of LFA-1 relative to that on K562-LFA-1 cells. CLSM analysis of 
LFA-1 surface distribution revealed that the majority of LFA-1 in both cell types is not 
clustered under physiological conditions (Fig. 9). Rather, LFA-1 was found either evenly 
diffused or in small patches on the entire cell surface of both cell types, but no major 
difference in the number or size of LFA-1 patches between the two cell types was detected 
(Fig. 9). Consistent with the CLSM analysis, the levels of NKI-L16, a Ca2+-dependent LFA-1 
clustering-associated epitope (van Kooyk et al., 1994), were similar on both cell types; a 
comparable ratio of NKI-L16 staining to LFA-1 staining was observed in K562-LFA-1 (0.36 
± 0.06) and in Jurkat cells (0.25 ± 0.03). These results suggest that before ligand binding, 
LFA-1 on both Jurkat cells and K562 cells as well as on PBL (Lub et al., 1997a) is largely 
unclustered. Thus, differences in constitutive pre-ligand binding of LFA-1 in resting T cells 
and K562 cells cannot account for the firm adhesion to ICAM-1 rapidly developed by these 
cells but not by K562-LFA-1 cells under dynamic conditions of shear flow.
Discussion
This study demonstrates several novel concepts in LFA-1-mediated adhesion. First, LFA-1 
exists in unstimulated PBL and in T cell lines in functionally adhesive states, which supports 
significant adhesion to immobilized ICAM-1 during short static contact with ligand. LFA-1 
on subsets of T cells and K562 transfectants can develop different modes of adhesion to high- 
density ICAM-1 within fractions of a second, even without agonist stimulation. These types 
of LFA-1-mediated adhesion do not involve cell spreading triggered by ligand occupancy of 
LFA-1, which contributes to adhesion strengthening through diffusion-limited integrin
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clustering events (Stewart et al., 1996). Like early events of LFA-1-dependent adhesive 
cascades, these interactions are not discernible in standard adhesion assays, which apply 
stringent washing steps with high, uncontrolled detachment forces. Second, low-avidity LFA- 
1 states with similar affinity to that of soluble ICAM-1 can have strikingly different adhesive 
properties when expressed on different cellular backgrounds. In K562 cells, LFA-1 can 
establish weak rolling adhesions on ICAM-1 under physiological shear flow, the first direct 
demonstration that this integrin can associate rapidly and reversibly with ICAM-1 under flow 
conditions. In Jurkat T leukemia cells and in subsets of peripheral blood T lymphocytes, LFA- 
1 can spontaneously support high-avidity interactions with immobilized ICAM-1, leading to 
cellular arrest under shear flow. Third, the ability of LFA-1 to mediate cell rolling on ICAM-1 
is associated with an impaired ability to undergo adhesion strengthening; increased adhesion 
strengthening by an LFA-1 tail mutant results in loss of rolling and its replacement by firm 
adhesion of K562 cells. Therefore, our findings indicate a reciprocal relationship between 
ability of LFA-1 to roll and to undergo adhesion strengthening under shear flow conditions.
Figure 8. Susceptibility o f LFA-1-dependent adhesion o f K562 cells and PBL to inhibition 
by soluble ICAM-1-Fc. Cells were suspended in physiological binding medium containing
soluble ICAM-1-Fc at the indicated concentrations for 5 min at 24°C and then perfused
2 2 unwashed at 0.25 dyn/cm for 1 min over a substrate coated with sICAM-1 at 200 sites/pm .
Accumulated cells were subjected to incremented shear stresses as described in Fig. 2, and
the number of cells remaining adherent at the end of each shear stress interval was
determined. Values represent the mean (± range) of two fields of view. Control VCAM-1-Fc
had no inhibitory effect on cell accumulation or on adhesion to the ICAM-1 substrates at the
indicated concentrations (data not shown). A representative experiment of three.
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K562-LFA-1 Jurkat
5 micron
Figure 9. Constitutive LFA-1 distribution on Jurkat and K562-LFA-1 cells determined by 
confocal microscopy. K562 cells (top panel) or Jurkat cells (bottom panel) were prefixed in 
medium containing 1 mM each of Ca2+ and Mgf+, and cells were stained with the anti-LFA-1 
mAb TS2/4 and then with FITC-labeled goat F(ab)2 anti-mouse IgG. Single representative 
cells from each experimental group are depicted. The majority of LFA-1 is dispersed, but 
small patches can be seen on both cell types.
To support reversible rolling adhesions, major rolling receptors like selectins need to 
rapidly and reversibly bind a small number of ligands at the adhesive contact zone (Alon et 
al., 1997). To engage in rolling interactions with its endothelial ligand, LFA-1 might also 
need to be prevented from engaging in highly multivalent interactions with ICAM-1. We have 
shown that a ß2 tail-truncated LFA-1 mutant with conserved affinity to ICAM-1 but impaired 
cytoskeletal constraints in the K562 cell system exhibited enhanced ability to undergo rapid 
adhesion strengthening on ICAM-1 under shear flow. These results suggest that the inability 
of wt LFA-1 to mediate rolling in Jurkat cells and PBL subsets may also result in reduced 
cytoskeletal constraints and hence increased adhesion strengthening of wt LFA-1 in T cells 
relative to those imposed on the integrin in K562 cells. Ligand-induced LFA-1 clustering in T 
cells requires the release of cytoskeletal restraints on LFA-1, which restricts its lateral 
clustering (Kucik et al., 1996; Lub et al., 1997a; Stewart et al., 1998). Notably, release of 
cytoskeletal constraints of LFA-1 and adhesion strengthening is facilitated upon T cell 
activation by PMA without alteration of LFA-1 affinity (Stewart et al., 1996). PMA fails to 
induce adhesion strengthening to ICAM-1 in K562 cells (Lub et al., 1997a; van Kooyk et al., 
1999), which supports major reduced susceptibility of LFA-1 association with the actin 
cytoskeleton to PMA stimulation in these cells. Consistent with an inherent defect in LFA-1 
release of cytoskeletal constraints in K562 cells, cytochalasin D treatment has been reported 
to induce LFA-1 clustering in resting PBL but not in K562 cells (Lub et al., 1997a,b). Higher 
cytoskeletal restraints of LFA-1 in K562 cells and impaired adhesion strengthening may keep
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LFA-1:ICAM-1 interactions at low avidity and may allow reversible fast-breaking rolling 
interactions to form under constant shear flow. Thus, a cell-type-dependent restriction in 
LFA-1-mediated adhesion strengthening, rather than intrinsic integrin properties, appears to 
control the ability of LFA-1 to promote rolling adhesions of circulating leukocytes on its 
endothelial ligand. Enhanced constitutive clustering of LFA-1 before ligand binding has been 
shown to correlate with increased avidity to ICAM-1 in various cellular systems (Kucik et al., 
1996; Lub et al., 1997a). However, the impaired ability of K562-LFA-1 to support high- 
avidity adherence was not because of impaired constitutive clustering of LFA-1 in K562 cells 
relative to Jurkat T cells or PBL (Fig. 9; Lub et al., 1997a,b). Taken together, these 
observations suggest that the deficient adhesion strengthening properties of LFA-1 in K562 
cells and the acquisition of a rolling phenotype by LFA-1 in these cells reflect a defect in 
postligand binding clustering, rather than a constitutive, i.e., pre-ligand binding, LFA-1 
clustering defect.
LFA-1-mediated rolling requires an intact I-domain, suggesting the critical contribution 
of this module to recognition of ICAM-1 under both static and dynamic conditions (Landis et 
al., 1994). The I-domain of LFA-1 has recently been shown to act as a transient Mg2+- 
dependent binding module that supports transient rolling adhesions on substrates containing 
ICAM-1 or ICAM-3 (Knorr and Dustin, 1997). Unstimulated T cell LFA-1 binds ICAM-1 
with a Kd of 100 |iM (Lollo et al., 1993); a slightly lower affinity (Kd of 100-200 ^M) was 
estimated for the binding of ICAM-1 to the isolated I-domain (Knorr and Dustin, 1997). This 
affinity is similar to the recently determined affinity between L-selectin and its endothelial 
ligand, glycosylation-dependent cell adhesion molecule-1 (Nicholson et al., 1998). 
Nevertheless, the ability of LFA-1 to mediate rolling does not depend on its affinity to ligand 
because the affinity of LFA-1 to ICAM-1 in the T cell systems that failed to roll on ICAM-1 
was not higher than LFA-1 affinity in the K562 cells that efficiently rolled on the LFA-1 
ligand. ICAM-1-Fc bound saturably to K562-LFA-1 and Jurkat cells with comparable half­
saturation concentrations (10 nM; data not shown), and comparable levels of high-affinity 
LFA-1 contributed to adhesion of both T cells and K562-LFA-1 cells to ICAM-1 because 
both cells exhibited similar susceptibility to inhibition by soluble ICAM-1. Therefore, our 
results suggest that affinity-independent mechanisms of integrin clustering control LFA-1 
ability to undergo adhesion strengthening in T cells and also engage weak reversible rolling 
interactions on ICAM-1 in K562 cells.
Cell adhesive bonds that support rolling adhesions have been suggested to share fast 
kinetics of formation and dissociation (Alon et al., 1995b; Alon et al., 1997). Cellular 
environment may alter the kinetics of tether bond formation under flow, and faster kinetics of 
bond formation by LFA-1 can be favored by increased cell-surface availability of the integrin 
(Moore et al., 1995; von Andrian et al., 1995; Stein et al., 1999). ß2 Integrins are generally 
excluded from microvilli in most leukocytes (Abitorabi et al., 1997). A recent study showed 
that about 30% of LFA-1 is located on microvilli in transfected K562 cells (Abitorabi et al., 
1997). Our electron microscopy studies confirm that more than 20% of the cell-surface LFA-1 
in K562 cells is localized to microvilli, whereas a diminished fraction of LFA-1 on Jurkat 
cells or PBL is distributed to these cellular projections (Y.v.K., unpublished observations).
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Nevertheless, exclusion of selectins from microvilli does not preclude their ability to support 
rolling (Stein et al., 1999), suggesting that exclusion of LFA-1 from these surface extensions 
in T cells could not have accounted for the complete loss of rolling activity of LFA-1 
expressed in these cells. Indeed, although excluded from microvilli, LFA-1 on Jurkat cells 
was still able to tether to ICAM-1 at comparably high shear stresses relative to those 
permissive for LFA-1-mediated tethering of K562 cells to ICAM-1 (data not shown). 
Therefore, the ability of LFA-1 expressed in K562 cells to mediate rolling appears to be 
primarily because of a defect in LFA-1 avidity to ICAM-1 rather than because of markedly 
higher topographical availability of the integrin for rapid interactions with ICAM-1.
The ability of the LFA-1 :ICAM-1 pair to participate in rolling adhesions under 
physiological conditions is clearly more limited than that of the a4 integrins. First, tethering 
of LFA-1 to ICAM-1 in the presence of physiological cation concentrations was not as 
efficient as the tethering of VLA-4 to VCAM-1 or of a4ß7 to mucosal addressin cell adhesion 
molecule-1 (Alon et al., 1995a; Berlin et al., 1995). Second, LFA-1-mediated rolling required 
higher-density ICAM-1 than was required for a4 integrin-mediated rolling on VCAM-1 (data 
not shown). Third, in contrast to LFA-1, the ability of the VLA-4 integrin to support rolling 
on its endothelial ligand VCAM-1 is not cell-type-restricted, in that this integrin supports 
rolling of several types of cells, including T cells, polymorphonuclear cells, and 
hematopoietic progenitors (Jones et al., 1994; Alon et al., 1995a; Berlin et al., 1995; Johnston 
et al., 1996; Campbell et al., 1996; Mazo et al., 1998). Therefore, we predict that rolling 
through LFA-1 may take place mainly in a context of another rolling interaction initiated by a 
selectin or a4 integrin. Indeed, recent studies implicate the LFA-1 :ICAM-1 interaction in 
rolling adhesions promoted by P- and L-selectin. The stability of leukocyte rolling mediated 
by these selectins on inflamed vessel walls is significantly reduced in ICAM-1 knockout mice 
(Steeber et al., 1998) after either trauma or cytokine-induced inflammation. Reduction in 
physiologic shear rates has been shown in another study to enhance CD11/CD18-dependent, 
selectin-independent leukocyte rolling in vivo, suggesting that LFA-1 mediates weak rolling 
interactions on inflamed vessel walls under particular conditions (Gaboury and Kubes, 1994). 
Our results would predict that to engage in rolling interactions with endothelial ICAM-1, 
LFA-1 must be restricted from forming multivalent receptor:ligand clusters. Such restriction 
may be regulated by the cytoskeletal associations of the integrin. Small subsets of circulating 
leukocytes may regulate the cytoskeletal associations of LFA-1 such that they can engage in 
reversible rolling adhesions on ICAM-1 in vivo. Taken together, the multistep paradigm of 
leukocyte adhesion to specific endothelial sites may be more complex than previously 
realized. Rather than a sequential process conducted by distinct adhesive steps, which are 
exclusively mediated by either selectins or integrins, leukocytes may use weak interactions of 
both a4 integrins and LFA-1 with their respective ligands to stabilize selectin-initiated 
rolling. The LFA-1-mediated rolling demonstrated in the present study further increases the 
complexity and functional diversity of adhesive cascades, which determine the cell-type- 
specific recruitment of circulating leukocytes at sites of inflammation and at specialized 
hematopoietic beds.
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Abstract
The activity of the integrin LFA-1 can be regulated by avidity changes that regulate cell 
adhesion. Wild-type LFA-1 expressed in K562 cells (K562-aL/ß2) exists in a low avidity 
state, which has been shown to support reversible rolling adhesions on ICAM-1 under 
physiological shear flow. The dynamics of these interactions allow key insights into rapid 
avidity modulations. Now we report that PMA activation of K562-aL/ß2 cells causes 
dramatic strengthening of rolling adhesions under flow. The PMA induced rolling adhesions 
are due to clustering of LFA-1 only after ligand binding (post-ligand clustering) leading to 
high avidity LFA-1. An LFA-1 mutant containing a point mutation in the ß2 cytoplasmic 
domain (K562-aL/L732R-ß2) that keeps LFA-1 in a yet clustered state (pre-ligand clustering) 
also supported rolling interactions under flow and displayed a further strengthening of rolling 
adhesions upon PMA stimulation. These results indicate that PMA differently regulates low 
and high avidity forms of LFA-1 by transforming low avidity LFA-1 into high avidity LFA-1 
only after ligand has bound (post-ligand clustering). Moreover, high avidity clustered LFA-1 
can even be further activated by PMA without any affinity changes. We observed that the 
PMA induced adhesion under flow is dependent on calpain, which releases LFA-1 from the 
cytoskeleton, indicating active cytoskeletal rearrangements. Taken together, our study 
demonstrates that LFA-1 regulation of avidity is a dynamic and fast process in which both 
pre- and post-ligand clustering events contribute to a variety of LFA-1 adhesion states.
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Introduction
The migration of leukocytes through the endothelial wall into sites of inflammation involves a 
cascade of cellular interactions, which are initiated by the selectin family of adhesion 
molecules (Springer, 1994). Leukocyte tethering and rolling by selectins are essential to 
reduce the velocity of the cells that are constitutively exposed to high flow rates within the 
blood vessel. This weak interaction is followed by arrest and subsequently firm adhesion 
mediated by the ß1, ß2, and ß7 integrin family. Especially the ß1 integrin VLA-4 is involved 
in both the primary selectin-mediated rolling and the firm adhesion supported by the ß2 
integrin family. The lymphocyte function-associated antigen-1 (LFA-1; CD11a/CD18; aL/ß2) 
is a member of the ß2 integrin family and mainly mediates lymphocyte binding. LFA-1 is a 
leukocyte specific adhesion receptor composed of an unique aL and common ß2 subunit that 
can bind to the intercellular adhesion molecules (ICAM)-1, -2, or -3 (Marlin and Springer, 
1987; Staunton et al., 1989; Springer, 1990; Vazeux et al., 1992). ICAM-2 is constitutively 
expressed on endothelial cells, whereas ICAM-1 expression can be strongly upregulated by 
inflammatory cytokines (Dustin et al., 1986).
For adequate functioning of the immune system, it is a prerequisite that leukocytes adhere 
to the blood vessel in a strictly controlled manner. This means that on freely flowing resting 
leukocytes LFA-1 is in a default inactive state not capable to bind its ligands with high 
affinity (Bleijs et al., 2000). Upon certain stimuli, LFA-1 is activated to slow down the 
selectin-mediated rolling of the lymphocytes and initiate firm adhesion and diapedesis. 
Signals that alter LFA-1 activity can either come from inside-out or outside-in signals. Inside­
out signals are initiated upon triggering of specific cell surface molecules, such as T cell 
receptor (TCR) or chemokine receptors, leading to active LFA-1 (van Kooyk et al., 1989; Lub 
et al., 1995; Campbell et al., 1998). Direct activation of PKC by the phorbol ester PMA has 
also been shown to activate LFA-1 (Rothlein and Springer, 1986), resulting in increased LFA- 
1 affinity and changing the LFA-1 surface distribution into clusters (avidity) (Figdor et al., 
1990; Kucik et al., 1996). Outside-in signaling is induced by LFA-1 activating antibodies 
(Andrew et al., 1993) or binding of ligand such as ICAM-3 (Bleijs et al., 2000).
Chemokine activation signals rapidly activate LFA-1 on rolling leukocytes to establish 
strong adhesion to the endothelium (Campbell et al., 1998; Constantin et al., 2000). Several 
reports have demonstrated that weak rolling adhesions on the vessel wall through selectins, 
CD44, or VAP-1 triggers high avidity LFA-1 binding to endothelial ICAM-1 (Springer, 1994; 
Butcher and Picker, 1996). Lateral diffusion and clustering of LFA-1 on the cell surface is 
thought to be regulated by intracellular proteins like cytohesin (Kolanus et al., 1996),
MacMARCKS (Zhou and Li, 2000), and calpain (Stewart et al., 1998). Increased LFA-1
2+clustering leading to high avidity state of LFA-1 is dependent on the presence of Ca ,
2+whereas Mg induces a high affinity state of the LFA-1 molecule (Rothlein and Springer, 
1986; Figdor et al., 1990; van Kooyk et al., 1994). Both affinity and avidity are necessary for 
strong adhesion of LFA-1 to its ligand (Lub et al., 1995).
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Although T cells in a classical static adhesion assay do not spontaneously bind to ICAM-
1, they immediately arrest on ICAM-1 coated surfaces under shear flow (Sigal et al., 2000). 
However, when wild-type LFA-1 is expressed in a different cellular environment, like the 
erythroleukemic cell line K562 (K562-aL/ß2), LFA-1 fails to generate firm adhesion and 
arrest of cells interacting with ICAM-1 under flow. Instead, K562-aL/ß2 cells establish 
rolling interactions on ICAM-1, the result of fast formation and dissociation of short-lived 
tethers (Sigal et al., 2000). The advantage of this flow system is that relatively weak 
interactions between integrins and ligands can be detected and evaluated for relative strength 
(Chen et al., 1999), in contrast to static adhesion assays that employs vigorous washing forces 
whereby K562-aL/ß2 cells do not adhere to ICAM-1 (Lub et al., 1997). Thus, cell-type 
differences in LFA-1 activity and/or avidity regulate the ability of LFA-1 to support rolling 
adhesions (Sigal et al., 2000). Wild-type LFA-1 in K562 cells is homogeneously distributed 
along the cell surface and is unresponsive to PMA to bind ICAM-1 in a static adhesion assay. 
The relatively short ß2 cytoplasmic domain of LFA-1 is important for the adhesive function 
of LFA-1, since deletion of the ß2 cytoplasmic domain results in a constitutive active and 
clustered LFA-1 molecule when expressed in the K562 cells (Lub et al., 1997). Recently we 
identified a single amino acid in the ß2 cytoplasmic tail (L732R) that is involved in 
cytoskeletal reorganization and LFA-1 clustering on the cell surface (Bleijs et al., 2001). 
Expression of this mutant in K562 cells (K562-aL/L732R-ß2) also restores the PMA 
unresponsiveness of wild-type LFA-1 expressing K562 cells, indicating that LFA-1 avidity 
changes seem to play a crucial role in PMA responsiveness of LFA-1 adhesion (van Kooyk 
and Figdor, 2000). In addition, PMA activation of wild-type LFA-1 and mutant LFA-1 does 
not change the affinity of LFA-1 for its ligand ICAM-1 (Bleijs et al., 2001). As this LFA-1 
clustered mutant K562-aL/L732R-ß2 is in a high avidity state prior to ICAM-1 adhesion, it 
can be regarded as a pre-ligand clustering mutant.
In this study, we investigated the adhesion dynamics and rolling characteristics of low 
avidity K562-aL/ß2 cells versus the high avidity K562-aL/L732R-ß2 cells and the effect of 
'inside-out' signaling induced by PMA. We provide evidence that both wild-type LFA-1 as 
well as the mutant LFA-1 have the ability to establish rolling on ICAM-1 coated surfaces in a 
controlled flow assay performed in laminar flow chambers. Surprisingly, low and high avidity 
states of LFA-1 differentially respond to PMA activation. The PMA-induced activation of 
LFA-1 results in cytoskeletal reorganization during rolling on ICAM-1, since avidity 
regulation of LFA-1 is regulated by calpain, which cleaves LFA-1 from the cytoskeleton 
(Stewart et al., 1998). This study provides new insights into how different LFA-1 avidity 
states are regulated by the PKC signaling pathway during LFA-1-mediated rolling on ICAM- 
1 under physiological shear flow.
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Materials and methods
Monoclonal antibodies
The non-blocking mAb TS2/4 (IgG1) reactive with aL (Sanchez-Madrid et al., 1982) and the 
mAb 60.3 (IgG1) directed against ß2 (Beatty et al., 1983) were used to detect LFA-1. The 
mAb L15 (IgG2a) was used to block LFA-1 interactions and mAb KIM185 (IgG1) to activate 
LFA-1 (Andrew et al., 1993). TS1/18 directed against the ß2 was a kind gift of T. Springer 
and the mAb 4B9 against VCAM-1 was provided by R. Lobb.
Cell culture and transfection
Stable LFA-1 expressing K562 transfectants were established by electroporation with the 
wild-type aL (in pCDM8) together with wild-type ß2 subunit (in pRc/CMV), truncated ß2 
subunit, or point-mutated ß2 subunit as described previously (Bleijs et al., 2001). K562-aL/ß2 
transfectants were cultured in RPMI 1640 medium (Life Technologies ltd, Paisley, Scotland), 
supplemented with 10% FCS (Bio Whitaker, Verviers, Belgium), 1% antibiotics/antimycotics 
(Life Technologies, Inc., Grand Island, NY). After 48 hrs, the neomycin analogue, geneticin 
(2 mg/ml; Life Technologies ltd, Paisley, Scotland) was added to the culture medium. The 
different transfectants were sorted three or more times to obtain a homogeneous population of 
cells expressing high levels of LFA-1. Positive cells were stained with FITC-conjugated 
TS2/4 mAb and isolated using a Coulter Epics Elite cell sorter (Coulter, Hialeah, FL).
Immunofluorescence analysis
Expression of LFA-1 on the transfectants was determined by immunofluorescence. Cells were 
incubated (30 min, 4°C) in PBS, containing 0.5% w/v BSA (Boehringer, Mannheim, 
Germany) and 0.01% sodiumazide (10 mM; Merck, Hohenbrunn, Germany), with appropriate 
dilutions of either an anti-integrin mAb or an isotype-matched control antibody, followed by 
incubation with (FITC)-labeled goat (Fab')2 anti-mouse IgG mAb (Zymed laboratories, San 
Francisco, CA) for 30 min at 4°C. The relative fluorescence intensity was measured by 
FACScan analysis (Becton Dickinson & Co., Oxnard, CA).
Fluorescent beads adhesion assay
Ligand-coated TransFluoSpheres (1.0 |im, Molecular Probes, Eugen, OR) were incubated 
with cells pre-incubated with/without LFA-1-blocking mAb (20 |ig/ml) for 10 min at RT in a 
96-wells V-shaped bottom plate, alone, or in the presence of 100 ng/ml PMA (Calbiochem, 
La Jolla, CA), or 10^g/ml KIM185 for 30 min at 37°C. LFA-1-mediated bead adhesion was 
measured by flowcytometry using FACScan, as previously described (Geijtenbeek et al., 
1999). Values are depicted as integrin-specific adhesion i.e. cell adhesion percentage minus 
cell adhesion percentage in the presence of an LFA-1 blocking mAb.
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Laminar Flow Assays
ICAM-1-Fc coated substrates were prepared as previously described (Sigal et al., 2000). LFA- 
1-specific mAbs were coated (0.1 |ig/ml) on surfaces which had been pre-coated with 20 |ig/ml 
Protein A (Sigma), followed by overlay with 2 |ig/ml IgG-Fc-specific rabbit anti mouse. The 
polystyrene coated with an adhesive ligand was assembled in a parallel plate laminar flow 
chamber (260-^m gap) as described (Sigal et al., 2000). Cells were washed twice with cation­
free H/H medium (HBSS (Sigma) containing 2 mg/ml BSA and 10 mM HEPES, pH 7.4) 
containing 5 mM EDTA, resuspended in H/H medium and kept at room temperature until use. 
Cells were suspended at room temperature in binding medium (H/H containing BSA and 
supplemented with 1 mM each of Ca2+ and Mg2+). For antibody inhibition studies, cells 
(107/ml) were preincubated (5 min, 4°C) in H/H medium with LFA-1-blocking mAb (20 
|ig/ml). For LFA-1 activation/inhibition studies, cells were pre-incubated with PMA (100 ^M) 
for 2 min, or with 50 |ig/ml calpeptin (Calbiochem) for 30 min. Suspended cells (106 cells/ml) 
were perfused through the flow chamber and allowed to settle on the plate for one minute at a 
constant low shear flow (0.5 dyn/cm2, unless otherwise indicated), before being subjected to 
incremented shear stresses. Shear flow was generated and automatically controlled with an 
automated syringe pump (Harvard Apparatus; Natick, MA). The wall shear stress was increased 
step-wise every 5 sec (by a programmed set of flow rates) until it reached 10 dyn/cm2 (unless 
otherwise indicated). Cell images were videotaped and the number of cells that remained bound 
at the end of each 5 sec interval was determined relative to the number of cells that had 
originally accumulated at low shear flow on the substrate coated field in the beginning of the 
assay. Cellular interactions were determined on two representative fields of view (each 
typically 0.34 mm2 of area). The fractions of cells rolling or remaining stationary at a given 
shear stress were determined during the detachment experiments as previously described (Sigal 
et al., 2000).
Confocal Microscopy
Cells were incubated with ICAM-1Fc (2 |ig/ml) or BSA (2 |ig/ml) coated 3.0 |im polystyrene 
beads (Sigma) under identical conditions used for the laminar flow assays. Cells were 
suspended in binding medium at room temperature with coated beads for 15 min, or with 
PMA (100 ng/ml, 2 min), washed, and subsequently fixed with 0.5% paraformaldehyde. Cells 
were stained with TS2/4 mAb (10 |ig/ml) for 30 min at 37°C, followed by incubation with 
FITC-labeled goat (Fab')2 anti-mouse IgG mAb for 30 min at 37°C. Cells were attached to 
poly-L-lysine coated glass slides, after which cell surface distribution of LFA-1 was 
determined by Confocal Laser Scanning Microscopy (CLSM) at 488 nm with a krypton/argon 
Laser (Biorad 1000, Hercules, CA). The CLSM settings were: lens, 60x; gain, 1300; pinhole,
1.5 |im; and magnification, 2.0x. The same instrument settings of the CLSM were used 
throughout the distinct experiments.
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Results
Characteristics of static adhesion to ICAM-1 of low and high avidity LFA-1 molecules
LFA-1 expressed on leukocytes has to be activated in order to undergo conformational 
changes and to efficiently bind its ligand ICAM-1. Inside-out signals, such as phorbol esters, 
stimulate LFA-1 adhesiveness to ICAM-1 in a static beads adhesion assay via PKC. However, 
this PMA responsiveness is lost when wild-type LFA-1 is expressed in the erythroleukemic 
cell line K562 (K562-aL/ß2) (Lub et al., 1997). Recently, we have demonstrated that 
substitution of a single amino acid in the ß2 cytoplasmic tail for ß1 residue arginine (K562- 
aL/L732R-ß2) in the DLRE motif is of essential importance in restoring the PMA 
responsiveness of LFA-1 in K562 cells when performed in a static adhesion assay (Fig. 1 and 
Bleijs et al., 2001). The ability of this mutant LFA-1 to adhere to ICAM-1 upon PMA 
activation is not due to changes in LFA-1 affinity or phosphorylation state of the ß2 
cytoplasmic tail. Interestingly, this mutant exhibits an increased constitutive LFA-1 clustering 
on the cell surface (high avidity), in contrast to wild-type LFA-1 that is homogeneously 
distributed (low avidity). The fact that this clustering of the mutant LFA-1 is independent of 
any ligand binding, since anti-ICAM-1 antibodies do not prevent LFA-1 clustering (data not 
shown), indicates that LFA-1 in mutant K562-aL/L732R-ß2 exists in a pre-ligand clustering 
state, reflecting altered cytoskeletal associations of the mutated tail. The close linkage 
between LFA-1 clustering and its enhanced sensitivity for PMA in static adhesion assays, 
prompted us to analyze how rapid avidity changes of LFA-1 may take place at subsecond 
contacts formed between LFA-1 and ICAM-1, such as during leukocyte interactions with 
surface-bound ICAM-1 under shear flow.
Adhesive properties of different LFA-1 avidity mutants under physiological shear flow
To study the cytoplasmic regulation of dynamic adhesion of LFA-1 expressing K562 cells to 
ICAM-1 under shear flow, we used controlled flow assays to monitor rapid adhesion 
stabilization events. Unstimulated K562-aL/ß2 and mutant K562-aL/L732R-ß2 were allowed 
to adhere to an ICAM-1 coated substrate assembled in a flow chamber. Both LFA-1 
expressing cells adhered to ICAM-1 under a low subphysiological shear stress of 0.5 dyn/cm2 
(Fig 2A) in an LFA-1-dependent manner, since LFA-1-blocking antibodies as well as EDTA 
completely inhibited all adhesive interactions with ICAM-1 (data not shown). As the shear 
stress was incremented, originally adherent cells rapidly detached from the substrate (Fig. 
2A). The number of the high avidity LFA-1 mutant K562-aL/L732R-ß2 cells remaining 
adherent to ICAM-1 was considerably higher than that of wild-type LFA-1 expressing cells 
(Fig. 2A). In a static adhesion assay, both types of cells exhibited low spontaneous adhesion 
to ICAM-1 in the absence of stimulation by PMA or mAb KIM185 (Fig. 1). These data 
clearly demonstrate that avidity differences of the LFA-1 variants not detected in static 
spontaneous adhesion assays, result in significant adhesion differences depicted by controlled 
flow assays that monitor dynamic adhesive contacts between these LFA-1 variants and 
ICAM-1-bearing surfaces.
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Figure 1. PMA responsiveness in static adhesion assay of low and high avidity LFA-1 
forms expressed in K562 cells. (A). One letter code amino acid sequence of wild-type ß2 
cytoplasmic domain and point mutant L732R (B). Expression of both LFA-1 variants in K562 
cells stained with TS2/4 antibody recognizing heterodimeric LFA-1 (bold line) or an isotype- 
matching control antibody (dashed line). (C). Cells were incubated in medium, PMA (100 
nM), the activating anti-ß2 mAb KIM185 (10 ¡Jg/ml) together with ligand-coated 
TransFluoSpheres for 30 min at 37°C as described in section Material and Methods. Depicted 
is the mean percentage ±  SD) of LFA-1-specific adhesion to ICAM-1 of the gated cells that 
expressed equal amounts of LFA-1 (mean fluorescent intensity 70 - 80) as determined by 
staining with the FITC-conjugated non-blocking anti-LFA-1 antibody (TS2/4). Integrin 
specific adhesion: Percentage of cells binding - percentage of cells binding in the presence of 
an integrin blocking mAb (NKI-L15). LFA-1 surface distribution is depicted in the lower 
panel. Cells were fixed (0.5% paraformaldehyde) and subsequently stained with the anti- 
LFA-1 mAb TS2/4 and GAM-(Fab')2-FITC second antibodies. Clustering of LFA-1 is 
indicated with arrows. Data are representative of four experiments.
Recently, we reported that LFA-1 expressed in K562 cells established both reversible 
rolling adhesions as well as rapidly generated firm adhesion on ICAM-1-coated surfaces 
under shear flow (Sigal et al., 2000). To determine whether the various LFA-1 avidity states 
result in different types of rolling adhesions on ICAM-1, we compared the rolling capacity of 
the low avidity wild-type LFA-1 (K562-aL/ß2) versus the high avidity mutant LFA-1 (K562- 
aL/L732R-ß2) on high density ICAM-1 (1900 sites/^m2). Consistent with their weaker 
adhesion, a large fraction of the K562-aL/ß2 cells (50%) was observed to roll on ICAM-1 
while the rest remained stationary adherent (arrested) upon interacting with ICAM-1 under
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shear flow (Fig. 2B). With increasing shear stresses a considerable fraction of adherent cells 
detached from ICAM-1, but all cells resisting detachment could roll on the LFA-1 ligand. In 
contrast, less than 20% of the high avidity LFA-1 mutant K562-aL/L732R-ß2 interacting 
with ICAM-1 rolled on it at any shear flow tested (Fig. 2B). The diverse rolling interactions 
between the low and high avidity LFA-1 forms is not due to different LFA-1 expression 
levels (Fig. 1B). Thus the avidity levels generated by each of the LFA-1 mutants closely 
correlated with the relative ability of each variant integrin to mediate firm stationary adhesion 
and resist detachment from ICAM-1 by elevated shear forces.
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Figure 2. Adhesion under shear flow to ICAM-1 of various avidity LFA-1 mutants. (A). 
Cells were introduced into a flow chamber on a substrate containing 950 sites/pm2 of ICAM- 
1-Fc molecules (1900 ICAM-1 sites/pm2) at a shear stress of 0.5 dyn/cm2 for 60 sec before 
being subjected to increment shear stresses as indicated in the figure. Each increment lasted 
for 5 sec, and the number of cells remaining adherent to the substrate at the end of each 
interval of incremented shear was determined in two representative fields. Reduction in the 
number of remaining cells bound was a result of cell detachment and not of adherent cells 
rolling out of the field. Adhesion of LFA-1-expressing K562 cells was completely blocked with 
anti-LFA-1 antibodies (NKI-L15, 50 pg/ml) and no adhesion was detected on substrates 
coated with protein A or HSA alone. (B). Fraction of adherent cells that arrested (i.e. 
remained stationary) or maintained steady rolling (i.e. rolling for at least 3 seconds at 
average velocities less than 15 pm/sec) on the ICAM-1 substrate at the indicated shear 
stresses. Rolling (white bars) and stationary (black bars) fractions were determined in two 
representative fields at a shear stress of1.5, 5, or 10 dyn/cm2. One of five similar independent 
experiments is shown.
Effect of PMA on LFA-1 rolling under physiological shear flow
Since mutation of a single amino acid in mutant K562-aL/L732R-ß2 could restore in a static 
adhesion assay the PMA responsiveness of LFA-1, we next investigated the effect of PMA on 
wild-type LFA-1 (PMA unresponsive) and on mutant LFA-1 (PMA responsive) under 
different shear flow conditions. In contrast to the static adhesion assay, in the dynamic
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Figure 3. Effect o f PMA on adhesion and kinetics o f LFA-1 mutants under shear flow.
Wild-type LFA-1 and mutant LFA-1-expressing K562 cells (10/ml) were preincubated for 2 
min with or without PMA (100 pM) and introduced into a flow chamber on a substrate 
containing 475 sites/pm2 of ICAM-1-Fc molecules as described in figure 2. The number of 
cells remaining adherent to the substrate at the end of each interval of incremented shear was 
determined in two representative fields. K562-aL/ß2 (B,C) or K562-aL/L732R-ß2 (D,E) cells 
were preincubated with PMA (C,E) or without (B,D) under similar conditions as in figure 3A. 
Cells coming in from upstream fields during the experiment were also included in figure 3B- 
E, which explains the higher number of cells at increasing shear flow c.q. time compared to 
figure 3A. Fraction of cells are indicated that arrested (black bars), rolled smoothly (white 
bars) as defined by an average velocity < 15 —m/sec, or rolled jerky (hatched bars) as defined 
by an average velocity > 15 —m/sec. On top of the bars is the mean rolling velocity of the 
smoothly rolling cells depicted in pm/sec. Cell number and velocities were determined by 
computerized image analysis. One ofthree similar independent experiments is shown.
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adhesion assay wild-type LFA-1 could effectively respond to PMA stimulation (Fig. 3 A). 
This indicates that the lack of PMA-induced adhesion of wild-type LFA-1 to ICAM-1 
observed in a static adhesion assay is probably due to the stringent washing steps in this assay 
with high uncontrolled detachment forces. PMA induced a 3-fold increase of K562-aL/ß2 
cells adhered to ICAM-1 under low flow rates of 0.5-4 dyn/cm . PMA also augmented the 
magnitude of the K562-aL/L732R-ß2 mutant to bind ICAM-1 under similar dynamic 
conditions. Intriguingly, the relative enhancement of LFA-1 adhesion by PMA treatment was 
higher for wild-type LFA-1 than for the high avidity point mutant of LFA-1. Consistent with 
these adhesion strengthening effects of PMA, the rolling adhesions mediated by both wild­
type or mutant LFA-1 treated with PMA dramatically decreased (Fig. 3C+E). In contrast, the 
high avidity mutant LFA-1 showed even prior to PMA stimulation, high arrest fractions (Fig. 
3D vs. 3E). Thus, PMA seems to stimulate the LFA-1 adhesiveness of both clustered (K562- 
aL/L732R-ß2) and non-clustered LFA-1 (K562-aL/ß2) to ICAM-1, resulting in firm 
stationary adhesions to ligand under physiological flow conditions. Notably, unstimulated 
smoothly rolling K562-aL/ß2 cells had a mean rolling velocity varying between 5.1 and 11.4 
|im/sec, which was weakly dependent on applied shear stress (Fig. 3B) and was similar to the 
velocity of rolling mediated by the pre-ligand clustered K562-aL/L732R-ß2 cells (Fig. 3D). 
Thus, rolling adhesions are preferentially mediated by low avidity, unstimulated wild-type 
LFA-1, whereas constitutive clustered high avidity LFA-1 engage in stronger non-rolling 
adhesions on ICAM-1 under shear flow.
Effect of ligand density on LFA-1 adhesiveness and PMA stimulation
We further determined whether PMA could stimulate both the low and high avidity LFA-1 
expressing cells to a similar extent on different ICAM-1 densities. Interestingly, low avidity 
wild-type LFA-1 (K562-aL/ß2) adhered to ICAM-1 at comparable levels at low shear stress 
on both low (47 sites/^m2) and high (950 sites/^m2) ICAM-1 density (Fig. 4A), although cells 
that adhered to higher ICAM-1 densities developed more stable adhesion and less readily 
detached from the ligand when subjected to elevated shear stresses (data not shown). In 
contrast, adhesion developed by the high avidity mutant LFA-1 (K562-aL/L732R-ß2) to 
ICAM-1 was highly sensitive to ICAM-1 density (Fig. 4B). As a result, at low ICAM-1 
concentration (less than 190 sites/^m2) both high (K562-aL/L732R-ß2) and low (K562- 
aL/ß2) avidity forms of LFA-1 bound ICAM-1 at similar levels, whereas at high ICAM-1 
density (> 475 sites/—m ) the clustered LFA-1 mutant progressively demonstrated higher 
capacity to establish stable adhesion to the ICAM-1 substrates. This result strongly suggest 
that the higher spontaneous adhesion developed by the K562-aL/L732R-ß2 clustering mutant 
is ligand-dependent and reflects improved capacity of the mutant to form multivalent 
adhesions to ICAM-1.
Interestingly, stimulation of wild-type LFA-1 by PMA increased adhesiveness to ICAM- 
1 density only above 475 sites/^m (Fig. 4A), whereas activation of the mutant LFA-1 (K562- 
aL/L732R-ß2) by PMA required a lower ICAM-1 density (190 sites/^m2) (Fig. 4B). Thus the 
effects of PMA on both the low and high avidity LFA-1 forms requires a threshold of ligand
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density to enhance adhesion. In addition, activation of wild-type low avidity LFA-1 by PMA 
probably occurs after ligand binding by LFA-1, since ligand density determines the PMA 
induced increased adhesion. The fact that PMA still enhanced adhesion of the high avidity 
clustered mutant LFA-1, indicates that PMA has an additive effect to the pre-ligand clustered 
LFA-1. Thus in mutant K562-aL/L732R-ß2, PMA stimulation and pre-ligand clustering 
contribute additively to the enhancement of LFA-1 adhesiveness at dynamic contacts with 
ICAM-1.
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Figure 4. Effect o f ICAM-1 density and LFA-1 clustering on adhesion levels and on PMA 
enhancement of adhesion. Equal number of K562-aL/ß2 (A) or K562-aL/L732R-ß2 (B) cells 
were perfused through a laminar flow chamber on a substrate coated with ICAM-1 varying 
from 47 up to 950 sites/pm2 of ICAM-1-Fc molecules at a shear stress of 0.5 dyn/cm2 for 60 
sec. Next the shear stress was incremented to 1 dyn/cm2 for 5 sec and to 1.5 dyn/cm2 for 
additional 5 sec. The number of cells remaining bound at the end of the assay was determined 
in two representative fields. The mean values ± SD is depicted. One of three similar 
independent experiments is shown.
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Figure 5. Effect o f PMA pre-treatment on affinity-independent adhesion to immobilized 
anti-LFA-1 antibody. Cells were preincubated for 2 min with or without PMA (100 fjM) 
before being perfused through the flow chamber for 1 min at 0.5 dyn/cm2 on a substrate 
coated with immobilized anti-LFA-1 antibody TS1/18 (0.1 jg/ml). Shear was then 
incremented with each increment lasting for 5 sec, and the number of cells remaining 
adherent to the substrate at the end of 5.5 dyn/cm2 shear was determined in two 
representative fields. As a control, unstimulated cells were perfused over a substrate coated 
with a non-binding mAb (4B9, anti-VCAM-1). Depicted are the mean values ± SD of one of 
two identical experiments. Inset: schematic coating procedure as described in section 
material and methods.
Mechanism of PMA induced adhesiveness
Since we observed that PMA acts on both non-clustered (K562-aL/ß2) and clustered (K562- 
aL/L732R-ß2) LFA-1 molecules, we investigated the mechanism of PMA activation on LFA- 
1 avidity upon binding to ICAM-1. To distinguish whether PMA modulates LFA-1 avidity 
and/or affinity, the ICAM-1 substrate was replaced by suboptimal concentrations of the anti- 
LFA-1 antibody TS1/18 and binding of both LFA-1 variants was measured in the presence or 
absence of PMA. Differences in LFA-1 affinity to ICAM-1 have no influence on the binding 
of LFA-1 to immobilized TS1/18 antibody due to the intrinsic affinity conserved between the 
antibody and its antigenic determinant on LFA-1 (Bell, 1978). Surprisingly, PMA could 
significantly increase the adhesiveness of the wild-type LFA-1 to the LFA-1 antibody (Fig. 
5), suggesting that PMA can locally cluster LFA-1 at adhesive contact zones bearing anti-
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LFA-1 mAb. As expected, the high avidity LFA-1 mutant (K562-aL/L732R-ß2) adhered 
stronger to the antibody than the low avidity wild-type LFA-1 (K562-aL/ß2) even prior to 
PMA stimulation (Fig. 5). Notably, PMA could not further increase the adhesiveness of the 
clustering mutant LFA-1. This suggests that the clustered LFA-1 mutant established maximal 
adhesive contact to the antibody, which could not be further modulated by PMA-induced 
clustering under the experimental conditions tested. Increasing the density of antibody already 
resulted in strong maximal adhesion of both low and high avidity LFA-1 forms independent 
of PMA stimulation (data not shown). In addition, we cannot exclude that PMA is able to 
increase the clustering of the mutant LFA-1, since no interactions were observed under even 
lower antibody densities, that only at suboptimal antibody density these differences were 
observed (data not shown). Taken together, PMA could efficiently trigger clustering and thus 
avidity changes of wild-type LFA-1 with a counter molecule (mAb) at dynamic adhesive 
contacts. This clustering resulted in augmented adhesive interactions, with a magnitude 
comparable to that caused by altering the cytoplasmic association of the integrin rendering it 
constitutively clustered on the cell surface.
We next investigated whether the increase of avidity of wild-type LFA-1 by PMA 
stimulation involves rapid cytoskeletal rearrangements. Increased LFA-1 avidity has been 
shown to be induced by increased levels of intracellular Ca2+ through the activation of a the 
Ca2+-dependent protease calpain. This protease disrupts the cytoskeletal association of LFA-1 
and renders the integrin to freely move in the membrane and therefore readily cluster (Stewart 
et al., 1998). We recently demonstrated that the calpain inhibitor calpeptin completely 
abrogated the PMA responsiveness of the high avidity mutant K562-aL/L732R-ß2 in a static 
adhesion assay (Bleijs et al., 2001). As shown in figure 6, augmentation of LFA-1 adhesion to 
ICAM-1 coated surfaces under shear flow of wild-type LFA-1 was completely suppressed in 
the presence of the calpain inhibitor. This indicates that the avidity changes triggered by PMA 
require intact calpain activity. However, additional cytoskeletal rearrangements are required 
for the LFA-1-mediated adhesion strengthening, since treatment with the actin assembly 
inhibitor cytochalasin D also resulted in unresponsiveness to PMA (data not shown).
To further test the hypothesis that PMA increases LFA-1 avidity after ligand binding in 
wild-type LFA-1 expressing K562 cells, we investigated whether PMA could induce 
clustering of LFA-1 in the presence of ICAM-1, but not in its absence. Confocal microscopy 
analysis of K562-aL/ß2 cells incubated with control BSA-coated beads (3.0 |im) revealed a 
homogenous LFA-1 distribution along the cell surface (Fig. 7). Although K562 cells express 
moderate levels of ICAM-1, this is insufficient to induce clustering of wild-type LFA-1. 
Indeed, LFA-1 clustering could not be detected even in the presence of ICAM-1-coated beads 
(Fig. 7B). Thus ICAM-1 ligand binding by wild-type LFA-1 in the experimental system 
characterized in this study, failed to induce clustering of LFA-1 and subsequently increase 
LFA-1 avidity to ICAM-1. Likewise, PMA activation of wild-type LFA-1 alone did not 
enhance LFA-1 clustering (Fig. 7C). However, stimulation of K562-aL/ß2 cells with PMA in 
the presence of ICAM-1-coated beads induced clustering of LFA-1 as shown in figure 7D. 
Interestingly, the already clustered LFA-1 in the K562-aL/L732R-ß2 mutant could not be 
further clustered by PMA activation or in the presence of ICAM-1 beads (data not shown).
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Figure 6. PMA induced LFA-1 adhesion under shear flow is calpeptin sensitive. K562- 
aL/ß2 cells (2x10/ml) were preincubated for 30 min with 50 pg/ml calpeptin or DMSO as 
control and then cells were pre-treated PMA (100 pM) for 2 min before being perfused on a 
substrate coated with immobilized ICAM-1-Fc molecules (950 sites/pm2) at a shear stress of 
0.5 dyn/cm2 for 60 sec. Next the shear stress was incremented each 5 sec up to 1.5 dyn/cm2 
whereby the number of cells remaining adherent to the substrate was determined in two 
representative fields. Depicted are the mean values ± SD of two experiments.
This result is in agreement with the failure of PMA to further increase LFA-1 clustering of the 
mutant K562-aL/L732R-ß2 at contact sites containing anti-LFA-1 mAb (Fig. 5). The 2-2.5- 
fold enhancement of adhesion mediated by K562-aL/ß2 cells stimulated with PMA (Fig. 5) is 
thus a result of increased LFA-1 clustering after occupancy by anti-LFA-1 mAb. The 
clustering of the K562-aL/ß2 cells induced by PMA in the presence of ICAM-1 was much 
weaker than that observed for the constitutively clustered LFA-1 mutant K562-aL/L732R-ß2. 
This was not due to higher LFA-1 expression levels as examined by FACS analysis (data not 
shown). Notably, several ICAM-1-coated beads were located near the LFA-1 clusters, 
suggesting active receptor rearrangement. These results collectively indicate that when LFA-1 
is homogeneously distributed on the cell membrane it can rapidly undergo clustering after 
ligand binding (post-ligand clustering) in response to PMA-triggered cytoskeletal-mediated 
signals. This clustering leads to enhanced LFA-1 avidity and stabilization of LFA-1/ICAM-1 
binding at dynamic adhesive contacts under shear flow. The PMA enhancement of LFA-1 
clustering by ligand can be differentiated from the constitutive pre-ligand clustering of the 
integrin induced by the point mutant K562-aL/L732R-ß2. Since post-ligand clustering by 
PMA can further stabilize adhesions mediated by a pre-ligand clustered LFA-1 (K562- 
aL/L732R-ß2), indicate that pre- and post-ligand clustering mechanisms contribute to overall 
adhesion strengthening events between LFA-1 and ICAM-1 at dynamic contact sites.
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Figure 7. PMA induces ligand-dependent LFA-1 clustering in K562 cells. K562-aL/ß2 cells 
were incubated with ICAM-1Fc (B, D) or BSA (A, C) coated beads (3.0 pm) for 15 min and 
then treated for 2 min with (C, D) or without (A, B) PMA (100 ng/ml). LFA-1 was stained 
with TS2/4 mAb (10 pg/ml) followed by incubation with FITC-labeled goat (Fab)2 anti­
mouse IgG mAb. Cells were fixed (0.5% paraformaldehyde) and subsequently stained with the 
anti-LFA-1 mAb TS2/4 and GAM-(Fab)2~FITC second antibodies. Clustering of LFA-1 is 
only induced upon PMA in the presence of ICAM-1 ligand (D) as indicated with arrows. One 
out of three representative experiments is shown.
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Discussion
In this study we investigated in a controlled flow assay the role of pre- and post-ligand 
induced LFA-1 clustering in relation to LFA-1 activation via PMA. LFA-1 expressed in K562 
cells occurs in a low avidity state which supports reversible rolling adhesions on ICAM-1 
(Sigal et al., 2000). Prolonged contact duration of the subsecond rolling interactions results in 
firm arrest and in augmentation of the resistance of the arrested cells to detachment by 
elevated shear stress. In such a system, small differences in integrin avidity or affinity to 
ligand results in dramatic stabilization of the LFA-1 rolling interactions with immobilized 
ICAM-1. This sensitive assay allowed us to monitor and dissect the differential contribution 
of pre- and post-ligand LFA-1 clustering towards LFA-1 avidity regulation at ICAM-1 
contact sites. In order to increase the adhesiveness of cells in which LFA-1 is homogeneously 
distributed, PMA requires a threshold of ligand density. The effect of PMA on wild-type 
LFA-1 is termed post-ligand clustering, since PMA alone does not induce LFA-1 clustering 
but needs PMA in the context of ligand binding (Fig. 8). On the other hand, mutant K562- 
aL/L732R-ß2, which shows a pre-ligand spontaneous clustering, PMA has an additive effect 
leading to enhanced adhesion. This suggests that pre-ligand LFA-1 clustering does not 
prevent the integrin from further modulating its avidity to ICAM-1, probably by additional 
clustering processes, since the affinity for soluble ICAM-1 is not altered upon PMA activation 
(Bleijs et al., 2001).
The increase in LFA-1 avidity strongly depends on cytoskeletal rearrangements involving 
both the release of LFA-1 from the cytoskeleton by calpain, as well as association of the 
integrin with the actin cytoskeleton, since disruption of the cytoskeleton abolished both 
rolling and firm adhesion of LFA-1 to ICAM-1 under flow conditions. The DLRE motif in the 
LFA-1 clustered mutant K562-aL/L732R-ß2 has been changed into a DRRE motif. The wild­
type LFA-1 DLRE motif in the ß2 cytoplasmic domain has been demonstrated to interact with 
the aL chain and both these cytoplasmic domains serve to constrain LFA-1 into a default low 
affinity state (Hughes et al., 1996; Lu et al., 2001). The a  chain plays also a prominent role in 
integrin clustering as reported for ß1 as well as ß2 integrins (Yauch et al., 1997; van Kooyk et 
al., 1999). In addition, many cytoskeletal proteins (a-actinin, vinculin, filamin, or talin) and 
lateral mobility regulating proteins (cytohesin, Rack1, or calpain) are known to associate with 
the ß2 cytoplasmic tail (Burn et al., 1988; Pavalko and LaRoche, 1993; Sharma et al., 1995; 
Pardi et al., 1995; Stewart et al., 1998; Sampath et al., 1998; Geiger et al., 2000). We 
speculate that in mutant K562-aL/L732R-ß2 these connections are disturbed or that LFA-1 is 
localized at specialized lipid microdomains on the cells, such as rafts (Krauss and Altevogt, 
1999; Pande, 2000), which results in constitutive LFA-1 clustering (Bleijs et al., 2001).
The adhesiveness of low avidity wild-type LFA-1 (K562-aL/ß2) and the high avidity 
mutant LFA-1 (K562-aL/L732R-ß2) under flow conditions is increased by PMA in a manner 
dependent on a threshold of ICAM-1 density. The finding that wild-type LFA-1 responded as 
efficiently to PMA as mutant LFA-1, and the additive effect of PMA on this pre-ligand 
clustered LFA-1 mutant, suggest that pre- and post-ligand adhesion stabilization are
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controlled by distinct yet complementary mechanisms. Interestingly, pre-ligand clustering 
dramatically changes the ligand sensitivity of LFA-1 adhesion and enhance the 
responsiveness of adhesion to PMA triggering. Highly clustered LFA-1 is insufficient to 
support adhesion on a substrate containing very low amounts of ICAM-1, consistent with the 
possibility that LFA-1 avidity is tightly controlled by ligand. Indeed, ligand binding has been 
shown to directly regulate movement of integrins along the cell surface and promote 
enhancement of avidity (Schmidt et al., 1993; Felsenfeld et al., 1996). Previous reports using 
single particle tracking assays demonstrate that also PMA increases the diffusion rate of LFA- 
1 due to a release of cytoskeletal constraints (Kucik et al., 1996). Disconnecting the 
cytoskeleton results in freely moving LFA-1 molecules in K562 cells (Peters et al., 1999).
Figure 8. Model for LFA-1 avidity and adhesive states. LFA-1 expressed in K562 cells exist 
in a non-clustered low avidity state able to support rolling adhesion on ICAM-1 (Sigal et al., 
2000). Activation of wild-type LFA-1 by only PMA or ligand does not increase its avidity 
However, stimulation by both PMA and ligand results in activation and clustering of LFA-1 
termed post-ligand clustering As a result cells adhere stronger to ICAM-1 under shear flow 
A point mutation in the cytoplasmic tail of LFA-1 (K562-aL/L732R-ß2) leads to a pre-ligand 
clustered LFA-1 molecule, which has similar adhesion characteristics as wild-type LFA-1 
stimulated with PMA. Activation of this clustered LFA-1 mutant with PMA in the presence of 
a adequate density of ICAM-1 leads to a further strengthening of adhesive interactions. PMA 
does not change the affinity of LFA-1 for ICAM-1 (Bleijs et al, 2001). Since this mutant LFA- 
1 exist in an already clustered and thus high avidity state, indicates that additional unknown 
adhesion strengthening events or enhanced avidity account for the further increased 
adhesiveness. This activated mutant LFA-1 immediately arrest on ICAM-1. This model 
demonstrates the contribution of the different LFA-1 avidity states thereby regulating the 
adhesion strength and interactions with ICAM-1 bearing endothelial surfaces.
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Taken together, increasing LFA-1 avidity requires both signals provided by ligand as well as 
PKC activation by PMA. We provide evidence that LFA-1 avidity regulation is a highly 
dynamic process involving cytoskeletal rearrangements contributed by both pre- and post­
ligand integrin clustering events.
The physiological relevance of LFA-1-mediated rolling is still not clear. LFA-1-mediated 
rolling probably takes places together with another rolling interaction mediated by selectins or 
a4 integrins. Selectin-mediated rolling is reduced in ICAM-1 knock-out mice, indicating that 
the LFA-1 interaction with ICAM-1 stabilizes rolling adhesions by P- and L-selectin (Steeber 
et al., 1998). Another study shows that a decrease in physiological shear stress enhance ß2- 
dependent but selectin-independent leukocyte rolling in vivo, indicating that LFA-1-mediated 
rolling interactions are favored at low shear stresses (Gaboury and Kubes, 1994). Once 
leukocytes are rolling through the L-selectins, the LFA-1 molecule has to change its avidity, 
but it becomes clear from our data that upregulation of ICAM-1 on the endothelium, either by 
shear stress or chemokines (Tsuboi et al., 1995) is an earlier step in the cascade in order to 
guarantee firm adhesion. Outside-in signaling via L-selectin alone does not stimulate ß2 
integrin dependent binding to ICAM-1, which indicates that additional signals such as the 
formyl peptide chemoattractant fMLP, IL-8, or PKC activation by PMA are required for firm 
adhesion (Lawrence et al., 1995; Simon et al., 2000; Hafezi-Moghadam et al., 2001).
In recent years chemokines have taken a central role in the extravasation of circulating 
leukocytes through the endothelium. The presence of stromal cell-derived factor-1 (SDF-1), 
interleukin-8 (IL-8), macrophage inflammatory protein-3ß (MIP-3ß), and thymus-derived 
chemotactic agent (TCA-4) have been shown to induce activation of ß2 integrins leading to 
the arrest of rolling lymphocytes on either vascular endothelium or on substrates coated with 
selectin-ligand and ICAM-1 (Campbell et al., 1996; Campbell et al., 1998; Weber et al., 1999; 
Stein et al., 2000; Kantele et al., 2000). Stimulation of human umbilical vein endothelial cells 
(HUVEC) with interferon-y (IFN-y) and tumor necrosis factor-a (TNF-a) led to production of 
IFN-y induced protein-10 (IP 10) and monokine induced by IFN-y (Mig), which in turn 
resulted in firm chemokine-dependent adhesion of IL-2 stimulated T lymphocytes (Piali et al.,
1998). Like PMA in our K562 system, chemokines may have different effects on LFA-1 - 
mediated rolling of leukocyte subsets (Carr et al., 1996; Weber et al., 1999). The 
complementary mechanisms of LFA-1 clustering and ligand-dependent avidity modulation 
studied here may be mediated by distinct chemokine signals. Indeed, recent studies suggest 
that chemokines can rapidly stimulate integrin clustering at short termed contacts with ligand 
under shear flow (Grabovsky et al., 2000; Constantin et al., 2000).
A detailed molecular mechanism for the avidity regulation of ß2 integrins in the process 
of leukocyte rolling and subsequent arrest on vascular endothelium remains to be explored. 
The rolling integrin VLA-4 can rapidly respond to endothelial chemokines by increasing its 
avidity but not affinity to VCAM-1 (Jakubowski et al., 1995; Grabovsky et al., 2000). 
However, high-affinity VLA-4 is necessary for arrest on VCAM-1 but not for rolling under 
flow (Chen et al., 1999; Lim et al., 2000). We recently reported that immobilized chemokines 
presented together with ligand rapidly augment VLA-4 clustering (Grabovsky et al., 2000), 
which is in line with our observation of LFA-1 clustering induced by PMA in the presence of
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ICAM-1. In case of LFA-1, we demonstrate here that both pre- and post-ligand clustering lead 
to additive avidity enhancement of LFA-1. Moreover, LFA-1 avidity regulation is tightly 
dependent on ICAM-1 density rather than on intrinsic affinity to individual ligand molecules. 
Thus, our data suggest the existence of a crosstalk between ligand density and integrin 
clustering on the leukocyte surface and PKC activation of cytoskeletal effectors which 
translate LFA-1 occupancy by ligand to avidity enhancement. LFA-1 avidity regulation by 
PKC at the adhesive contact allows different adhesive states of LFA-1 with variable strength. 
These flexible forms of LFA-1 depend on the duration of contact, ligand composition, and the 
context of activation. This highly dynamic regulation of LFA-1 allows participation of this 
integrin in a large variety of adhesive processes taking place at dynamic leukocyte- 
endothelium contacts under shear flow. The wide range of adhesive states mediated by LFA-1 
provides means for the integrin to generate high avidity between rolling leukocyte and the 
endothelial surface in a step-wise rather than in an abrupt manner. Thus, leukocyte arrest on 
vascular ICAM-1 may in fact take place through a gradual build-up of adhesion. Indeed, a 
recent in vivo study suggest that LFA-1 contributes to slow down rolling leukocytes prior to 
their final arrest (Kunkel et al., 2000). Rather than discrete processes, rolling and arrest of 
leukocytes over vascular endothelium may be regarded as a continuum of successive, rapid 
adhesive interactions, in which both stimulatory signals and integrin ligands orchestra to 
modulate integrin activity on the interacting leukocyte without changes in integrin 
conformation and affinity to ligand.
References
Andrew, D., A. Shock, E. Ball, S. Ortlepp, J. Bell, and M. Robinson. (1993). KIM185, a monoclonal 
antibody to CD18 which induces a change in the conformation of CD18 and promotes both LFA-1- and CR3- 
dependent adhesion. Eur.J.Immunol. 23: 2217-2222.
Beatty, P.G., J.A. Ledbetter, P.J. Martin, T.H. Price, and J.A. Hansen. (1983). Definition of a common 
leukocyte cell-surface antigen (Lp95-150) associated with diverse cell-mediated immune functions. J.Immunol. 
131: 2913-2918.
Bell, G.I. (1978). Models for the specific adhesion of cells to cells. Science 200: 618-627.
Bleijs, D.A., M.E. Binnerts, S.J. van Vliet, C.G. Figdor, and Y. van Kooyk. (2000). Low-affinity LFA- 
1/ICAM-3 interactions augment LFA-1/ICAM-1-mediated T cell adhesion and signaling by redistribution of 
LFA-1. J.Cell Sci. 113: 391-400.
Bleijs, D.A., G.C. van Duijnhoven, S.J. van Vliet, J.P.H. Thijssen, C.G. Figdor, and Y. van Kooyk. (2001). 
A Single Amino Acid in the Cytoplasmic Domain of the ß2 Integrin Lymphocyte Function-associated Antigen- 
1 Regulates Avidity-dependent Inside-out Signaling. J.Biol.Chem. 276: 10338-10346.
Burn, P., A. Kupfer, and S.J. Singer. (1988). Dynamic membrane-cytoskeletal interactions: specific 
association of integrin and talin arises in vivo after phorbol ester treatment of peripheral blood lymphocytes.
Proc.Natl.Acad.Sci.U.S.A. 85: 497-501.
141
Chapter 6
Butcher, E.C. and L.J. Picker. (1996). Lymphocyte homing and homeostasis. Science 272: 60-66.
Campbell, J.J., J. Hedrick, A. Zlotnik, M.A. Siani, D.A. Thompson, and E.C. Butcher. (1998). Chemokines 
and the arrest of lymphocytes rolling under flow conditions. Science 279: 381-384.
Campbell, J.J., S. Qin, K.B. Bacon, C.R. Mackay, and E.C. Butcher. (1996). Biology of chemokine and 
classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic 
responses in lymphoid cells. J.Cell Biol. 134: 255-266.
Carr, M.W., R. Alon, and T.A. Springer. (1996). The C-C chemokine MCP-1 differentially modulates the 
avidity of beta 1 and beta 2 integrins on T lymphocytes. Immunity 4: 179-187.
Chen, C., J.L. Mobley, O. Dwir, F. Shimron, V. Grabovsky, R.R. Lobb, Y. Shimizu, and R. Alon. (1999). 
High affinity very late antigen-4 subsets expressed on T cells are mandatory for spontaneous adhesion 
strengthening but not for rolling on VCAM-1 in shear flow. J.Immunol. 162: 1084-1095.
Constantin, G., M. Majeed, C. Giagulli, L. Piccio, J.Y. Kim, E.C. Butcher, and C. Laudanna. (2000). 
Chemokines trigger immediate ß2 integrin affinity and mobility changes: differential regulation and roles in 
lymphocyte arrest under flow. Immunity 13: 759-769.
Dustin, M.L., R. Rothlein, A .K  Bhan, C.A. Dinarello, and T.A. Springer. (1986). Induction by IL1 and
interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). 
J.Immunol. 137: 245-254.
Felsenfeld, D.P., D. Choquet, and M.P. Sheetz. (1996). Ligand binding regulates the directed movement of 
beta 1 integrins on fibroblasts. Nature 383: 438-440.
Figdor, C.G., Y. van Kooyk, and G.D. Keizer. (1990). On the mode of action of LFA-1. Immunol.Today 11: 
277-280.
Gaboury, J.P. and P. Kubes. (1994). Reductions in physiologic shear rates lead to CD11/CD18-dependent, 
selectin-independent leukocyte rolling in vivo. Blood 83: 345-350.
Geiger, C., W. Nagel, T. Boehm, Y. van Kooyk, C.G. Figdor, E. Kremmer, N. Hogg, L. Zeitlmann, H. 
Dierks, K.S. Weber, and W. Kolanus. (2000). Cytohesin-1 regulates beta-2 integrin-mediated adhesion 
through both ARF-GEF function and interaction with LFA-1. EMBO J  19: 2525-2536.
Geijtenbeek, T.B., Y. van Kooyk, S.J. van Vliet, M.H. Renes, R.A. Raymakers, and C.G. Figdor. (1999). 
High frequency of adhesion defects in B-lineage acute lymphoblastic leukemia. Blood 94: 754-764.
Grabovsky, V., S. Feigelson, C. Chen, D.A. Bleijs, A. Peled, G. Cinamon, F. Baleux, F. Arenzana- 
Seisdedos, T. Lapidot, Y. van Kooyk, R. Lobb, and R. Alon. (2000). Sub-second Induction of a4 Integrin 
Clustering by Immobilized Chemokines Stimulates Leukocyte Tethering and Rolling on Endothelial VCAM-1 
Under Flow Conditions. J  Exp Med 192: 495-505.
Hafezi-Moghadam, A., K.L. Thomas, A.J. Prorock, Y. Huo, and K. Ley. (2001). L-selectin shedding 
regulates leukocyte recruitment. J.Exp.Med. 7: 863-872.
Hughes, P.E., F. Diazgonzalez, L. Leong, C.Y. Wu, J.A. McDonald, S.J. Shattil, and M.H. Ginsberg.
(1996). Breaking the integrin hinge - A defined structural constraint regulates integrin signaling. J.Biol.Chem. 
271: 6571-6574.
142
LFA-1 avidity regulation
Jakubowski, A., M.D. Rosa, S. Bixler, R. Lobb, and L.C. Burkly. (1995). Vascular cell adhesion molecule 
(VCAM)-Ig fusion protein defines distinct affinity states of the very late antigen-4 (VLA-4) receptor. Cell 
Adhes.Commun. 3: 131-142.
Kantele, J.M., S. Kurk, and M.A. Jutila. (2000). Effects of continuous exposure to stromal cell-derived factor- 
1 alpha on T cell rolling and tight adhesion to monolayers of activated endothelial cells. J  Immunol 164: 5035­
5040.
Kolanus, W., W. Nagel, B. Schiller, L. Zeitlmann, S. Godar, H. Stockinger, and B. Seed. (1996). alpha L 
beta 2 integrin/LFA-1 binding to ICAM-1 induced by cytohesin-1, a cytoplasmic regulatory molecule. Cell 86: 
233-242.
Krauss, K. and P. Altevogt. (1999). Integrin leukocyte function-associated antigen-1-mediated cell binding can 
be activated by clustering of membrane rafts. J  Biol Chem 274: 36921-36927.
Kucik, D.F., M.L. Dustin, J.M. Miller, and E.J. Brown. (1996). Adhesion-activating phorbol ester increases 
the mobility of leukocyte integrin LFA-1 in cultured lymphocytes. J.Clin.Invest. 97: 2139-2144.
Kunkel, E.J., J.L. Dunne, and K. Ley. (2000). Leukocyte arrest during cytokine-dependent inflammation in 
vivo. J.Immunol. 164: 3301-3308.
Lawrence, M.B., E.L. Berg, E.C. Butcher, and T.A. Springer. (1995). Rolling of lymphocytes and 
neutrophils on peripheral node addressin and subsequent arrest on ICAM-1 in shear flow. Eur J  Immunol 25: 
1025-31.
Lim, Y.C., M.W. Wakelin, L. Henault, D.J. Goetz, T. Yednock, C. Cabanas, F. Sanchez-Madrid, A.H. 
Lichtman, and F.W. Luscinskas. (2000). Alpha4beta1-integrin activation is necessary for high-efficiency T- 
cell subset interactions with VCAM-1 under flow. Microcirculation 7: 201-214.
Lu, C., J. Takagi, and T.A. Springer. (2001). Association of the membrane-proximal regions of the {alpha} 
and {beta} subunit cytoplasmic domains constrains an integrin in the inactive state. J.Biol.Chem. In press.
Lub, M., Y. van Kooyk, and C.G. Figdor. (1995). Ins and outs of LFA-1. Immunol.Today 16: 479-483.
Lub, M., S.J. van Vliet, S.P. Oomen, R.A. Pieters, M. Robinson, C.G. Figdor, and Y. van Kooyk. (1997). 
Cytoplasmic tails of beta 1, beta 2, and beta 7 integrins differentially regulate LFA-1 function in K562 cells. 
Mol.Biol Cell8: 719-728.
Marlin, S.D. and T.A. Springer. (1987). Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for 
lymphocyte function-associated antigen 1 (LFA-1). Cell 51: 813-819.
Pande, G. (2000). The role of membrane lipids in regulation of integrin functions. Curr.Opin.Cell Biol. 12: 
569-574.
Pardi, R., G. Bossi, L. Inverardi, E. Rovida, and J.R. Bender. (1995). Conserved regions in the cytoplasmic 
domains of the leukocyte integrin alpha L beta 2 are involved in endoplasmic reticulum retention, dimerization, 
and cytoskeletal association. J.Immunol. 155: 1252-1263.
Pavalko, F.M. and S.M. LaRoche. (1993). Activation of human neutrophils induces an interaction between the 
integrin ß2 -subunit (CD18) and the actin binding protein a  -actinin. J.Immunol. 151: 3795-3807.
143
Chapter 6
Peters, I.M., Y. van Kooyk, S.J. van Vliet, B.G. de Grooth, C.G. Figdor, and J. Greve. (1999). 3D single­
particle tracking and optical trap measurements on adhesion proteins. Cytometry 36: 189-94.
Piali, L., C. Weber, G. LaRosa, C.R. Mackay, T.A. Springer, I. Clark-Lewis, and B. Moser. (1998). The 
chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes 
by the chemokines IP10 and Mig. Eur.J.Immunol. 28: 961-972.
Rothlein, R. and T.A. Springer. (1986). The requirement for lymphocyte function-associated antigen 1 in 
homotypic leukocyte adhesion simulated by phorbol ester. J.Exp.Med. 163: 1132-1149.
Sampath, R., P.J. Gallagher, and F.M. Pavalko. (1998). Cytoskeletal interactions with the leukocyte integrin 
beta2 cytoplasmic tail. Activation-dependent regulation of associations with talin and alpha-actinin. J  Biol 
Chem 273: 33588-33594.
Sanchez-Madrid, F., A.M. Krensky, C.F. Ware, E. Robbins, J.L. Strominger, S.J. Burakoff, and T.A. 
Springer. (1982). Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, 
LFA-2, and LFA-3. Proc.Natl.Acad.Sci.U.S.A. 79: 7489-7493.
Schmidt, C.E., A.F. Horwitz, D.A. Lauffenburger, and M.P. Sheetz. (1993). Integrin-cytoskeletal interactions 
in migrating fibroblasts are dynamic, asymmetric, and regulated. J.Cell Biol. 123: 977-991.
Sharma, C.P., R.M. Ezzell, and M.A. Arnaout. (1995). Direct interaction of filamin (ABP-280) with the beta 
2- integrin subunit CD18. J.Immunol. 154: 3461-3470.
Sigal, A., D.A. Bleijs, V. Grabovsky, S.J. van Vliet, O. Dwir, C.G. Figdor, Y. van Kooyk, and R. Alon.
(2000). The LFA-1 Integrin Supports Rolling Adhesions on ICAM-1 Under Physiological Shear Flow in a 
Permissive Cellular Environment. J  Immunol 165: 442-452.
Simon, S.I., Y. Hu, D. Vestweber, and C.W. Smith. (2000). Neutrophil Tethering on E-Selectin Activates 
beta2 Integrin Binding to ICAM-1 Through a Mitogen-Activated Protein Kinase Signal Transduction Pathway. 
J  Immunol 164: 4348-4358.
Springer, T.A. (1990). Adhesion receptors of the immune system. Nature 346: 425-434.
Springer, T.A. (1994). Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep 
paradigm. Cell 76: 301-314.
Staunton, D.E., M.L. Dustin, and T.A. Springer. (1989). Functional cloning of ICAM-2, a cell adhesion 
ligand for LFA-1 homologous to ICAM-1. Nature 339: 61-64.
Steeber, D.A., M.A. Campbell, A. Basit, K. Ley, and T.F. Tedder. (1998). Optimal selectin-mediated rolling 
of leukocytes during inflammation in vivo requires intercellular adhesion molecule-1 expression. Proc. 
Natl.Acad.Sci. U.S.A. 95: 7562-7567.
Stein, J.V., A. Rot, Y. Luo, M. Narasimhaswamy, H. Nakano, M.D. Gunn, A. Matsuzawa, E.J. 
Quackenbush, M.E. Dorf, and U.H. von Andrian. (2000). The CC chemokine thymus-derived chemotactic 
agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function- 
associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial 
venules. J  Exp Med 191: 61-76.
Stewart, M.P., A. McDowall, and N. Hogg. (1998). LFA-1-mediated adhesion is regulated by cytoskeletal 
restraint and by a Ca2+-dependent protease, calpain. J  Cell Biol 140: 699-707.
144
LFA-1 avidity regulation
Tsuboi, H., J. Ando, R. Korenaga, Y. Takada, and A. Kamiya. (1995). Flow stimulates ICAM-1 expression 
time and shear stress dependently in cultured human endothelial cells. Biochem.Biophys.Res.Commun. 206: 
988-996.
Van Kooyk, Y. and C.G. Figdor. (2000). Avidity regulation of integrins: the driving force in leukocyte 
adhesion. Curr.Opin.Cell Biol. 12: 542-547.
Van Kooyk, Y., P. van de Wiel-van Kemenade, P. Weder, T.W. Kuijpers, and C.G. Figdor. (1989). 
Enhancement of LFA-1-mediated cell adhesion by triggering through CD2 or CD3 on T lymphocytes. Nature 
342: 811-813.
Van Kooyk, Y., S.J. van Vliet, and C.G. Figdor. (1999). The Actin Cytoskeleton Regulates LFA-1 Ligand 
Binding through Avidity Rather than Affinity Changes. J  Biol Chem 274: 26869-26877.
Van Kooyk, Y., P. Weder, K. Heije, and C.G. Figdor. (1994). Extracellular Ca2+ modulates leukocyte 
function-associated antigen-1 cell surface distribution on T lymphocytes and consequently affects cell 
adhesion. J.Cell Biol. 124: 1061-1070.
Vazeux, R., P.A. Hoffman, J.K. Tomita, E.S. Dickinson, R.L. Jasman, T. Stjohn, and W.M. Gallatin.
(1992). Cloning and characterization of a new intercellular adhesion molecule ICAM-R. Nature 360: 485-488.
Weber, K.S., L.B. Klickstein, and C. Weber. (1999). Specific activation of leukocyte beta2 integrins 
lymphocyte function- associated antigen-1 and Mac-1 by chemokines mediated by distinct pathways via the 
alpha subunit cytoplasmic domains. Mol Biol Cell 10: 861-73.
Yauch, R.L., D.P. Felsenfeld, S.K. Kraeft, L.B. Chen, M.P. Sheetz, and M.E. Hemler. (1997). Mutational 
evidence for control of cell adhesion through integrin diffusion/clustering, independent of ligand binding. 
J.Exp.Med. 186: 1347-1355.
Zhou, X. and J. Li. (2000). Macrophage-enriched Myristoylated Alanine-rich C Kinase Substrate and its 
phosphorylation is required for the phorbol ester-stimulated diffusion of ß2 integrin molecules. J.Biol.Chem. 
275: 20217-20222.
145
Chapter 6
146
& H A P  T E R 7
DC-SIGN/ICAM-2 interaction mediates Dendritic 
cell trafficking
Teunis B.H. Geijtenbeek', Diederik A. Bleijs'#, Danielle J.E.B. Krooshoop'#, Sandra J. van
4> • • ' I * .  H5 ÿ  j A
Vliet', Gerard C.F. van Duijnhoven', Valentin Grabovsky , Ronen Alon , Carl G. Figdor',
and Yvette van Kooyk'
From 'Department of Tumor Immunology, UMC Nijmegen, The Netherlands and
*
Department of Immunology, The Weizmann Institute of Science, Rehovot, Israel.
#Authors have contributed equally to this work

DC-SIGN/ICAM-2 interaction mediates migration of DC
Abstract
Dendritic cells (DC) are recruited from blood into tissues to patrol for foreign antigens. After 
antigen uptake and processing DC migrate to the secondary lymphoid organs to initiate 
immune responses. We now show that DC-SIGN, a DC-specific C-type lectin, supports 
tethering and rolling of DC-SIGN-positive cells on the vascular ligand ICAM-2 under shear 
flow, a prerequisite for emigration from blood. The DC-SIGN/ICAM-2 interaction regulates 
chemokine-induced transmigration of DC across both resting and activated endothelium. 
Thus, DC-SIGN is central to the unusual trafficking capacity of DC, further supported by the 
expression of DC-SIGN on precursors in blood, and on immature as well as mature DC in 
both peripheral and lymphoid tissues.
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Introduction
A fundamental aspect of dendritic cell (DC) function to control immunity is their capacity to 
migrate (Banchereau and Steinman, 1998). Immature DC migrate from the blood into 
peripheral tissues to exert a continuous surveillance for incoming foreign antigens. This 
migration from blood is tightly regulated to provide a rapid response to inflammatory signals. 
Immature DC in peripheral tissues are highly proficient in antigen capture and processing 
(Inaba et al., 1993; Svensson et al., 1997). Upon receiving an activation signal, immature DC 
mature and specifically migrate from the periphery to secondary lymphoid organs for 
interaction with specific T cells and initiation of an immune response (Banchereau and 
Steinman, 1998). Little is known about the molecular basis of DC migration and whether DC 
express specific molecules that regulate their adhesion and migratory capacity. We have 
recently identified the human DC-specific adhesion receptor DC-SIGN, a C-type lectin, 
through its high affinity interaction with ICAM-3 and which enables transient DC-T cell 
interactions, thus facilitating primary immune responses (Geijtenbeek et al., 2000b). 
Furthermore, DC-SIGN functions as a novel HIV-1 trans-receptor important in the 
dissemination of HIV-1 (Geijtenbeek et al., 2000a). HIV-1 is captured on DC present in the 
periphery by DC-SIGN and thus transported by DC that migrate into lymphoid tissues where 
DC-SIGN-associated HIV-1 efficiently infects target CD4+ T cells.
Immature DC express high levels of DC-SIGN (Geijtenbeek et al., 2000b), and since 
several lectins have also been reported to function as rolling receptors allowing leukocyte 
transendothelial migration (Vestweber and Blanks, 1999), we hypothesized that DC-SIGN 
might play a role in the specific migratory capacity of DC. We investigated whether ICAM-2 
functions as a ligand for DC-SIGN, since ICAM-2 has a high homology with ICAM-3 (de 
Fougerolles et al., 1993) and, in contrast to ICAM-3, is abundantly expressed by vascular as 
well as lymphoid endothelium (Nortamo et al., 1991). Strikingly, DC-SIGN functions not 
only as the primary receptor for ICAM-2 on DC, but also mediates DC rolling and 
transendothelial migration, thus demonstrating that DC-SIGN is crucial in the specific 
migratory processes of DC.
Materials and Methods
Adhesion
Fluorescent bead adhesion assays were performed as described (Geijtenbeek et al., 1999; 
Geijtenbeek et al., 2000b). Briefly, carboxylate-modified Transfluospheres (488/645nm; 
Molecular Probes, Eugene, OR) were coated with ICAM-2Fc. Cells (50,000) were 
preincubated with mAb at 20 ng/ml for 10 min at room temperature. ICAM-2Fc-coated 
fluorescent beads (20 beads/cell) were added, and the suspension was incubated for 30 min at 
37°C. Adhesion was determined by measuring the percentage of cells which had bound 
fluorescent beads by flowcytometry using the FACScan (Becton Dickinson, Oxnard, CA).
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Ca2+ affinity was determined by measuring the binding of DC to ICAM-coated beads at 
different Ca2+ concentrations. Specificity is determined in the presence of antibodies to DC- 
SIGN (AZN-D1; 20 ng/ml). The resulting curves for both ICAM-2 and ICAM-3 were fitted 
to the equation for second order dependence to Ca2+ (fractional binding)= 
[Ca2+]2/((KCa)2+[Ca2+]2) (Mullin et al., 1997). Ligand affinity was determined by titrations of 
soluble ICAM-1, -2, -3Fc and measuring the binding to either LFA-1- or DC-SIGN- 
transfectants. Binding was measured after 30 min at 37°C by staining the ligand Fc chimeras 
with FITC-conjugated goat-anti-human Fc antibodies and determining the fraction of labeled 
cells by flowcytometry. Specificity was determined by measuring in the presence of blocking 
antibodies to either LFA-1 (NKI-L15; 20 ng/ml) or DC-SIGN (AZN-D1; 20 ng/ml).
Laminar flow assay
The laminar flow assay was performed as previously described (Alon et al., 1995; Chen et al.,
1999). Briefly, a polystyrene plate was coated with either ICAM-1, ICAM-2, or ICAM-3Fc 
bound to immobilized protein A. The plate was assembled in a parallel-plate laminar flow 
chamber (260-nm gap) and mounted on the stage of an inverted phase contrast microscope 
(Diaphot 300; Nikon, Tokyo, Japan). K562-DC-SIGN transfectants (100 to 200 cells per field 
of view) were introduced into the flow chamber for 1 min at a constant low shear flow (0.25 
dyn/cm2) before being subjected to an incremental increase in shear stress. Shear flow was 
generated and controlled with an automated syringe pump (Harvard Apparatus, Natick, MA) 
attached to the outlet side of the flow chamber. The wall shear stress was increased step-wise 
every 5 s until it reached 10 dyn/cm2. At the end of each 5-s interval at a particular shear 
stress, the number of cells that remained bound (stationary or rolling) was determined relative 
to the number of cells that had accumulated at low shear flow on the ICAM-coated field. 
Cellular interactions were determined on two representative fields of view (each typically
0.34 mm2 of area). Displacement velocities were determined only for persistently-rolling cells 
which remained adherent throughout the entire shear stress assay.
Adhesion and transendothelial migration
Heterotypic cell clustering of DC with the endothelial HMEC-1 cell-line was performed as 
described previously for DC-T cell clustering (Geijtenbeek et al., 2000b). Briefly, HMEC-1 
cells, cultured in MCDB131 medium (supplemented with 10% FCS), were labeled with the 
fluorescent dye hydroethidine. DC were labeled with the fluorescent dye sulfofluorescein. The 
cells were incubated with or without blocking antibodies (20 ng/ml) at 37°C. Heterotypic cell 
clustering was measured by flowcytometry. Transwell 24 well plate (8 nm pore) were coated 
with fibronectin (20 ng/ml; 1 hour at 37°C). 40,000 HMEC-1 cells were seeded on the inserts 
and after 24 hours the cells were activated with TNF-a (5 ng/ml) for 16 hours. 200,000 DC 
were added to the monolayer of endothelial HMEC-1 cells. The lower chamber contained 10 
ng/ml SDF-1. After 20 hours at 37°C, the number of transmigrated DC (lower chamber) was 
determined by flowcytometry. The transendothelial migration was measured in the presence 
of blocking antibodies (40 ng/ml).
151
Chapter 7
Isolation of DC-SIGN-positive cells from blood
PBMC obtained from a buffy coat were depleted for CD3-, CD20-, and CD56-positive cells 
with magnetic beads (Dynal, Oslo, Norway) according to standard procedures. The depleted 
cell fraction was incubated with FITC-conjugated anti-DC-SIGN Ab (AZN-D1) and the DC- 
SIGN-positive cells were sorted by flowcytometry with the Coulter Epics Elite (Coulter, 
Hialeah, FL). The sorted cell fraction was analyzed for the expression of DC-SIGN (AZN- 
D1), CD 14 and CD83 (Immunotech, Fullertone, CA), CD80 (Becton Dickinson, Oxnard, 
CA), CD86 (BD Pharmingen, San Diego, CA), CD83 (Immunotech, Marseille, France) MHC 
class I (W6/32), MHC class II (Q5/13), CD 11b (KIM225), and CD11c (SHCL3) by three- 
color fluorescence staining using FITC-, PE-, and Cy5PE-conjugated directly labeled 
antibodies.
Immunohistochemical staining
Cryosections (8 nm) of tissues were fixed in 100% aceton for 10 min, washed with PBS and 
incubated with the primary antibody 10 ng/ml for 60 min at 37°C. After washing, the final 
staining was performed with the ABC-PO/ABC-AP Vectastain kit (Vector Laboratories, 
Burlingame, CA) according to the manufacturer’s protocol. Nuclear counterstaining was 
performed using hematoxylin.
Results
ICAM-2, a novel counterstructure for DC-SIGN
Monocyte-derived immature DC (Sallusto and Lanzavecchia, 1994; Romani et al., 1994) 
express high levels of DC-SIGN and moderate levels of LFA-1, the primary ICAM-2 receptor 
on leukocytes (Fig. 1a). Immature DC strongly bind ICAM-2 comparable to our results for 
ICAM-3 (Geijtenbeek et al., 2000b) (Fig. 1b), as determined by the novel ICAM-Fc-coated 
fluorescent bead adhesion assay (Geijtenbeek et al., 2000b). Adhesion of DC to ICAM-2 is 
completely mediated by the DC-specific C-type lectin DC-SIGN and not by LFA-1 (Fig. 1b) 
since antibodies to DC-SIGN inhibit the adhesion in contrast to antibodies to the ß2-integrin 
chain (Fig. 1b) or the LFA-1 a-chain (results not shown). The interaction with ICAM-2 is 
also inhibited by either EGTA or mannan (Fig. 1b), indicating that the adhesion is mediated 
by the C-type lectin domain of DC-SIGN. Even after activation of LFA-1 on DC with the 
stimulatory anti-ß2 antibody KIM185, adhesion to ICAM-2 remains completely DC-SIGN- 
specific (Fig. 1c).
In order to determine the relative affinity of DC-SIGN for ICAM-2 without any 
contribution from LFA-1, we generated a stable DC-SIGN-positive transfectant from the 
LFA-1-negative cell-line K562 (Fig. 1a). This DC-SIGN-positive transfectant strongly binds 
to both ICAM-2 and ICAM-3, but not to ICAM-1, and the binding is inhibited by either 
EGTA or mannan as was observed for DC (Fig. 1d). The relative binding affinity of DC- 
SIGN for soluble ICAM-2 (IC50 of 1 ng/ml) is higher than that of LFA-1 on the HSB T cell- 
line (IC50 of 8 ng/ml) (Fig. 2a, b) demonstrating that DC-SIGN is the primary receptor for
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Figure 1. ICAM-2 is a novel endothelial counter structure for the DC-specific C-type lectin 
DC-SIGN. (a) Immature DC express high levels of DC-SIGN (AZN-D1) and intermediate 
levels of LFA-1 (NKI-L7). K562-DC-SIGN transfectants express high levels of DC-SIGN but 
no LFA-1. Transfectants were generated as previously described (Geijtenbeek et al., 2000a). 
Dotted line represents isotype control and filled histogram indicates specific antibody 
staining of gated population. (b) Immature DC bind both ICAM-2 and ICAM-3 through DC- 
SIGN. Cells were allowed to bind ICAM-Fc-coated fluorescent beads for 30 min at 37°C. 
Adhesion was measured by flowcytometry. The adhesion was determined in the presence of 
either mannan (5 mM), EGTA (5 mM), or blocking antibodies to DC-SIGN (AZN-D1, 20 
pg/ml) or ß2 integrins (AZN-L19, 20 pg/ml). One representative experiment out of three is 
shown. (c) DC-SIGN is the major ICAM-2 receptor on immature DC even after LFA-1 
activation. LFA-1 on DC was activated by the stimulatory anti-ß2 Ab KIM185 and adhesion
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to both ICAM-1 and ICAM-2 was determined in the presence of either anti-DC-SIGN (AZN- 
D1) or anti-LFA-1 (NKI-L15) Ab, as described in Fig. 1b. One representative experiment out 
of two is shown. (d) DC-SIGN expressed by K562 transfectants bind to ICAM-2 as well as to 
ICAM-3. Adhesion was determined as described in Fig. 1b. One representative experiment 
out of three is shown.
ICAM-2. Until now the primary receptor for ICAM-2 has been thought to be the ß2 integrin 
LFA-1. Moreover the affinity of DC-SIGN for ICAM-2 (IC50 of 1 ng/ml) is higher than that 
for ICAM-3 (IC50 of 6 ng/ml) (Fig. 2a). Similar to the binding of ICAM-3, the ICAM-2 
interaction with DC-SIGN requires two Ca2+-ions as demonstrated by the second order Ca2+ 
ion-dependency (Fig. 2c) that is characteristic for C-type lectins (Drickamer, 1995; 
Geijtenbeek et al., 2000b). Thus, we have identified ICAM-2 as a novel endothelial counter 
structure for DC-SIGN.
DC-SIGN mediates rolling on ICAM-2
A prerequisite for vascular migration of circulating immune cells from blood into tissues is 
establishment of shear-resistant contacts with blood vessel walls for transmigration through 
their endothelial lining (Springer, 1994). We investigated whether the DC-SIGN/ICAM-2 
interaction enables DC to establish these shear-resistant contacts under physiological flow 
conditions by using the laminar flow chamber system, since ICAM-2 is abundantly expressed 
by vascular endothelium. This system has been extensively used to investigate leukocyte 
rolling mediated by receptors such as the selectins (Lawrence and Springer, 1991; Alon et al., 
1997; Smith et al., 1999). We analyzed the adhesive properties of DC-SIGN-expressing K562 
transfectants under shear flow to surfaces coated with similar densities of either the vascular 
endothelial ligands ICAM-1 or ICAM-2, or the resting T cell ligand ICAM-3. No contribution 
of the ß2 integrin ICAM receptors, such as LFA-1 or Mac-1 is possible since K562 cells do 
not endogenously express ß2 integrins. DC-SIGN interacts only with ICAM-2 under shear 
flow (Fig. 3a), although DC-SIGN supports adhesion to both ICAM-2 and ICAM-3 equally 
under static conditions (Fig. 1d). Both the frequency of cell tethers as well as their resistance 
to detachment by incrementally increasing shear forces was augmented on ICAM-2 in 
contrast to ICAM-3 (Fig. 3a). Tethering and rolling on ICAM-2 is DC-SIGN-specific, since 
antibodies to DC-SIGN inhibited the observed interactions (data not shown). DC-SIGN 
binding to ICAM-2, but not to ICAM-3, supported continuous rolling of DC-SIGN- 
expressing transfectants, reminiscent of selectin-mediated leukocyte rolling (Fig. 3b, c). 
Average rolling velocity of DC-SIGN-positive cells at 1.5 and 2.0 dyn/cm is 17.9±1.4 and 
19.8±1.4 nm/s, respectively. Furthermore, DC-SIGN-expressing cells are recruited to the 
ICAM-2-coated surface, since the cells bound to ICAM-2 when introduced into the flow 
chamber under shear flow. ICAM-2 serves as a rolling ligand only for DC-SIGN and not for 
LFA-1, as the binding of LFA-1-expressing cells to ICAM-2 is abolished when shear stress 
was applied (data not shown), demonstrating that the DC-SIGN/ICAM-2 rolling interaction is 
a characteristic of the C-type lectin DC-SIGN and not of the integrin LFA-1. Thus, DC-SIGN
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enables DC to interact with vascular endothelium under shear flow, a prerequisite for 
extravasation from blood into tissues.
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Figure 2. DC-SIGN has a higher affinity for both ICAM-2 and ICAM-3 than LFA-1. (a)
DC-SIGN has the highest affinity for ICAM-2, intermediate for ICAM-3 and does not bind 
ICAM-1. Adhesion of soluble ICAM-2Fc and ICAM-3Fc to K562-DC-SIGN transfectants was 
measured. Binding was analyzed by flowcytometry after staining with FITC-conjugated anti­
human Fc antibody The expression level of DC-SIGN on K562 cells is similar to the level of 
LFA-1 on HSB cells (data not shown). One representative experiment out of three is shown 
(SD<5%). (b) LFA-1 has a low affinity for both ICAM-2 and ICAM-3 and high affinity for 
ICAM-1. LFA-1 on HSB cells was activated by the stimulatory anti-ß2 integrin KIM185 
antibody (10 pg/ml). The binding assay was performed similar as in Fig. 2a. One 
representative experiment out of three is shown (SD<5%). (c) DC-SIGN-mediated binding to 
both ICAM-2 and ICAM-3 is Ca2+-dependent and DC-SIGN has a slightly higher KCa for 
ICAM-2 (0.28 mM) than for ICAM-3 (0.22 mM). Adhesion was determined by the fluorescent 
bead adhesion assay at different Ca + concentrations. One representative experiment out of 
three is shown.
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Figure 3. DC-SIGN mediates tethering to and rolling on ICAM-2 but not on ICAM-3 under 
physiological shear flow. (a) DC-SIGN mediates tethering to ICAM-2 but not to ICAM-3. All 
adhesions were confirmed to be DC-SIGN-specific by blocking with the anti-DC-SIGN 
antibody AZN-D1. DC-SIGN-mediated tethering to ICAM-2 was 5% when the shear flow was 
increased to 10 dyn/cm2 (data not shown). One representative experiment out of three is 
shown. (b) DC-SIGN mediates rolling on ICAM-2 coated surfaces. Fractions of adherent 
K562-DC-SIGN cells that maintained steady rolling or were arrested on the ICAM substrate 
at the indicated shear stresses are depicted. The fractions were determined in two 
representative fields at shear stresses of 1.5 and 2.0 dyn/cm2. One representative experiment 
out of three is shown. (c) Displacement with time of individual DC-SIGN-transfected cells 
rolling on ICAM-2 and subjected to incremental shear stresses at the indicated time points. 
One representative experiment out of two is shown.
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DC-SIGN mediates transendothelial migration of DC
We next investigated whether DC-SIGN is necessary for the endothelial transmigration of 
DC. Both resting and Tumor Necrosis Factor (TNF)-a-activated endothelial cells express 
intermediate levels of ICAM-1 and high levels of ICAM-2 but no ICAM-3, whereas TNF-a- 
activation strongly upregulates both ICAM-1 and VCAM-1 expression (Fig. 4a). DC bind to 
resting endothelial cells through DC-SIGN, whereas binding to TNF-a-activated endothelium 
is both DC-SIGN- and B1/B2 integrin-dependent (Fig. 4b) due to upregulation of the ß1 and 
ß2 integrin ligands VCAM-1 and ICAM-1, respectively.
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Figure 4. DC-SIGN mediates SDF-1 induced transmigration of DC across both resting and 
TNF-a-activated endothelium. (a) Expression levels of ICAM-1 (Rek-1), ICAM-2 (CBR- 
IC2/2) and VCAM-1 (4B9) on both resting and TNF-a-activated endothelial HMEC-1 cells, 
(b) Adhesion of DC to both resting and TNF-a-activated endothelium is mediated by DC- 
SIGN. Adhesion specificity was determined in the presence of blocking anti-DC-SIGN (AZN- 
D1; 20 pg/ml) or anti-ß1/ß2 integrin (AIIB2 and AZN-L19; 20 pg/ml) Ab at 37°C. One 
representative experiment out of 2 experiments is shown. (c) DC-SIGN mediates trans­
migration of DC across both resting and TNF-a-activated endothelium in response to a SDF- 
1 gradient. The trans-endothelial migration was measured in the presence of antibodies to 
DC-SIGN (AZN-D1 and AZN-D2; 40 pg/ml), VLA-4 integrin (HP2/1; 40 pg/ml) and ß2 
integrins (AZN-L19; 40 pg/ml). One representative experiment out ofthree is shown.
Subsequently we investigated the involvement of DC-SIGN in the endothelial 
transmigration of DC. Members of the chemokine family, such as SDF-1, have been shown to 
direct specific transendothelial migration of DC (Banchereau and Steinman, 1998; D'Amico et
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al., 1998; Delgado et al., 1998; Sallusto and Lanzavecchia, 1999). In a physiological system, 
SDF-1 induced migration of DC across both resting and TNF-a-activated endothelium (Fig. 
4c). DC-SIGN also mediated transmigration to other chemokines such as MIP-1a and Rantes 
(data not shown). Both spontaneous and SDF-1-induced migration across resting endothelium 
was predominantly mediated by DC-SIGN, whereas the contribution of the ß1/ß2 integrins 
was minimal (Fig. 4c). SDF-1-induced migration of DC across TNF-a-activated endothelium 
was strongly dependent on DC-SIGN (Fig. 4c), despite the elevated levels of integrin ligands 
on the TNF-a-activated endothelium (Fig. 4a). The discrepancy between the relatively minor 
contribution of DC-SIGN to the static adhesion of DC to endothelium, compared to the major 
contribution of DC-SIGN to the transendothelial migration of DC (Fig. 4b, c) demonstrates 
that the transient, more dynamic interactions, provided by DC-SIGN, are essential for 
transendothelial migration.
DC-SIGN-positive precursors are present in blood
We next assessed the in vivo relevance of these interactions by immunohistochemistry. 
ICAM-2 is abundantly expressed on the endothelial linings of both vascular and lymphatic 
vessels in vivo (Fig. 5a), suggesting that ICAM-2/DC-SIGN interactions might play a role in 
the migration of DC-SIGN-positive blood precursors into peripheral tissues as well as of 
immature and mature DC into lymphoid tissues. Indeed we found that in blood two DC- 
SIGN-positive subpopulations, CD14+ and CD14-, were present (Fig. 5b). Both cell 
populations express high levels of MHC class I, MHC class II, CD 11b, and CD 11c, 
intermediate levels of CD83 and CD86, and no CD80 (Fig. 5c). This together with the 
expression of DC-SIGN on immature DC in the periphery (Geijtenbeek et al., 2000b) (Fig. 
5d), and on mature DC in the lymphoid organs (Geijtenbeek et al., 2000b) (Fig. 5e), indicate 
that DC-SIGN/ICAM-2 interactions may regulate DC migration from blood into peripheral 
tissues and subsequently into lymphoid tissues.
Discussion
DC-SIGN, a DC-specific adhesion receptor, and a Type II transmembrane mannose binding 
C-type lectin, regulates primary immune responses by establishing transient DC-T cell 
interactions through binding of the leukocyte counter structure ICAM-3 (Geijtenbeek et al., 
2000b). We now show that this novel DC-specific adhesion molecule recognizes with high 
affinity the endothelial counter-structure ICAM-2, also a well-known ligand of the ß2 integrin 
LFA-1. In contrast DC-SIGN does not bind ICAM-1, the major ligand of LFA-1. Thus, DC- 
SIGN is the primary DC-specific receptor for both ICAM-2 and ICAM-3, even though DC 
express LFA-1. Although DC-SIGN binds to both ICAM-2 and ICAM-3 under static 
conditions, under physiological flow conditions, only the DC-SIGN/ICAM-2 interaction 
resists shear stresses, allowing DC-SIGN-positive cells to tether to and roll along ICAM-2- 
coated surfaces. ICAM-2 serves as a rolling counter receptor for DC-SIGN but not for LFA-1
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(data not shown) indicating that only DC-SIGN but not LFA-1 functions as a rolling receptor. 
ICAM-2 is abundantly expressed on endothelial blood vessels (Nortamo et al., 1991), which 
would enable DC-SIGN-positive DC to tether to and roll along vascular endothelium, a 
prerequisite for transendothelial migration into the peripheral tissues. DC-SIGN-mediated 
rolling on ICAM-2 was observed over the entire range of physiological shear stresses reported 
to occur in post-capillary venules that are known to support leukocyte emigration (Heisig, 
1968). Thus, DC-SIGN is a DC-specific rolling receptor and apart from the P-, E-, and L- 
selectins (Vestweber and Blanks, 1999), the only other known adhesion molecules involved in 
general leukocyte tethering and rolling on vascular endothelium were the a4-integrins VLA-4 
(a4ß1), and a4ß7 (Springer, 1994; Alon et al., 1995; Berlin et al., 1995). DC-SIGN contains a 
C-type lectin domain, similar to the selectins, indicating that this particular class of lectin 
domains is well-suited to mediate rolling. The interaction of DC-SIGN with ICAM-2 resisted 
shear stress whereas binding of DC-SIGN to ICAM-3 was abolished under similar conditions. 
DC-SIGN-mediated binding to ICAM-3 in vivo does not need to resist shear forces since 
ICAM-3 is absent on endothelial cells and the DC-SIGN/ICAM-3 interaction mediates DC-T 
cell clustering in secondary lymphoid tissues, which are not exposed to shear forces.
Monocytes have been demonstrated to be precursors of DC (Randolph et al., 1998) and 
we have demonstrated that DC-SIGN is rapidly upregulated on monocytes in the presence of 
IL-4 and GM-CSF (Geijtenbeek et al., 2000b). Thus, DC-SIGN-upregulation by cytokine 
mediators may induce migration of precursor DC from blood into the periphery. The presence 
of DC-SIGN-positive cells in blood further supports our model that under physiological 
circumstances DC-SIGN/ICAM-2 interactions mediate rolling along endothelial linings and 
transmigration of DC into the periphery. The ICAM-2/DC-SIGN-mediated tethering to and 
rolling interactions along the blood vessels enable these cells to react swiftly to inflammatory 
chemoattractants that direct extravasation of DC into peripheral tissues as demonstrated by 
the abundant expression of DC-SIGN on DC present in these tissues (Geijtenbeek et al., 
2000b) (Fig. 5d). Upon antigen challenge these immature DC will mature and migrate to the 
lymphoid tissues (Fig. 5e) where ICAM-2 is abundantly expressed on the endothelial linings 
in both vascular and lymphatic vessels (Fig. 5a). Therefore these results demonstrate a central 
role for ICAM-2 in DC-specific migration from blood into periphery, inflamed or not 
inflamed, and subsequently of immature DC via lymph into lymphatic tissues.
Our findings emphasize the importance of DC-SIGN in the unique function of DC, both 
in mediating naive T cell interactions through ICAM-3, and as a rolling receptor that mediates 
the DC-specific ICAM-2-dependent migration processes. The fact that DC-SIGN functions as 
a novel HIV-1 trans-receptor important in the initial capture of HIV-1 at the periphery and 
transport by DC into lymphoid tissues, again demonstrates that the unique migratory capacity 
of DC can be exploited for dissemination of viruses such as HIV (Geijtenbeek et al., 2000a). 
We have found that DC-SIGN is involved in the migratory capacity of both blood-borne DC 
precursors and tissue DC; this suggests that clinical strategies which target DC-SIGN will be 
successful both in restricting HIV-1 dissemination and pathogenesis, and in directing the 
migration of DC to manipulate appropriate immune responses in autoimmunity and 
tumorigenic situations.
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Figure 5. DC-SIGN is expressed by DC precursors in blood, immature DC in skin and 
mature DC in lymphoid tissues, (a) ICAM-2 is abundantly expressed on endothelial vascular 
(HEV) as well as lymphatic vessels in tonsils, Tissue sections of tonsil were stained for the 
expression of ICAM-2 (CBR-IC2/2), (b) Blood contains two DC-SIGN-positive cell
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populations which are CD14-positive (90%) and -negative (5%), respectively (ratios between 
CD14-positive and CD14-negative varies between blood donors from 20:1 to 3:1), The DC- 
SIGN-positive fraction, representing 0.04 % of total PBMC, was isolated from 
CD3/CD20/CD56-depleted PBMC by positive flowcytometric cell-sorting after staining with 
FITC-conjugated anti-DC-SIGN Ab (AZN-D2). One representative experiment out of three is 
shown. (c) DC-SIGN-positive blood precursors express both antigen-presenting and co­
stimulatory molecules. DC-SIGN-positive blood cells (Fig. 5b) were stained for the 
expression of different markers, (d-e). DC-SIGN is abundantly expressed by immature dermal 
DC in the skin (D=dermal, ED=epidermal) (d) and by mature DC in tonsils (G=germinal 
center, T=T cell area) (e). Tissue sections of tonsil were stained for the expression of DC- 
SIGN (AZN-D1).
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General discussion
Introduction
Cell adhesion events are vital in both migration of leukocytes as well as T cell activation. In 
this thesis, two cell adhesion molecules, LFA-1 and DC-SIGN, are being studied. The integrin 
LFA-1 is not only involved in pure adhesive interactions through binding of ICAM-1, ICAM-
2, and ICAM-3, but has also been reported to have potent signaling capacities. Signaling is 
required to swiftly activate and de-activate integrins to regulate leukocyte rolling, firm 
adhesion, and transmigration. The signaling function of integrins is bi-directional, indicated 
by "outside-in" and "inside-out" signaling (Lub et al., 1995; Aplin et al., 1998). The affinity 
and/or avidity changes of integrins required to bind ligand can be modulated via several 
intracellular pathways, termed inside-out signaling. LFA-1 can be activated through the TCR, 
by phorbol esters that activate PKC, by chemokines, or by binding of unique LFA-1 
activating antibodies (Rothlein and Springer, 1986; van Kooyk et al., 1989; van Kooyk et al., 
1991; Robinson et al., 1992; Andrew et al., 1993; Landis et al., 1994; Springer, 1994; 
Campbell et al., 1998). Ligand binding by integrins can induce a variety of outside-in signals, 
such as cell proliferation, cytotoxicity, phosphorylation, co-stimulatory signals, gene 
transcription, and cytokine production (Wacholtz et al., 1989; van Seventer et al., 1990; 
Figdor et al., 1990; van Seventer et al., 1992; Kanner et al., 1993; Lub et al., 1995).
The intracellular signals that direct activation of LFA-1 and induce ligand binding need to 
be strictly coordinated. Many modulators have been identified to play a role in regulating 
LFA-1 activation, such as calcium and pH, protein tyrosine phosphorylation, alteration in 
phosphoinositol levels, MAPK signaling, the cytoskeleton, and LFA-1-linked proteins like 
cytohesin, Rack1, MacMARCKS, Calpain, Jab1, and many others known or yet to be 
discovered proteins (Figdor et al., 1990; Pardi et al., 1992; Collins et al., 1994; Lub et al., 
1995; Aplin et al., 1998; Liu et al., 2000). Still, the exact mechanism and parameters that 
regulate adhesion and signaling are not clearly defined.
In contrast to LFA-1 activation, the C-type lectin DC-SIGN is constitutively active. The 
DC-specific adhesion molecule shares with LFA-1 the feature to bind ICAM-2 and ICAM-3 
(Geijtenbeek et al., 2000a; 2000b). It is likely that ligand binding to DC-SIGN also activates 
possible associated proteins to induce intracellular signals. However, the function of the 
cytoplasmic tail of DC-SIGN still needs to be investigated in more detail. In this chapter I 
discuss the function and signaling of the regulators of LFA-1-mediated adhesion and how 
they associate with the ß2 cytoplasmic tail of LFA-1. Finally, preliminary data on the 
potential role of DC-SIGN as regulator of LFA-1-mediated adhesion will be discussed briefly.
LFA-1 signaling through the ICAMs
The main ligands for LFA-1 are ICAM-1, ICAM-2, and ICAM-3. LFA-1 recognizes these 
ligands as a result of several structural and physiological differences. The homology between 
the Ig-like domains of the ICAMs, responsible for binding, is not very high, leading to
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different binding properties. Within the I domain of LFA-1, the ligand binding site is not 
similar for the three ligands (Binnerts and van Kooyk, 1999). The affinity of LFA-1 for these 
ligands is different; LFA-1 has the highest affinity for ICAM-1, less for ICAM-2, and low for 
ICAM-3 (Woska et al., 1998). Finally, the ICAMs have a different tissue distribution. This 
selective expression of the ICAMs at different tissues allows controlled LFA-1-mediated 
adhesion to that particular ligand that is expressed at a certain place. For example, ICAM-2 is 
predominantly expressed on resting endothelium, whereas ICAM-1 is upregulated on 
activated endothelium. ICAM-3 is absent on endothelium, but highly expressed on naive T 
cells. LFA-1 binding to its different ligands can result in different intracellular signals leading 
to different cytokine production and T cell proliferation (chapter 3). LFA-1 co-stimulation 
with ICAM-1 predominantly results in secretion of the Th2 cytokine IL-10, whereas ICAM-2 
or ICAM-3 strongly induce the production of the Th1 cytokine TNF-a.
Migration of lymphocytes is also dependent on LFA-1-mediated adhesion. It has been 
shown that crosslinking of LFA-1 induces the secretion of the chemokines MIP-1a and MIP- 
1ß (Murphy et al., 2000). This suggest that LFA-1 adhesion during migration further directs 
the fate of the lymphocytes by releasing chemokines and/or inflammatory cytokines such as 
TNF-a. Endothelial cells express constitutively levels of ICAM-2. The initial binding of T 
cells to resting endothelium via LFA-1/ICAM-2 induce the secretion of TNF-a by the T cells. 
Since TNF-a enhances ICAM-1 expression, firm arrest of the T cells through LFA-1/ICAM-1 
interaction takes place. Thus, cytokine production induced upon ligand binding by LFA-1 not 
only regulate T helper differentiation, but also participate in transendothelial migration of 
lymphocytes.
LFA-1 can both bind ICAM-1 and ICAM-3 due to different binding pockets within the 
LFA-1 molecule. In chapter 3, I described that LFA-1 ligand binding may also modulate the 
activation state of LFA-1. The low affinity ligand ICAM-3 is able to enhance the adhesion of 
LFA-1 to its other ligand ICAM-1 by altering LFA-1 clustering on the cell surface. ICAM-3 
binds to a different site within the LFA-1 I domain compared to ICAM-1 which enables them 
to bind simultaneously to LFA-1 (Landis et al., 1994; Binnerts and van Kooyk, 1999).
Furthermore, ICAM-1-mediated co-stimulation results in an increased LFA-1 avidity as
2+detected by the NKI-L16 antibody, which recognizes a Ca -dependent epitope (Keizer et al.,
2+  2+1988). Clustering of LFA-1 (avidity) is dependent on the presence of Ca , whereas Mg 
induces high affinity of LFA-1. Both high affinity and avidity results in changes of LFA-1 
adhesion to its ligands. In agreement with our observation, binding of LFA-1 to ICAM-1 has 
been shown to increase the adhesion to ICAM-3, probably due to enhancing the avidity of 
LFA-1 (Buckley et al., 1997). Taken together, the LFA-1 molecule is capable to distinguish 
its different ligands, thereby inducing distinct intracellular signals. Intriguingly, these outside­
in signals all have to be guided via the LFA-1 molecule and likely also via its cytoplasmic tail 
and associated proteins. Especially the cytoplasmic tail of the ß2 subunit is predominantly 
involved in inside-out signaling. In addition, avidity rather than affinity changes play an 
important role in regulating ß2 integrin mediated adhesion (Lobb et al., 1995; van Kooyk et 
al., 1999; van Kooyk and Figdor, 2000).
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Role of ß2 cytoplasmic tail in modulating LFA-1 avidity
The role of the ß2 cytoplasmic tail in LFA-1 inside-out signaling is discussed in chapter 4. 
We identified several amino acids within this tail that regulate the PMA-induced inside-out 
activation of LFA-1. In contrast to T cells, PMA activation of LFA-1 when expressed in K562 
cells does not lead to LFA-1 activation and subsequent LFA-1/ICAM-1 mediated adhesion. 
However, substitution of a leucine in the DRLE motif for an arginine (L732R) was sufficient 
to restore the PMA responsiveness. The created DRRE motif, which is present in the ß1 
cytoplasmic domain, resulted in a default clustered cell surface distribution of LFA-1. Thus, 
this point mutation affected the localization of LFA-1 within the cell membrane. Since we 
presume that the increased LFA-1 avidity is primarily responsible for the gained LFA-1 
activation by PMA, it is still unclear why this mutation results in a clustering of LFA-1. The 
DLRE motif has been proposed to bind the GFFKR motif in the a  chain and both these 
cytoplasmic domains serve to constrain LFA-1 into a default low affinity state (Hughes et al., 
1996; Lu et al., 2001). Deletion of the ß2 cytoplasmic tail results in an constitutive active 
LFA-1 molecule (Lub et al., 1997; Pyszniak et al., 1997). Furthermore, residues 756-762 and 
767 are important for the PMA induced LFA-1 activation in the B lymphoblastoid cell line JY 
(Petruzzelli et al., 1998). When a threonine in the distal part of the ß2 cytoplasmic domain 
was mutated (T758V) next to the L732R mutation, the PMA responsiveness was lost and 
LFA-1 was no longer localized into clusters (chapter 4). Mutations in this TTT region 
(position 758-760) have been shown to reduce the default adhesion to ICAM-1 (Hibbs et al., 
1991; Peter and O'Toole, 1995; Rey-Ladino et al., 1998). In addition, threonine- 
phosphorylated CD18 molecules associate with the cytoskeleton (Valmu et al., 1999) and play 
an important role in the formation of stressfibers and localization into specialized 
microdomains (Peter and O'Toole, 1995; Krauss and Altevogt, 1999; Pande, 2000). These 
data strongly indicate that the L732R mutation affects the cytoskeleton by using the threonine 
to cluster the LFA-1 molecule.
Why is LFA-1 with the DRRE instead of the DLRE motif clustered? There are several 
hypothesis that might explain this effect. First, due to the mutation the three-dimensional 
structure of the cytoplasmic tail and/or the whole LFA-1 molecule is changed (Fig. 1). This 
could result in an inappropriate association with the cytoskeleton leading to clustered 
molecules. Insertion of glycine residues in the sequence of the ß1 cytoplasmic tail results in 
different binding of ß1 linked proteins (Pfaff et al., 1998). This indicates that the folded 
structure of the cytoplasmic tail is important for interactions with cytoplasmic proteins (Lu et 
al., 2001).
Secondly, activation of ß1 integrins results in a shift in the position of the transmembrane 
domains towards the cytoplasm thereby exposing more residues of the cytoplasmic tail. A 
change in the charge of certain residues could favor the tail to either move into or out of the 
lipid bilayer (Armulik et al., 1999). Since the L732R mutation introduces a positively charged 
amino acid instead of a neutral, it is possible that the overall charge of transmembrane region 
is changed. The cell membrane is composed of lipids, such as cholesterol and 
glycosphingolipids that can directly interact with integrins. Both lipids are also involved in
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the organization of rafts in the membrane. Rafts are specialized lipid microdomains which 
may function as platforms for signaling molecules (Pande, 2000). The TCR and several 
signaling molecules like PKC are localized in lipid rafts and TCR crosslinking causes 
aggregation of raft-associated proteins (Janes et al., 2000). Here LFA-1 forms the outer ring 
of the immunological synapse linked to the cytoskeleton (Sampath et al., 1998; Monks et al., 
1998; Dustin and Cooper, 2000). However, the immunological synapse seems not to be an 
absolute requirement for the ICAM-1 enhancement of T cell activation, but merely functions 
to amplify stimuli (Goldstein et al., 2000). Thus, changes in the localization of the 
transmembrane region of LFA-1 in the lipid bilayer could results in a different organization of 
LFA-1 in rafts. This could lead to clustering of the LFA-1 molecules.
Figure 1. Model for LFA-1 clustering induced by point mutant L732R. Wild type LFA-1 
expressed in K562 cells is homogeneously distributed along the cell surface. Substitution of a 
single amino acid in the ß2 cytoplasmic domain for a ß1 residue (L732R) results in clustering 
of the LFA-1 receptor by several distinct or overlapping ways. (1) The mutation causes a 
change in the three-dimensional structure of the cytoplasmic tail and/or the whole LFA-1 
molecule, leading to a different association with the cytoskeleton resulting in LFA-1 
clustering (2) The introduced positive charge of the mutation results in a change in the 
localization of the transmembrane region of LFA-1 in the lipid bilayer. This could lead to a 
different organization of LFA-1 in rafts accompanied by clustering of LFA-1. (3) Cytoplasmic 
proteins are now able to interact with the mutated cytoplasmic tail leading to different 
regulation of the LFA-1 avidity.
170
General discussion
Thirdly, other proteins can interact with the mutated cytoplasmic tail leading to different 
regulation of the LFA-1 avidity. The ß1 as well as the ß2 cytoplasmic tail are known to bind a 
number of overlapping but also different proteins (Table I). The introduced L732R mutation 
could have a positive or negative effect on the association with these proteins. ß1-specific 
associated proteins can bind the mutated ß2 cytoplasmic tail and induce clustering of LFA-1. 
Likewise, ß2-specific proteins can no longer interact to keep LFA-1 in a homogeneous cell 
surface distribution. Binding of certain proteins to the ß2 cytoplasmic tail could be increased 
due to changes in affinity for the proteins introduced by the point mutation. Thus, there are 
still several ways by which the one amino acid change in the cytoplasmic tail of LFA-1 can 
result clustering and PMA induced LFA-1 activation, either via increased avidity and/or 
affinity (Fig. 2). A number of proteins that may be involved in LFA-1 activation and 
clustering of LFA-1 mutant L732R will be discussed below.
LFA-1 regulators
Regulators of LFA-1 adhesion can be roughly divided into different groups as shown in table 
I. The first group are the cytoskeleton-associated proteins such as talin, a-actinin, vinculin, 
and filamin. Included are components that regulate the interplay between LFA-1 and the actin 
cytoskeleton. These proteins, like calpain, cytohesin, and L-plastin, are involved in activating 
LFA-1 via avidity changes. The second group are the signaling proteins involved in 
phosphorylation and recruitment of PKC leading to increased LFA-1 activity, such as 
MacMARCKS, Rack1, as well as proteins of the GTPase family. GPI-anchored proteins and 
cytokine/chemokine receptors are well known to modulate the activity of LFA-1. The third 
group are proteins known to specifically interact and regulate ß1 or ß2 integrins. The 
contribution of each of these proteins in the regulation of the ß2 integrin LFA-1 will be 
discussed as well as how the LFA-1 mutant L732R can efficiently respond to PMA.
Cytoskeleton-associated proteins
The actin cytoskeleton plays a key role in integrin activation. The ß2 cytoplasmic domain has 
been demonstrated to be associated with the cytoskeletal components a-actinin, vinculin, 
filamin, or talin (Burn et al., 1988; Pavalko and LaRoche, 1993; Sharma et al., 1995; Pardi et 
al., 1995; Cattelino et al., 1999; Goldmann, 2000). Talin forms the bridge between the ß2 
integrin and actin filaments. For avidity changes and LFA-1 activation, the integrin must be 
released from the cytoskeleton to allow mobilization of LFA-1 in the cell membrane to form 
clusters. Rapid cytoskeletal rearrangements are necessary for rolling interaction under shear 
flow as demonstrated for Mac-1 and in chapter 5 and 6 for LFA-1 (Anderson et al., 2000). 
The cleavage of LFA-1 from the cytoskeleton is thought to be regulated by the cysteine 
protease calpain that is activated by local Ca2+ fluxes after T cell activation (Stewart et al., 
1998; Potter et al., 1998). Calpain not only controls ß2 activity, but also ß1 integrin-mediated 
T cell adhesion and cell spreading (Rock et al., 2000). Talin is probably proteolysed by 
calpain leading to freely mobile integrin (Sampath et al., 1998). The binding site for talin in
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LFA-1 is thought to be situated in the membrane distal tail, because mutation of a tyrosine 
residue (Y788V) in the ß1 cytoplasmic tail abrogates the binding of talin (Calderwood et al., 
1999; Calderwood et al., 2000). Filamin and a-actinin are also identified as potential calpain 
targets. Filamin and talin probably bind to the same site in ß1 integrins in which the NPXY 
motif plays an important role (Loo et al., 1998; Kaapa et al., 1999). The binding site for a- 
actinin in the ß2 cytoplasmic domain is located between residues 736-746 C-terminal of the 
DLRE motif. In contrast to ß1 integrins, filamin does not bind to the a-actinin site but uses 
the amino acids at position 724-747 (Sharma et al., 1995). It is likely that the DRRE mutation 
influences this cytoskeletal organization and calpain activity resulting in active LFA-1 
molecules. Inhibiting calpain with calpeptin abrogates the PMA responsiveness of the LFA-1 
DRRE mutant (chapter 4). This indicates that PMA acts via calpain although calpeptin also 
has been reported to induce stressfiber formation in fibroblasts due to its inhibitory action on 
protein tyrosine phosphatases (PTPases) upstream of the small GTPase Rho (Schoenwaelder 
and Burridge, 1999). However, it is rather unlikely that this additional effect of calpeptin on 
PTPases occurs during the integrin mediated adhesion of the LFA-1 DRRE mutant when 
expressed in the non-adherent K562 cells, which cannot induce stressfiber formation.
Figure 2. Different ways to activate the LFA-1 molecule. LFA-1 can be directly activated by 
antibodies or low-avidity ligand binding (outside-in signaling). Receptors, such as TCR, 
chemokine receptors, and possibly also DC-SIGN, can activate LFA-1 via an intracellular 
pool of signal transduction molecules (inside-out signaling). These can be either cytohesin, 
MacMARCKS, PKC, Rack1, FAK, ILK, and the cytoskeleton with their associated proteins. 
Adaptor proteins closely situated next to LFA-1, such as uPAR, CD14, CD24, CD59, or 
CD73 can enhance LFA-1 activity often due to increased LFA-1 avidity Finally artificial 
reagents like PMA directly activate PKC leading to activation ofLFA-1.
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Next to calpain, cytohesin has been described to be an important protein to regulate LFA- 
1 activity by maintaining LFA-1 in a high avidity state. Cytohesins are members of guanine 
nucleotide exchange factors for ARF G-proteins, which play a role in remodeling of the 
plasma membrane actin-cytoskeleton, such as paxillin deposition at focal contacts or 
induction of membrane ruffling (Norman et al., 1998; Radhakrishna et al., 1999). Cytohesin-1 
and -3 specifically interact with the ß2 cytoplasmic domain directly after the transmembrane 
region thereby controlling T cell receptor or phorbol ester induced activation of LFA-1 
(Kolanus et al., 1996; Hmama et al., 1999; Geiger et al., 2000; Korthauer et al., 2000). The 
binding sequence WKA (position 723-725) of the ß2 cytoplasmic tail interacts with the Sec7 
domain of cytohesin. Thus, the LFA-1 DRRE mutant that response to PMA might show that 
this sequence is not buried within the lipid bilayer and shifted into the cytoplasm due to the 
mutation (Armulik et al., 1999). Since cytohesin-1 is expressed in K562 cells, although at 
lower levels compared to T cells, it is likely that the high avidity state of the DRRE mutant is 
thus a direct result of cytohesin binding.
The leukocyte specific actin bundling protein L-plastin proved to be important in 
enhanced ß2 integrin avidity. L-plastin is a member of the fimbrin family of actin-binding 
proteins characterized by two actin-binding domains. Several studies indicate that L-plastin 
may be a critical component of the cytoskeletal restriction of integrin diffusion in inactivated 
cells. Thus, L-plastin-actin bundles may be essential components of the cortical cytoskeletal 
structures that constrain the integrin from free diffusion. Phosphorylation of L-plastin by PKA 
or PKC is thought to disrupt the cytoskeletal structure resulting in increased avidity of ß2 
integrins (Jones et al., 1998; Wang and Brown, 1999).
Signaling binding proteins
To constrain LFA-1 in a high avidity state resulting in activation, cytohesin, calpain, and L- 
plastin might not be the only components involved. LFA-1 molecules forming 
micromolecular clusters are an ideal environment in which signaling proteins can accumulate 
and localize near the cytoplasmic tail of LFA-1. These accumulated proteins can activate each 
other in order to trigger the signaling cascade leading to LFA-1 activation. It has been 
demonstrated that expression of the ß1 or ß2 cytoplasmic tail fused to the extracellular part of 
CD4 could completely inhibit the integrin mediated adhesion by capturing all the signaling 
proteins necessary for efficient adhesion (Lukashev et al., 1994; Rey-Ladino et al., 1998). The 
phorbol ester PMA activates PKC, which in turn triggers a cascade of transducer molecules 
able to activate LFA-1. One of the proteins that link PKC and the ß2 integrin is 
MacMARCKS (Li et al., 1996; Yue et al., 1999; Zhou and Li, 2000; Yue et al., 2000a; Yue et 
al., 2000b; Jin et al., 2001). MacMARCKS is a PKC substrate phosphorylated upon PMA 
activation which leads to an increased LFA-1 avidity. MacMARCKS is potential involved in 
PMA-induced LFA-1 activation in K562 cells, since MacMARCKS expression was detected 
by confocal microscopy in these cells (chapter 4). Paxillin is tyrosine phosphorylated by 
MacMARCKS in ß2 integrins and both colocalize in the membrane ruffles of spreading 
macrophages (Li et al., 1996). Many proteins like focal adhesion kinase (FAK), Src, PTP- 
PEST, vinculin, Crk, p95PKL, PIX, and PAK are linked to the adaptor protein paxillin, which
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have been implicated in regulation of cell migration, cytoskeletal organization, and gene 
expression (Turner, 2000). Mutating the DRRE sequence in the ß1 cytoplasmic tail reduces 
the FAK and paxillin binding (Schaller et al., 1995; David et al., 1999). FAK binding to talin 
is another mechanism by which FAK might regulate ß2 integrins (Chen et al., 1995; 
Borowsky and Hynes, 1998). Expression of different splice forms of the ß1 integrin has been 
shown to differently modulate FAK and MAPK pathways, illustrating the relevance of the 
correct structure of the integrin for signaling (Zheng et al., 1997; Fornaro et al., 2000). 
Besides FAK, the Integrin Linked Kinase (ILK) also associates with ß2 integrins as well as 
ß1. ILK is serine-threonine kinase and plays a possible role in cytoskeletal assembly of ß1 
integrins (Hannigan et al., 1996; Dedhar and Hannigan, 1996; Dedhar et al., 1999; 2000; 
Nikolopoulos and Turner, 2001).
Not only is MacMARCKS a substrate for PKC, but also Rack1 (receptor for activated 
protein kinase C), which has been identified in yeast two-hybrid screenings for ß-tail-binding 
proteins. The protein is a member of the Gß superfamily and is composed of seven WD 
(Tryptophan-Aspartic acid) motifs. Only phosphorylated Rack1 binds PKC allowing 
subsequent recruitment of Rack1 to the KALI-region in the ß2 cytoplasmic domain (Liliental 
and Chang, 1998; Zhang and Hemler, 1999). The WD repeats 5-7 of Rack1 interact with ß 
integrins, leaving the other repeats free for binding to PKC and possibly cytohesin. Another 
family member of Rack1 is WAIT-1 (WD protein associated with integrin tails) that 
specifically interacts with ß7-integrins involving residue T735 of the ß7 cytoplasmic tail 
(Rietzler et al., 1998).
PKC, PI-3 kinase, and the small GTPase Rap1 have been shown to differently modulate 
LFA-1 avidity (Reedquist et al., 2000; Katagiri et al., 2000). Rap1-induced adhesion was 
mediated by H-Ras and Rac, which are members of the Ras/Rho family of small GTPases that 
regulate the actin cytoskeleton (O'Rourke et al., 1998). Rho has also been described to be 
involved in the control of LFA-1-mediated adhesion (Laudanna et al., 1996). Only the TCR- 
but not the PMA-induced LFA-1 activation was dependent on Rap1 activation. Both Rap1 
and the PI-3 kinase, but not PKC, mediated LFA-1 activation upregulated the NKI-L16 
epitope on LFA-1, indicating that both PI-3 kinase and Rap1 activate LFA-1 through avidity 
alterations. Recently, Rap1 activation has been shown to mediate the CD98 induces LFA-1- 
mediated cell adhesion (Suga et al., 2001). The Lymphocyte Orientated Kinase (LOK) is part 
of the PAK family of kinases containing a Rac binding domain. The absence of LOK greatly 
enhanced LFA-1-mediated T cell aggregation and LFA-1 clustering on the cell surface (Endo 
et al., 2000). Thus, many signaling proteins can alter the activity of LFA-1, including 
MacMARCKS, Rack1, and GTPases. The clustering of LFA-1 mutant L732R and its 
subsequent high PMA responsiveness is probably due to the concentration of several of these 
signaling proteins near the LFA-1 cytoplasmic tails. Blocking these proteins would 
significantly contribute to the understanding of the LFA-1 activation cascade.
Associated transmembrane proteins
Besides intracellular adaptor proteins that regulate LFA-1 adhesion, receptors and GPI- 
anchored proteins are also able to regulate LFA-1 activity. The Urokinase receptor (uPAR)
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can indirectly influence ß2 adhesive properties and is found with LFA-1 in a single complex 
(Bohuslav et al., 1995; Preissner et al., 2000; Ossowski and Aguirre-Ghiso, 2000). uPAR 
belongs to the GPI-anchored proteins just like CD14, CD59 and CD73, which can associate 
with integrins. Removal of uPAR results in dysfunction of the ß2 integrin Mac-1, whereas 
adhesion via VLA-4 also requires uPAR functioning (May et al., 2000). CD73 is a GPI- 
anchored lymphocyte adhesion molecule with ecto-5'-nucleotidase enzyme activity. 
Crosslinking CD73 enhances LFA-1-dependent adhesion of lymphocytes to endothelial cells. 
CD73 engagement results in tyrosine phosphorylation and increases LFA-1 avidity that is 
sensitive to calpain inhibition (Airas et al., 1997; Airas et al., 2000). In addition, crosslinking 
of another GPI-anchored protein, CD24, can cluster LFA-1 and colocalizes with LFA-1 in 
rafts (Krauss and Altevogt, 1999). These GPI-anchored proteins probably localize to integrins 
or are situated within the same raft and could thereby support the integrins with signaling 
molecules.
Another group of important receptors that can activate LFA-1 are the chemokine and 
cytokine receptors that play a predominant role in lymphocyte trafficking and rolling. Stromal 
cell-derived factor-1 (SDF-1), interleukin-8 (IL-8), macrophage inflammatory protein-3ß 
(MIP-3ß), and thymus-derived chemotactic agent (TCA-4) have been shown to induce 
activation of ß2 integrins leading to the arrest of rolling lymphocytes (Campbell et al., 1996; 
Campbell et al., 1998; Sadhu et al., 1998; Weber et al., 1999; Stein et al., 2000; Kantele et al., 
2000; Soede et al., 2001). The cytokine TNF-a increases the affinity of LFA-1 as monitored 
with the expression of the LFA-1 epitope M24 (Menegazzi et al., 2000). The route of LFA-1 
activation by chemokine receptors is via G-proteins (Laudanna et al., 1996; Sadhu et al., 
1998). However, in case of VLA-4 activation, G-proteins signal via a different DAG- 
dependent PKC compared to PMA (Grabovsky et al., 2000). A recent report demonstrated 
that chemokines (SLC, ELC, and SDF-1) induce high LFA-1 affinity and avidity states 
through distinct signaling pathways (Constantin et al., 2000) Although chemokine receptors 
do not participate in the PMA activation of mutant LFA-1 in K562 cells, their role in 
lymphocyte trafficking and activation of integrins is significant.
Other ß1 and ß2 binding proteins
Besides these three different groups of LFA-1 regulatory proteins, there are many other 
proteins known that specifically bind to ß1 or ß2 integrins. In the PMA responsive LFA-1 
mutant (L732R), a ß2 amino acid is replaced for a ß1 amino acid in the LFA-1 ß2 cytoplasmic 
tail. This introduced ß1 residue can lead to an altered binding of specific ß1 or ß2 associated 
proteins, which results in the restored PMA responsiveness (chapter 4). The most recently 
identified integrin-binding protein Jab1 binds specifically to the ß2 cytoplasmic tail of LFA-1 
(Bianchi et al., 2000). Jab1 is a co-activator of the c-Jun transcription factor and it co­
localizes with LFA-1 at the cell membrane. LFA-1 engagement is followed by an increase of 
the nuclear pool of Jab1, suggesting that signaling through the LFA-1 integrin may affect c- 
Jun-driven transcription by regulating Jab1 nuclear localization. The binding site of Jab1 on 
the ß2 cytoplasmic tail is yet unknown.
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Table I. Regulatory proteins for ß1 and ß2 integrins
Regulatory protein Integrin tail References
Cytoskeleton proteins
Paxillin ß1 (Schaller et al., 1995; Chen et al., 2000; Liu and 
Ginsberg, 2000)
Talin ß1, ß2 (Horwitz et al., 1986; Pfaff et al., 1998; Calderwood et 
al., 1999)
Filamin ß1, ß2 (Sharma et al., 1995; Loo et al., 1998; Pfaff et al., 
1998)
a-actinin ß1, ß2 (Otey et al., 1990; Pavalko and Burridge, 1991; Loo et 
al., 1998)
L-Plastin ß1, ß2 ? (Jones et al., 1998; Wang and Brown, 1999)
Calpain ß1, ß2 (Stewart et al., 1998; Rock et al., 2000)
Cytohesin ß2 (Kolanus et al., 1996; Hmama et al., 1999; Geiger et 
al., 2000)
Signaling proteins
ILK ß1, ß2 (Hannigan et al., 1996; Dedhar and Hannigan, 1996)
FAK ß1, ß2 (Schaller et al., 1995; Chen et al., 2000)
Rack-1 ß1, ß2 (Liliental and Chang, 1998)
Rap1 ß1, ß2 (Reedquist et al., 2000; Katagiri et al., 2000)
MacMARCKS ß2 (Yue et al., 1999; Yue et al., 2000a; 2000b)
LOK ß2 (Endo et al., 2000)
Transmembrane proteins
CC/CXC chemokine receptors ß1, ß2 (Campbell et al., 1996; Campbell et al., 1998; Sadhu et 
al., 1998; Weber et al., 1999; Stein et al., 2000; 
Kantele et al., 2000; Constantin et al., 2000)
Urokinase receptor ß1, ß2 (Bohuslav et al., 1995; Ossowski and Aguirre-Ghiso, 
2000)
CD24 ß2 (Krauss and Altevogt, 1999)
CD73 ß2 (Airas et al., 1997; Airas et al., 2000)
Other binding proteins
ICAP-1 ß1 (Chang et al., 1997)
Jab1 ß2 (Bianchi et al., 2000)
The NPKY region in the ß1 cytoplasmic tail is not only a binding site for filamin and 
talin (Loo et al., 1998; Kaapa et al., 1999), but also for the Integrin-Cytoplasmic-domain- 
Associated Protein 1 (ICAP-1), which contains consensus phosphorylation sites for PKC,
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cAMP- or cGMP-dependent kinases and Calcium/calModulin-dependent protein Kinase II 
(CaMKII). ICAP-1 binding might regulate cell spreading and migration in a manner 
dependent on CaMKII phosphorylation of ICAP-1 (Reszka et al., 1992; Chang et al., 1997; 
Bouvard and Block, 1998; Zhang and Hemler, 1999).
The above described proteins illustrate that although the ß1 and ß2 cytoplasmic domains 
have several identical regions, they are able to differentially bind distinct proteins and that the 
DRRE mutation in LFA-1 could influence this binding specificity. Taken together, there are 
many candidate signaling components that can account for the activation and increased 
avidity of LFA-1, although information provided by ligand binding to LFA-1, as 
demonstrated in chapter 6, also contributes to the activity of LFA-1.
Is there a crosstalk between the LFA-1 and DC-SIGN?
Next to TCR triggering and chemokine receptors involved in integrin activation, adhesion 
receptors have to communicate with each other for an effective immune response. During 
lymphocyte transendothelial migration involving tethering and rolling via the selectins and 
subsequently arrest and migration via the ß2 integrins, crosstalk between receptors is crucial 
(Springer, 1994; Chang et al., 2000). Integrin receptors have to be activated by receptors of 
the rolling leukocytes in order to establish cell arrest. However, studies have demonstrated 
that signaling via L-selectin alone does not stimulate ß2 integrin dependent binding to ICAM-
1. This indicates that additional signals such as chemokines are required for firm adhesion 
(Lawrence et al., 1995; Hwang et al., 1996; Simon et al., 2000; Hafezi-Moghadam et al., 
2001). A number of studies have shown that ß1 and ß2 integrins efficiently communicate with 
each other with respect to integrin activation (Porter and Hogg, 1998; van den Berg et al., 
2001). One of the first indications was that ß1 integrin (VLA-4) mediated adhesion of T cells 
to endothelium only occurs when LFA-1 is in an inactive state. Active LFA-1, as observed by 
using the antibody NKI-L16 that recognized an activation epitope on LFA-1, results in 
downregulation of the VLA-4-mediated adhesion (van Kooyk et al., 1993). Furthermore, 
adhesion of LFA-1 to ICAM-1 or crosslinking LFA-1 by antibodies has shown to decrease the 
ability of VLA-4 to bind fibronectin through an avidity-dependent mechanism (Porter and 
Hogg, 1997; Werr et al., 2000). VLA-4 is used by leukocytes to roll on the endothelium and 
this receptor is strongly influenced by chemokines through increasing its avidity for ligand 
(Jakubowski et al., 1995; Grabovsky et al., 2000). Another study demonstrated that VLA-1 
strengthens the LFA-1-mediated adhesion through avidity changes under shear flow 
conditions (Chan et al., 2000).
Despite these observations, very little is known about the molecular mechanisms that are 
involved in receptor crosstalk. It is obvious that they have to be linked to the cytoskeleton 
with the common associated proteins in order to fulfill their adhesive tasks (Pavalko et al., 
1995; Kansas and Pavalko, 1996; Liu et al., 2000). Most interestingly is the communication 
between the C-type lectin DC-SIGN and LFA-1 that are both receptors for the same ligands. 
The transendothelial migration of DC is initially mediated via DC-SIGN/ICAM-2
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interactions, followed by LFA-1/ICAM-1 interactions that take over as demonstrated in 
chapter 7. As the cytoplasmic tail of LFA-1 is crucial for signaling, this seems not to be the 
case for DC-SIGN. There are indications that deletion of the cytoplasmic tail of DC-SIGN 
does not abrogate ligand binding when expressed in K562 cells (unpublished results). K562 
cells are different from DC in which DC-SIGN is normally expressed. Therefore, it cannot be 
excluded that specific DC-SIGN signaling components are not present in K562 cells, which 
complicates the interpretation of the possible signaling defects generated with the mutant. We 
also observed that ligand binding to DC-SIGN resulted in a colocalization of several 
molecules involved in the immunological synapse, such as CD3 and LFA-1. Like LFA-1, DC- 
SIGN is homogeneously distributed along the cell surface. However, expressing the clustered 
LFA-1 point mutant L732R together with DC-SIGN in K562 cells caused a colocalization of 
DC-SIGN with the LFA-1 mutant (unpublished results). This suggest that LFA-1 and DC- 
SIGN, when active, are closely linked and potentially crosstalk with each other.
It should be noted that most of this work was carried out in the erythroleukemic cell 
K562. To investigate LFA-1 in a physiological environment, such as T cells, will greatly 
enhance the understanding of LFA-1 regulation. However, LFA-1 is endogenously expressed 
in T cells, but this can be circumvented by using T cells from patients that lack LFA-1 
expression. This defect is known as the leukocyte adhesion deficiency (LAD) syndrome, 
which is caused by a defect in the ß2 subunit resulting in loss of functional expression of the 
ß2 integrins (Arnaout, 1990; Mathew et al., 2000; Etzioni and Tonetti, 2000; Harris et al., 
2001). Patients die at very young age of recurrent bacterial infections due to impaired 
leukocyte adhesive functions. Transfection of wild type and mutated ß2 subunit via either 
retroviral or vaccinia transfection (Bauer et al., 1998; Geiger et al., 2000) will significantly 
contribute to the understanding of the adhesive and signaling properties of LFA-1 involving 
the ß2 cytoplasmic tail. In case of DC-SIGN, DC that express mutant forms of DC-SIGN is an 
ideal situation to study the molecule. However, this would be very difficult, because no DCs 
lacking DC-SIGN expression have been detected yet. To date, the best system to study DC- 
SIGN is the monocytic cell line THP-1, which does not express DC-SIGN. One of the 
disadvantages of THP-1 cells is that LFA-1 is very low expressed and cannot be activated 
with PMA or even with the LFA-1 activating antibody KIM185 (unpublished results). Further 
investigating the function and regulation of LFA-1 and DC-SIGN in a physiological 
environment is an ideal situation to better understand the fine tuning of cell adhesion in the 
immune system.
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Summary
The human body protects itself against bacteria, viruses, but also cancer, by using its own 
defend- or immune system. The defend system is a collection of specialized cells including 
white blood cells or so called leukocytes. There are various leukocytes each with its own 
function, such as T cells and dendritic cells. T cells develop in the thymus and play a role in 
the direct destruction of invaders. These cells first have to get instructions about where to go 
and what to do. These instructions are provided by dendritic cells, which form the first line of 
defence of the immune system. During an infection, dendritic cells gather information in the 
form of small protein parts that are unique for the bacteria or cancer cells. Subsequently, the 
dendritic cells with the protein information move from the infection site towards the lymph 
nodes via the lymph vessels. At this site the protein parts or antigens are presented to the T 
cells. During this transfer of information, the interactions between the cells are very 
important. Only a few T cells will eventually recognize the antigen, which directly results in a 
strong proliferation of these T cells (clonal expansion). The activated T cells leave the lymph 
node and travel via the blood stream to the infection site to kill the infected cells. Infected 
tissue induces cells to the produce several signal proteins, such as cytokines and chemokines. 
These products help to guide the mobilized T cells to the infected cells. Once they arrive at 
the infection site, the T cells first have to migrate through the blood vessel wall to reach the 
infected cells. This process is called transendothelial migration. The adherence of the T cells 
to the blood vessel wall (endothelium) is crucial for migration and takes place in several 
steps. First, the velocity of the cells have to be reduced. This happens through short 
interactions with the blood vessel wall resulting in rolling of the cells. Next, they come to 
arrest and migrate through the endothelial cells to the infection site. Finally, the T cells will 
attach to the infected cells and eradicate them.
These immune reactions require numerous interactions between cells, such as between 
dendritic cells and T cells, T cells and endothelial cells, and between T cells and infected 
cells. To establish these connections, cells are equipped with several specialized proteins on 
the cell surface, called adhesion molecules. An important group of adhesion molecules are the 
integrins. They consist of a complex of an a  and ß chain. LFA-1 is an integrin that is 
exclusively present on leukocytes, like T cells and dendritic cells. A small part of the 
transmembrane protein LFA-1 is situated inside the cell. The main part is presented on the 
outside of the cell. This part of LFA-1 is able to bind to three distinct proteins (ligands) 
localized on the surface of cells. These are the intercellular adhesion molecules-1, -2, and -3 
(ICAM-1, -2, and -3). The adhesion between LFA-1 and ICAM-1 plays a role in the 
transendothelial migration in which T cells bind with LFA-1 to ICAM-1 on the endothelial 
cell. If this adhesion takes place constitutively, all T cells in the blood would stick to the 
blood vessel wall. This could lead to clogging and a potential infarct. To prevent this, LFA-1 
is not always capable to bind to ICAM-1. LFA-1 can be activated when necessary to adhere to 
ICAM-1. In addition, cells can also remove ICAM-1 from their cell surface or increase the 
number of molecules, which results in stronger adhesion. The activation of LFA-1 is indicated
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by increasing its affinity and can be achieved via different ways. The interaction between 
dendritic cells and T cells leads to an activation of LFA-1. Chemical reagents like PMA or 
antibodies against LFA-1 (KIM185) can also activate LFA-1. Another trick to increase the 
adhesion between LFA-1 and ICAM-1 is to cluster the LFA-1 molecules. In a normal 
situation they are equally distributed along the cell surface. Clustering the molecules to one 
side enhances the number of molecules and thus adhesion. This clustering of molecules is 
termed increasing the avidity. Taken together, high affinity (activation) and avidity 
(clustering) of LFA-1 in combination with many ICAM-1 molecules gives maximal adhesion.
Another adhesion molecule investigated in this thesis is DC-SIGN. This transmembrane 
protein belongs to the group of C-type lectins and is only present on dendritic cells. In 
contrast to LFA-1, DC-SIGN consists of one chain and binds to ICAM-2 and ICAM-3. DC- 
SIGN is constitutively active and binds strongly to both ligands. The number of DC-SIGN, 
ICAM-2, or ICAM-3 molecules on the cell surface (expression) needs to be regulated for a 
balanced adhesion. Endothelial cells do not express ICAM-3, therefore DC-SIGN on the 
dendritic cell can only interact with ICAM-2 on the cell of the blood vessel wall. ICAM-3 is 
predominantly expressed on T cells and is important for the interaction between dendritic 
cells and T cells in the lymph node. In this way, there exists a fine tuning between the 
different interactions of the cells in the immune system in order to function optimally. This 
process is described as an overview in chapter 1. The different aspects of interactions 
between the ICAMs and its receptors LFA-1 and DC-SIGN is closely studied in this thesis.
In chapter 2, LFA-1 is not only studied as an adhesion molecule, but also as a regulation 
or signaling molecule. ICAM-1 binds with very high affinity to LFA-1, ICAM-2 has a lower 
affinity, whereas ICAM-3 hardly binds to LFA-1. Ligand binding together with minimal 
activation of the T cell receptor (TCR) on leukocytes induces several signals in the T cell. 
Binding to ICAM-1, but not ICAM-3 leads to a strong proliferation. This indicates that the 
binding strength determines the degree of proliferation and thus activation of the T cell. 
Another result is that ICAM-1 promotes the secretion of cytokine IL-10. In contrast, ICAM-2 
and ICAM-3 induce predominantly the production of TNF-a. These data suggests that LFA-1 
is able to distinguish between the different ligands.
The role of the low affinity interaction between LFA-1 and ICAM-3 is investigated in 
chapter 3. Although it is clear that ICAM-3 is a poor ligand for LFA-1, the weak adhesion of 
LFA-1 with ICAM-3 enhances the binding of ICAM-1 to LFA-1. ICAM-3 is also important 
for activation of resting T cells. ICAM-3 induces clustering of LFA-1 on the cell surface 
(avidity) leading to strong binding of LFA-1 to ICAM-1.
Activation of LFA-1 is important for adhesion to ICAM-1. Previous studies demonstrated 
that the part of the ß-chain inside of the cell (ß2 cytoplasmic domain) plays a role in activating 
LFA-1. Deletion of the ß2 cytoplasmic domain results in a constitutive active and clustered 
LFA-1 molecule with high affinity and avidity. LFA-1 expressed on T cells can be activated 
by PMA. However, several leukemic T cells fail to respond to PMA. To study LFA-1 in these 
leukemic T cells, the model cell line K562 was used, which has no LFA-1 on the cell surface. 
LFA-1 expressed in K562 cells is unresponsive to PMA, similar as in several leukemic T 
cells.
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The region in the ß2 cytoplasmic tail responsible for this defect in PMA responsiveness 
of LFA-1 is characterized in chapter 4. The building stones (amino acids) of the ß2 
cytoplasmic domain are swapped for amino acids of the ß1 integrin that is PMA inducible. 
Substitution of a single amino acid at position 732 in the ß2 cytoplasmic domain completely 
restores the PMA responsiveness of LFA-1. In addition, the amino acid threonine at position 
758 is required for the restored PMA responsiveness. The new amino acid arginine (mutant 
L732R) does not increase the LFA-1 affinity, but results in clustering of LFA-1 on the cell 
membrane. The elevated avidity could possibly explain why LFA-1 is able to respond to 
PMA. It is likely that due to the clustering more signaling molecules are situated next to the 
cytoplasmic part of LFA-1, resulting in an enhancement of the PMA signal. The anchoring of 
LFA-1 to the skeleton of the cell (cytoskeleton) is vital for activation. The cytoskeleton keeps 
the cell in its shape and helps to move membrane proteins through the cell membrane. 
Blocking the function of the cytoskeleton by using the protein calpeptin inhibits the PMA- 
induced activation of LFA-1. This implicates that the cytoskeleton is involved in the 
activation of LFA-1.
The interactions between LFA-1 and its ligands ICAM-1, -2, and -3 described so far are 
all studied in static conditions present in lymph nodes. Leukocytes binding to endothelium in 
the blood vessel are constantly exposed to high flow forces of the blood. In order to study 
these interactions, a flow system was used in chapter 5, in which T cells are able to flow with 
a certain velocity on an ICAM-1 coated surface. This system closely mimics the situation in 
the blood vessel. T cells immediately stick via LFA-1 to the ICAM-1 coated surface under 
flow. K562 cells expressing LFA-1 do not arrest on ICAM-1, but display rolling adhesions. 
During the transendothelial migration, T cells first start rolling on the endothelium before they 
come to arrest mediated by LFA-1/ICAM-1 interactions. Rolling is mainly mediated by other 
adhesion molecules, such as selectins. The results in chapter 5 indicate that LFA-1 is able to 
support rolling when expressed in a different kind of cell. A possible explanation is that LFA- 
1 in K562 cells is differently attached to the cytoskeleton compared to T cells. This allows 
LFA-1 in K562 cells to roll on ICAM-1.
The influence of LFA-1 clustering on rolling under flow is described in chapter 6. LFA-
1 expressed in K562 cells, but also the clustered LFA-1 mutant L732R display rolling 
adhesions on ICAM-1. Surprisingly, PMA can activate both wild-type LFA-1 and the mutant 
version of LFA-1 to bind ICAM-1. The kind of adhesion assay seems to be important for the 
binding of LFA-1 to ICAM-1. The fact that LFA-1 does not respond to PMA in a static 
adhesion assay is probably due to the vigorous washing forces applied in this assay in contrast 
to the adhesion assay under flow. Another observation is that PMA has different effects on the 
activation of LFA-1 dependent whether LFA-1 is clustered or not. These experiments stress 
the importance of LFA-1 affinity and avidity in adhesion.
ICAM-2, and -3 are also ligands for the adhesion molecule DC-SIGN, which is 
exclusively expressed on dendritic cells. Like T cells, dendritic cells have to migrate via the 
blood system to the infection site. Since only ICAM-1, and -2 are present on endothelial 
cells, the role of the DC-SIGN/ICAM-2 interaction is investigated in chapter 7. DC-SIGN 
binds to ICAM-2 under flow, but not to ICAM-3. The adhesion to ICAM-2 results in rolling
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of DC-SIGN expressing cells. This suggests a role in the transendothelial migration of 
dendritic cells. Indeed, the transendothelial migration of dendritic cells in the presence of 
chemokines was mediated via DC-SIGN/ICAM-2 interactions. Thus DC-SIGN is not only 
involved in T cell activation but also in migration of dendritic cells.
The current views about the interaction of LFA-1 with several proteins involved in 
signaling and adhesion of LFA-1 is discussed in chapter 8. These proteins are for instance 
receptors that can influence LFA-1, proteins binding the cytoplasmic domains of LFA-1, 
molecules of the cytoskeleton, or even the localization of LFA-1 in the cell membrane. In 
addition, several hypotheses are described explaining why LFA-1 containing the point 
mutation L732R is clustered on the cell surface of K562 cells. Since LFA-1 and DC-SIGN are 
both expressed by dendritic cells, it is likely that a possible cross-talk between the receptors 
exists, which is also described in chapter 8.
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Samenvatting voor niet-ingewijden
Het menselijk lichaam beschermt zich tegen bacteriën, virussen, maar ook kanker, door 
gebruik te maken van een eigen afweer- of immuunsysteem. Het afweersysteem is een 
verzameling van zeer gespecialiseerde cellen waartoe de witte bloedcellen behoren die in 
technische termen leukocyten genoemd worden. Er zijn vele verschillende leukocyten met 
ieder een eigen functie, zoals de zogenaamde T cellen en dendritische cellen. T cellen 
ontstaan in de thymus en spelen een rol bij de directe vernietiging van indringers. Deze cellen 
moeten eerst instructies krijgen over waar ze naartoe moeten en wat ze moeten doen. Hiervoor 
zorgen de dendritische cellen die de eerste verdedigingslinie van ons afweersysteem vormen. 
Wanneer een infectie optreedt verzamelen de dendritische cellen informatie in de vorm van 
kleine eiwit deeltjes die uniek zijn voor de bacterie of kankercel. Vervolgens gaan de 
dendritische cellen met de eiwit informatie van de infectieplaats via de lymfevaten naar de 
lymfeklieren. Hier worden de eiwit deeltjes oftewel antigenen gepresenteerd aan de 
aanwezige T cellen. Tijdens deze overdracht van informatie zijn de interacties tussen de 
cellen heel belangrijk. Slechts enkele T cellen zullen het antigeen herkennen wat direct leidt 
tot een sterke vermenigvuldiging van deze T cellen (klonale expansie). De geactiveerde T 
cellen verlaten de lymfeklier en gaan via de bloedbaan op weg naar de geïnfecteerde weefsels 
om de bacterie- of virusgeïnfecteerde cellen te doden. Het geïnfecteerde weefsel zorgt ervoor 
dat er allerlei signaaleiwitten geproduceerd worden zoals cytokines en chemokines. Deze 
stoffen zorgen er voor dat de gemobiliseerde T cellen naar de geïnfecteerde cellen gaan. Op 
de plaats van bestemming moeten ze eerst nog uit het bloedvat treden om bij de geïnfecteerde 
cellen te komen. Dit wordt transendotheliale migratie genoemd. Het hechten van de T cellen 
aan de bloedvatwand (endotheel) speelt hierbij een cruciale rol. Dit uittreden vindt in een 
aantal stappen plaats. Eerst dient de snelheid van de T cellen te worden afgeremd. Dit gebeurt 
door korte interacties met de bloedvatwand waardoor de cellen gaan rollen. Vervolgens 
komen ze geheel tot stilstand en gaan ze tussen de cellen van de bloedvatwand door naar de 
plaats van de infectie. Uiteindelijk zullen de T cellen aan de virusgeïnfecteerde cellen hechten 
om ze uit te schakelen.
Voor deze immuunreacties blijken dus erg veel verschillende interacties tussen cellen 
nodig te zijn, zoals dendritische cel met T cel, T cel met endotheel en T cel met 
virusgeïnfecteerde cel. Om deze verbindingen tot stand te brengen zijn de cellen uitgerust met 
diverse gespecialiseerde eiwitten op het celoppervlak die adhesiemoleculen genoemd worden. 
Een belangrijke groep van adhesiemoleculen zijn de integrines. Ze bestaan uit een complex 
van een a  en ß keten die aan elkaar gekoppeld zijn. LFA-1 is een integrine dat alleen 
voorkomt op de leukocyten, waaronder T cellen en dendritische cellen. Een klein gedeelte van 
het transmembraan eiwit LFA-1 bevindt zich in de cel. Het grootste deel zit op de buitenkant 
van de cel. Dit gedeelte van LFA-1 kan binden aan drie verschillende eiwitten (liganden) die 
op het oppervlak van cellen voorkomen. Dit zijn de intercellulaire adhesie moleculen-1, -2 en 
-3 (ICAM-1, -2 en -3). De adhesie tussen LFA-1 en ICAM-1 speelt bijvoorbeeld een rol bij de 
transendotheliale migratie waarbij de T cel met LFA-1 bindt aan ICAM-1 op de endotheelcel.
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Als dit continu zou plaatsvinden dan zullen op den duur alle in het bloed aanwezige T cellen 
gaan plakken aan de bloedvatwand. Dit kan tot verstopping en eventueel een infarct leiden. 
Om dit te voorkomen is LFA-1 niet altijd in staat om te binden aan ICAM-1. Indien nodig kan 
LFA-1 dus geactiveerd worden om aan ICAM-1 te binden. Daarnaast kunnen de cellen ook 
ICAM-1 van hun celoppervlak weghalen of juist extra veel ICAM moleculen erbij zetten 
waardoor er een sterkere binding (adhesie) optreedt. Het activeren van LFA-1 heet ook wel 
verhogen van de affiniteit en kan op verschillende manieren plaatsvinden. Zo zorgt de 
interactie tussen dendritische en T cellen ervoor dat LFA-1 geactiveerd wordt. Ook chemische 
stoffen zoals PMA of zelfs antilichamen tegen LFA-1 zoals KIM185 kunnen LFA-1 
activeren. Een andere truc om de adhesie tussen LFA-1 en ICAM-1 te verhogen is door de 
LFA-1 moleculen dichter bij elkaar te laten zitten. Normaal zitten ze gelijk verspreid op het 
celoppervlak, maar door ze allemaal naar één kant te laten komen zijn er veel moleculen 
samen die voor een sterkere adhesie kunnen zorgen. Dit bij elkaar trekken of clusteren van de 
moleculen is het verhogen van de aviditeit. Dus een sterke affiniteit (activatie) en aviditeit 
(clusteren) van LFA-1 samen met veel ICAM-1 moleculen geeft een maximale adhesie.
DC-SIGN is een ander adhesie molecuul dat in dit proefschrift onderzocht is. Dit 
transmembraan eiwit behoort tot de groep van C-type lectines en komt alleen maar voor op 
dendritische cellen. In tegenstelling tot LFA-1 bestaat DC-SIGN maar uit één enkele keten en 
kan alleen maar binding aan ICAM-2 en ICAM-3. Aangezien DC-SIGN continu actief is kan 
het dus altijd zeer sterk binden aan zijn beide liganden. Het aantal DC-SIGN, ICAM-2 of 
ICAM-3 moleculen op het celoppervlak, oftewel expressie, moet er dus op die manier voor 
zorgen dat er een uitgebalanceerde adhesie plaatsvindt. Zo is er geen expressie van ICAM-3 
op endotheel waardoor DC-SIGN op de dendritische cel alleen met ICAM-2 op de 
bloedvatwandcel kan binden. ICAM-3 zit voornamelijk op T cellen en is belangrijk voor de 
interactie in de lymfeklier tussen een dendritische en T cel. Zo ontstaat er dus een 
nauwkeurige afstemming van de verschillende interacties van cellen in het immuunsysteem 
om optimaal te functioneren. Dit proces staat beschreven als overzicht in hoofdstuk 1. In dit 
proefschrift zijn de diverse aspecten van de interacties tussen de ICAMs en zijn receptors 
LFA-1 en DC-SIGN nader onderzocht.
In hoofdstuk 2 wordt LFA-1 niet alleen als adhesie molecuul bestudeerd, maar ook als 
regulatie- of signal erings molecuul. ICAM-1 blijkt met zeer hoge affiniteit te binden aan 
LFA-1, ICAM-2 met iets lagere affiniteit, terwijl ICAM-3 nauwelijks aan LFA-1 bindt. 
Ligand binding samen met een minimale activatie van de T cel receptor (TCR) op leukocyten 
leidt tot verschillende signalen in de T cel. Ten eerste vindt er een sterke celdeling 
(proliferatie) plaats door ICAM-1, maar nauwelijks door ICAM-3. Dit geeft aan dat de 
bindingssterkte bepalend is voor de mate van celdeling en dus activatie van de T cel. Een 
andere bevinding is dat ICAM-1 zorgt voor de productie van het cytokine IL-10. Daarentegen 
geeft ICAM-2, en -3 voornamelijk productie van TNF-a. LFA-1 is dus in staat om 
onderscheid te maken tussen zijn verschillende liganden.
De rol van de lage affiniteit interactie tussen LFA-1 en ICAM-3 wordt in hoofdstuk 3 
nader bestudeerd. Hoewel het duidelijk is dat ICAM-3 een slecht adhesieligand voor LFA-1 
is, blijkt de zwakke adhesie van LFA-1 aan ICAM-3 de binding van ICAM-1 aan LFA-1 te
194
Summary/Samenvatting
versterken. ICAM-3 is ook belangrijk voor de activatie van rustende T cellen. ICAM-3 doet 
dit door LFA-1 te laten clusteren op het celoppervlak (aviditeit) waardoor dus ICAM-1 beter 
aan LFA-1 kan binden en signaleren.
Activatie van LFA-1 is belangrijk voor adhesie aan ICAM-1. Eerder onderzoek heeft 
aangetoond dat het gedeelte van de ß-keten dat in de cel zit, dus het ß2 cytoplasmatisch 
domein, een rol speelt bij de LFA-1 activatie. Het weghalen van het ß2 cytoplasmatisch 
domein leidt namelijk tot een continu actief en geclusterd LFA-1, dus hoge affiniteit en 
aviditeit. LFA-1 op T cellen kan met PMA geactiveerd worden, maar dit is niet het geval in 
diverse leukemie T cellen. Om het gedrag van LFA-1 in leukemie cellen te onderzoeken is 
uitgeweken naar een model cellijn K562 die zelf geen LFA-1 op het oppervlak heeft. Het tot 
expressie brengen van LFA-1 in K562 cellen geeft een LFA-1 molecuul dat niet met PMA te 
activeren is, net zoals in sommige leukemie cellen.
In hoofdstuk 4 wordt de regio in het ß2 cytoplasmatisch domein gekarakteriseerd dat 
verantwoordelijk is voor deze defecte PMA activatie van LFA-1. De bouwstenen 
(aminozuren) van het ß2 cytoplasmatisch domein zijn uitgewisseld met aminozuren van de ß1 
integrine die wel te activeren is met PMA. Het vervangen van slechts één enkel aminozuur op 
positie 732 in het ß2 cytoplasmatisch domein geeft een volledig herstel van de PMA 
activeerbaarheid van LFA-1. Daarnaast blijkt dat het aminozuur threonine op positie 758 
nodig is voor deze herstelde activatie van LFA-1. Het nieuwe aminozuur arginine (mutant 
L732R) heeft geen verhoging van de affiniteit tot gevolg, maar juist een clustering van LFA-1 
op het celoppervlak. Deze toegenomen aviditeit is mogelijk een verklaring waarom LFA-1 nu 
wel kan reageren op PMA. Waarschijnlijk zijn er door de clustering meer 
signaleringsmoleculen bij het cytoplasmatisch gedeelte van LFA-1 waardoor het signaal van 
PMA versterkt kan worden. De verankering van LFA-1 aan het skelet van de cel (cytoskelet) 
is ook belangrijk voor de activatie. Het cytoskelet zorgt ervoor dat de cel zijn vorm behoudt 
en dat membraaneiwitten kunnen bewegen over het celoppervlak. Het hinderen van de functie 
van het cytoskelet met het eiwit calpeptin heeft tot gevolg dat LFA-1 niet meer door PMA te 
activeren is. Dit impliceert dus dat het cytoskelet betrokken is bij de activatie van LFA-1.
De tot nu toe beschreven interacties tussen LFA-1 en zijn liganden ICAM-1, -2, en -3 zijn 
allemaal bestudeerd onder rustende condities zoals die bijvoorbeeld voorkomen in de 
lymfeklieren. In de bloedbaan staan leukocyten die binden aan het endotheel echter 
voortdurend onder druk door het stromen van het bloed. Om nu deze interacties te 
onderzoeken is in hoofdstuk 5 gebruik gemaakt van een "flow systeem" waarmee T cellen 
met een bepaalde snelheid stromen over een oppervlak met daarop ICAM-1. Op deze manier 
wordt dus de situatie in een bloedvat nagebootst. T cellen gaan direct plakken aan ICAM-1 
onder "flow" via LFA-1. K562 cellen die LFA-1 tot expressie brengen blijven niet vast zitten 
aan ICAM-1, maar gaan juist rollen over dit oppervlak. In de transendotheliale migratie gaan 
T cellen eerst rollen op het endotheel en komen dan pas tot stilstand via LFA-1/ICAM-1. Het 
rollen wordt voornamelijk gemediëerd via andere adhesiemoleculen, de selectines. Uit de 
resultaten blijkt echter dat ook LFA-1 indien aanwezig in een ander soort cel ook instaat is om 
cellen te laten rollen. Een mogelijke verklaring is dat LFA-1 in K562 cellen anders aan het
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cytoskelet vastzit in tegenstelling tot T cellen. Dit heeft tot gevolg dat LFA-1 in K562 wel kan 
rollen op ICAM-1.
In hoofdstuk 6 is de invloed van het clusteren van LFA-1 op het rollen zoals in 
voorgaand hoofdstuk beschreven nader onderzocht. LFA-1 in K562, maar ook de geclusterde 
LFA-1 mutant L732R zijn in staat om onder "flow" te rollen op ICAM-1. Opmerkelijk is dat 
toevoeging van PMA zowel het normale LFA-1 als de gemuteerde vorm van LFA-1 kan 
activeren. Het soort adhesietest is dus van belang voor de binding van LFA-1 aan ICAM-1. 
Het feit dat LFA-1 niet te activeren is met PMA in een adhesietest onder rustende condities 
komt waarschijnlijk doordat de krachten tijdens de test op LFA-1 hier veel groter zijn dan met 
een adhesietest onder flow. Een andere belangrijke bevinding is dat PMA verschillende 
effecten heeft op de activatie van LFA-1 afhankelijk of LFA-1 wel of niet in geclusterde 
toestand aanwezig is. Deze experimenten onderstrepen dus het belang van affiniteit en 
aviditeit van LFA-1 bij adhesie.
ICAM-2, en -3 zijn ook liganden voor het adhesiemolecuul DC-SIGN dat alleen op 
dendritische cellen voorkomt. Evenals T cellen moeten dendritische cellen ook via de 
bloedbaan migreren naar plaatsen van infectie. Aangezien alleen ICAM-1 en -2 op endotheel 
voorkomt en niet ICAM-3, is in hoofdstuk 7 onderzocht wat de rol van de DC-SIGN/ICAM-
2 interactie is. Het blijkt dat onder flow DC-SIGN niet kan binden aan ICAM-3, maar wel aan 
ICAM-2. Deze adhesie heeft tot gevolg dat de cellen via DC-SIGN gaan rollen. Dit suggereert 
een rol bij de transendotheliale migratie van dendritische cellen. Onder invloed van 
chemokines vindt er DC-SIGN/ICAM-2 gemediëerde transendotheliale migratie plaats. Dus 
DC-SIGN speelt naast T cel activatie ook een centrale rol bij de migratie van dendritische 
cellen.
Tenslotte wordt in hoofdstuk 8 de huidige inzichten beschreven over de interactie van 
LFA-1 met diverse eiwitten die betrokken kunnen zijn bij de signalering en adhesie van LFA- 
1. Bij deze eiwitten kan gedacht worden aan andere receptoren die LFA-1 beïnvloeden, 
eiwitten die direct binden aan de cytoplasmatische domeinen van LFA-1, moleculen van het 
cytoskelet, of de lokalisatie van LFA-1 in de celmembraan. Daarnaast wordt getracht om een 
verklaring te geven waarom LFA-1 met de mutatie L732R in een geclusterde toestand op de 
celoppervlak van K562 cellen voorkomt. Daar LFA-1 en DC-SIGN samen tot expressie 
komen op dendritische cellen is het aannemelijk dat ze met elkaar kunnen communiceren. 
Hoe ze dit doen en of dit werkelijk voorkomt wordt in dit laatste hoofdstuk beschreven.
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Abbreviations
AA amino-acids
Ab antibody(ies)
Ag antigen
APC antigen presenting cell
[Ca2+]i intracellular calcium
CLSM confocal laser scanning microscopy
CR3 complement receptor 3
DC dendritic cell
DC-SIGN DC-specific ICAM grabbing non-integrin
DMSO dimethylsulfoxide
ECM extracellular matrix
EDTA ethylenediaminetetraacetate
EGF epidermal growth factor
ELISA enzyme-linked immunosorbent assay
ERK extracellular signal-regulated kinase
FAC focal adhesion complex
FACS fluorescence activated cell sorter
F-actin filamentous actin
FAK focal adhesion kinase
Fc fragment crystallizable
FCS fetal calf serum
FITC fluorescence isothiocyanate
FN fibronectin
GAM goat-anti-mouse
GFR growth factor receptor
GTPase guanine triphosphatase
HEV high endothelial venules
HSA human serum albumin
HUVEC human umbilical vein endothelial cells
I domain inserted domain
ICAM intercellular adhesion molecule
IFN interferon
Ig immunoglobulin
IL interleukin
ILK integrin linked kinase
IPB immunoprecipitation buffer
IP10 IFN-y induced protein-10
kD kilo Dalton
LAD leukocyte adhesion deficiency
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LFA lymphocyte function-associated antigen
LIBS ligand induced binding site
LPS lipopolysaccharide
mAb monoclonal antibody(ies)
MAPK mitogen activated protein kinase
MARCKS myristoylated alanine-rich C kinase substrate
MIDAS metal ion dependent adhesion site
Mig monokine induced by IFN-y
MIP-3ß macrophage inflammatory protein-3ß
OD optical density
PAGE polyacrylamide gel electrophoresis
PBL peripheral blood lymphocytes
PBMC peripheral blood mononuclear cells
PBS phosphate buffered saline
PDGF platelet derived growth factor
PI3K phosphoinositol 3-kinase
PKC protein kinase C
PLC phospholipase C
PMA phorbol 12-myristate 13-acetate
PTK protein tyrosine kinase
PTP protein tyrosine phosphatase
Rack1 receptor for activated protein kinase C
RANTES Regulated upon Activation, Normal T cell Expressed and Secreted
RT room temperature
SD standard deviation
SDS sodium dodecyl sulfate
SDF-1 stromal cell-derived factor-1
SH Src homology
TCA thymus-derived chemotactic agent
TCR T cell receptor
TM transmembrane
TNF tumor necrosis factor
VCAM vascular cell adhesion molecule
VLA very late activation antigen
Wt wild-type
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